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ABSTRACT 
Integration of health services involves managing services to enhance quality for 
patient needs that cut across multiple services, providers and settings. The rapid 
growth of human immunodeficiency virus (HIV) has increased tuberculosis (TB) 
cases, and TB/HIV integration offers a unified strategy for control. This study 
evaluated TB/HIV integration in Ghana. The three sites evaluated applied  varying 
degrees of integration. A mixed methods approach comprised an uncontrolled 
before-and-after study involving 1330 TB cases, and qualitative interviews with 29 
providers and patients.  
TB treatment success was 51% before and 69% after integration [p<0.01; 
OR(95% CI)=2.17 (1.72 to 2.74)]. Treatment success increased in all sites after 
integration: 43% to 53% at the one-stop shop (OSS), 69% to 78% at the partially 
integrated site (PIS), and  46% to 78% at the referral site (RS). The change was 
significant only at the RS [(Χ2=64.54; p<0.01; OR(95% CI)=4.28 (2.97 to 6.18)]. HIV 
screening was highest (99%) at the OSS (Χ2=68.26; p<0.01), HIV-positive cases on 
CPT were highest (93.8%) at the RS (Χ2=9.29; p<0.01), and the PIS had the highest 
number (59.5%) on ART (Χ2=95.00; p<0.01). 
TB/HIV integration may improve TB treatment outcomes but effectiveness 
is difficult to ascertain due to study design limitations. TB treatment success and TB 
mortality might be more informative indicators for TB/HIV activities. TB/HIV 
outputs seemed unrelated to greater integration when compared across sites. This 
was probably due to existing barriers to integration including missed opportunities, 
provider fear of loss of influence, financial burden of illness, and stigma. Patient-
- v - 
provider interactions offered privacy and counselling but patients’ illness 
experiences were not explored, and there was lack of decision-sharing. Patients 
were also unaware of their right to dignity and respect, or their role in disease 
management. Facilitators of integration included direct supervision, mutual 
adjustment and standardisation.  
Recommendations include conducting more rigorous evaluation studies,  
including TB mortality in TB/HIV monitoring, prioritising health system 
strengthening instead of increasing degrees of integration, and improving patient-
centred care through provider communication and patient empowerment. 
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1 INTRODUCTION 
1.1  INTEGRATION OF HEALTH SERVICES 
Integration of health services is the organisation and management of health 
services so that people get the care they need, when they need it, in ways that are 
user-friendly, achieve the desired results and provide value for money (WHO 
2008a). It can also be defined as a coherent set of methods and models of funding, 
administrative, organisational, service delivery and clinical levels designed to create 
connectivity, alignment and collaboration between the different units of the health 
system (Kodner and Spreeuwenberg 2002). The aim is usually to enhance quality of 
care and life, and to improve consumer satisfaction and system efficiency for 
patients with problems that cut across multiple services, providers and settings. 
According to Kodner and Spreeuwenberg (2002) integration is a step in the process 
of health systems and health care delivery becoming more complete and 
comprehensive.  
Integration as an organisational concept has been successfully applied in 
management as a post acquisition process after a merger (Schweizer 2005),  to 
achieve process innovation in manufacturing (Ettlie and Reza 1992), and in the 
market context to achieve better competitive advantage and economic gains 
(Sobczak 2002). The integration of health services is promoted because it is 
anticipated to address the need for a comprehensive approach to service delivery 
in order to address fragmentation (WHO 2008a). Fragmentation is a state of 
differentiation that results when the integration required to achieve unity of effort 
in an organisation does not exist, and it results in problems associated with 
efficiency and quality i.e. duplication, gaps, inconsistencies and discontinuities in 
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the provision of services. Integration is therefore promoted for reasons including 
the following: 
 Integration bonds the different units or organisations together to ensure 
achievement of common goals and optimal results (Kodner and 
Spreeuwenberg 2002), 
 It is a means of organising health systems to offer universal access to a 
broad range of services as proposed through primary health care (WHO 
2008a), 
 There has been a dramatic increase in the funding for single-disease and 
population or group-specific programmes leading to concerns that this 
adversely affects less well-funded health priorities. Integration has the 
potential to promote efficient use of these resources to strengthen the 
health system and thus support these less funded health priorities, 
 Health services have been faced with resources constraints, especially 
human resource shortages in low-income countries. Integration is one of 
the strategies for using resources as efficiently as possible, 
 Some of the constraints to effective service delivery are common to several 
technical programmes, and integration offers a way of tackling some of 
these challenges and achieving goals together. 
Frequently health services integration results in a package of preventive and 
curative health interventions aimed at providing all appropriate interventions for a 
particular group of people, multi-purpose service delivery points which offer a 
range of services for a catchment population at one location and under one 
manager, or to achieve continuity of care over time between specific stages in the 
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life cycle of a specific health state or chronic condition. Integration can also be 
achieved through the organisation of policy-making and management so as to bring 
together decisions about different parts of the health services at different levels, or 
working across sectors to enable cross-sectional funding, regulation or service 
delivery (WHO 2008a). However despite the varying meanings that the word may 
infer, integration is believed to improve responsiveness, increase efficiency and 
thereby enhance performance. Introducing integration into TB and HIV services is 
anticipated to bring these potential efficiencies into their control.  
1.2 TB/HIV INTEGRATION 
The rapid growth of the HIV epidemic has led to a dramatic rise in the number of 
TB cases, and HIV-associated TB continues to increase even in countries with well-
organised national TB control programmes successfully implementing the WHO 
DOTS strategy (WHO 2004b). TB has become a major cause of morbidity and 
mortality in HIV patients, while HIV dramatically increases the risk of acquiring TB 
disease. This phenomenon suggests that existing control strategies for both 
conditions are inadequate, and closer collaboration is essential to improve 
diagnostic, care and prevention services for people living with TB and HIV. 
Integration of TB and HIV services is therefore intended to enhance collaboration 
between TB and HIV control programmes to provide a continuum of quality care at 
service delivery level (WHO 2004c).  Integration also provides a unified health 
sector strategy to control TB and HIV (WHO 2003).   
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1.3 PURPOSE OF STUDY 
The impact of HIV on TB has been increasing steadily in Ghana, a trend similar to 
that in many African countries (WHO 2010a, b). At the end of 2009, 12% of all new 
TB cases were HIV positive (WHO 2010b). Although Ghana is not in the top 22 TB 
endemic countries, and the HIV prevalence  of 1.9% among adults of 15 – 49 years 
(NACP 2010a) is among one of the lowest in Africa (UNAIDS 2010), the national HIV 
strategy has been to stabilise and then decrease HIV incidence rate (GAC 2005b).  
As part of the nation’s response to the TB and HIV dilemma, a technical and 
policy guidelines document was developed. This was in response to the demand for 
a more holistic approach to a growing tragedy, and in recognition that the existing 
structures and programmes of the NTP and NACP could not address the challenges 
associated with TB/HIV and the gaps in the health services delivery. Due to lack of 
resources for a nationwide implementation, the implementation strategy has 
therefore been gradual and incremental so that evidence of effective 
implementation can be acquired to inform upscale of the programme to all districts 
nationwide and for efficient use of limited resources. This study is therefore 
intended to generate recommendations to inform the improvement of TB/HIV 
integration based on lessons learnt from initial implementation sites to improve 
service delivery to TB/HIV patients, and support better control of both TB and HIV 
in the country. 
1.3.1 AIM OF THE STUDY 
The aim of the study is to evaluate TB/HIV services so as to gather evidence for the 
improvement of the integration of TB and HIV services in Ghana and facilitate 
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effective implementation and nation-wide scale-up. The objectives and research 
questions are outlined below. 
1.3.2 OBJECTIVES AND RESEARCH QUESTIONS 
Objectives Research Questions 
1. To explore the effects of TB/HIV 
services  integration on TB 
treatment outcomes 
 Has the integration of TB and HIV services 
affected TB treatment outcomes ? 
2. To compare different service 
delivery models of TB/HIV 
activities 
 Does increasing degrees of integration 
improve TB/HIV outputs? 
 What would be the best  TB/HIV service 
delivery model? 
3. To explore the influences of 
provider- and patient-related 
factors on TB/HIV outputs and 
outcomes 
 How does provider behaviour influence 
TB/HIV outputs and outcomes? 
 How do patient experiences and behaviours 
influence TB/HIV outputs and outcomes? 
 
1.4 STUDY BACKGROUND 
In 2003 I was recommended by the Director of the University Hospital where I 
worked as a medical officer to attend a training programme on the management of 
tuberculosis (TB). This was organised by the National TB Control Programme (NTP) 
of Ghana aimed at training more health workers as part of measures to expand 
access to management by the DOTS strategy. Subsequently I was given the 
responsibility of making up a TB control team and establishing a TB programme in 
the University Hospital, which was done in January 2004.  
As a team we observed that most patients improved significantly by the end 
of the intensive phase of TB treatment and throughout the continuation phase. 
However, there were some who did not, while others would improve initially and 
deteriorate in the continuation phase. Further investigations revealed most of 
these patients who did not improve or deteriorated after initial improvement were 
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HIV positive as well. We therefore decided to subsequently screen all TB patients 
for HIV. This generated a personal interest in the TB and HIV interaction, which 
eventually led to the desire to do a research programme in the area. My interest in 
TB/HIV also coincided with the period in Ghana when the TB and HIV control 
programmes were organising a series of meetings towards formation of a national 
TB/HIV technical workgroup to develop a national policy.  
I developed the proposal for this study in consultation with the National 
Programme Managers as a way of identifying what the national needs and interests 
were. This research was therefore done in fulfilment of a personal career objective 
as well as the desire to contribute to the nation’s quest to meet the needs of 
patients with TB and HIV.  
1.5 RELEVANCE OF STUDY 
The study will generate timely recommendations for improvement of TB/HIV 
integration in Ghana based on lessons learnt from initial implementation sites, and 
this will inform scale-up of collaborative TB and HIV services in all districts in 
Ghana. The study will examine how indicators approximate to national targets to 
provide information on how well integration has been achieved. In addition the 
study will identify barriers of the intervention underlying the observed indicators 
and that threaten to undermine effective evaluation, as well as components that 
have facilitated integration.  
  Due to the limited evidence of effectiveness, the focus of TB/HIV integration 
research globally has been to generate more evidence in different settings towards 
more effective control of the dual epidemic (WHO 2004c). This study will provide 
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information on integration in a context with high TB burden and low HIV incidence 
with comparison of different service delivery models in sub-Saharan Africa: an area 
in which there is a paucity of research evidence. Implementation research  like this 
study provides decision-makers with information to identify solutions to problems 
that limit program quality, efficiency and effectiveness, or to determine which 
alternative service delivery strategy would yield the best results (Remme et al. 
2010; WHO 2008c)  
Findings of the study will inform policy formulation, evaluation, and  
implementation in the area of integration in health services in general and TB/HIV 
services specifically with respect to the transferable findings that can be applied in 
similar settings.  
1.6 STUDY OUTPUTS 
The primary output of this study is a thesis to be submitted towards the award of a 
PhD. For more effective dissemination and to improve the utility of the research 
findings academic publications in conferences and journals will be generated, 
particularly with regard to the comparison of service delivery models and the 
influences of provider and patient behaviour on integration in sub-Saharan Africa. 
In order to enhance the potential for the findings to be embedded in TB/HIV 
practice in Ghana there has been an on-going partnership with the national 
programmes. This partnership has involved making presentations at the annual 
NTP stakeholders’ meeting 2010 in Accra and at the biannual NACP stakeholders’ 
conference in August 2009 in Tamale both in Ghana. Other opportunities to sustain 
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this partnership will be through participation in national workshops where relevant 
findings will contribute to the review of interventions and guidelines. 
The NTP in Ghana has been allocated funding from the GFATM for the 
strengthening of monitoring and evaluation. The findings of this study will be 
submitted to facilitate the exploration of strategies to achieve this end. 
1.7 THESIS OUTLINE 
Below is a brief of each chapter as presented in this thesis after this introductory 
chapter: 
 Chapter 2 is a review of the literature on TB/HIV integration with a focus on 
sub-Saharan Africa because of the location of the study and the fact that 
the region bears the biggest burden of both TB and HIV, 
 Chapter 3 is the chapter in which the relevant concepts relating to 
integration and integrated care are reviewed. Subsequently the conceptual 
framework for the study is developed and used to inform the research 
questions and methods,  
 Chapter 4 is used to describe the specific design and methods of data 
collection and analysis, including the underlying reasons justifying each 
choice, 
 In Chapter 5, the setting of the study is defined by describing the relevant 
local context: there is an introduction of the Ghana Health System and the 
hospitals, which served as study sites. I also used this chapter to describe 
what TB/HIV in Ghana had involved, 
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 Chapters 6 and 7 were the first two of three results chapters and were used 
to summarise the quantitative findings in addressing the first and second 
study objectives, 
 Chapter 8 summarised the findings of the qualitative study as the last of the 
results chapters, and also used to integrate the qualitative and quantitative 
results,  
 In Chapter 9 there is a summary of all the key findings of the study, the 
implications of the findings, and recommendations for policy, practice and 
future research,  
 Chapter 10 provides a summary of the study aims and objectives as well as 
the key findings and recommendations arising from the previous chapter. 
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2 TUBERCULOSIS (TB) AND HIV INTEGRATION 
2.1 INTRODUCTION 
The interaction between the tuberculosis (TB) and the HIV pandemics has 
magnified the disease burden of both TB and HIV especially in sub-Saharan Africa 
(WHO 2010a, b; Getahun et al. 2007). The implications of this interaction on the 
clinical presentation, diagnosis and effective treatment of either disease have 
made their control even more challenging. The need for new approaches and more 
effective strategies has been the main driving force behind TB and HIV services 
integration which is anticipated to provide access to seamless comprehensive care 
for TB/HIV co-infected patients (WHO 2004c). The purposes of this chapter are: 
 To explain the rationale for TB and HIV integration,  
 To do a comparative analysis of TB/HIV activities and service delivery 
models in sub-Saharan Africa, and  
 To identify barriers and facilitators of TB/HIV integration in sub-Saharan 
Africa. 
The findings of this review will provide a description of TB/HIV practice in sub-
Saharan Africa and be used to define and characterise the different service delivery 
models to be studied. 
2.2 TUBERCULOSIS  
TB is a disease caused by a bacillus called Mycobacterium tuberculosis and is the 
oldest of the world’s current epidemics. TB exposure means an individual has come 
in contact with the bacilli but the body’s responses were sufficient to prevent the 
bacilli from proliferating. A person is said to have TB infection when they have 
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viable but dormant bacilli in their body i.e.  they are not ill and they do not transmit 
the disease either. TB disease occurs when the host immune responses are unable 
to prevent the bacilli from proliferating and spreading in the body. This then 
progresses to physical symptoms. TB is most commonly found in the lungs 
(pulmonary), but may occur outside the lungs (extra-pulmonary).  
2.2.1 TRANSMISSION 
The primary source of TB infection is airborne transmission from a patient with 
pulmonary TB (PTB). PTB patients with cavitary lesions discharge massive amounts 
of the bacteria in respiratory secretions when they sing, cough or sneeze. 
Transmission is direct between human hosts with no intermediary hosts (Iseman 
2000). Transmissions from non-pulmonary sources are much less common. 
2.2.2 PATHOGENESIS AND IMMUNITY 
Once M. tuberculosis bacilli get into the lungs they are engulfed by macrophages, 
and the bacilli proliferate if the macrophages are unable to destroy them. Host 
defences to TB are mediated by macrophages and T-lymphocytes which work to 
destroy or prevent the bacilli from proliferating.  However the bacilli also primarily 
multiply in the same macrophages, and therefore if the macrophages fail to 
prevent bacilli proliferation the macrophages are destroyed as the bacilli multiply 
and spread, and host immune response is also initiated. 
 There are two main types of host immune response: acquired cellular 
resistance by which macrophages inhibit or kill the bacilli, and tissue-damaging 
immune responses that contain the bacilli. In most cases the body is able to 
successfully control the TB at this stage, keeping the infection as a latent one for 
life. For individuals in whom the immune response is not adequate, the primary 
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infection progresses to TB disease. This commonly occurs in children below 5 years, 
elderly people and people who are immune-compromised (Iseman 2000). Disease 
progression leads to cavitations, the patient starts expectorating the bacilli and is 
capable of transmission. This is primary infection. For individuals with latent 
infection, circumstances that compromise their immunity can also lead to 
reactivation of the infection and progress to TB disease and spread (Iseman 2000).  
2.2.3 TB CLINICAL PRESENTATION 
Most symptoms are related to the lungs and the commonest are cough, chest pain, 
haemoptysis and shortness of breath. Common constitutional symptoms are 
malaise, weakness, fever, sweats, and loss of appetite. Extra-pulmonary TB (EPTB) 
most commonly occurs in infants, the elderly, and in adults with compromised 
immunity. The clinical presentation of EPTB depends on the site of the disease in 
addition to subtle or minimal constitutional signs (Iseman 2000).   
2.2.4 DIAGNOSIS OF TB 
The commonest diagnostic techniques are tuberculin skin test (TST), sputum smear 
for AFBs or culture, molecular biology techniques, tissue biopsies and radiographic 
techniques. TST sensitivity is lowered when there is anergy i.e. where a patient fails 
to mount adequate immune response due to advanced age, extreme wasting, 
overwhelming or disseminated TB, HIV or debility. TST specificity is also affected by 
other mycobacterial organisms and is therefore used as a diagnostic aid  ( Siddiqi, 
Lambert and Walley 2003; Iseman 2000). Sputum and other specimens are used for 
smear staining or cultures to identify the bacilli. They are more specific but the 
cultures are slow (Lawn 2009). Molecular biology techniques are theoretically more 
sensitive, and are able to distinguish M. tuberculosis from other types, and are also 
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able to identify resistant strains. Chest x-rays pick up characteristic abnormalities 
and help estimate the probability of TB infection. Typical findings are apical 
scarring in the lungs, calcified hilar nodes and the primary site of infection. X-rays 
and ultrasonography studies of other involved body parts may be relevant for EPTB 
(Iseman 2000). 
2.2.5 TREATMENT OF TB 
Current WHO recommendations for first-line anti-TB drugs for adults are Isoniazid 
(H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E) and Streptomycin (S). For new 
patients presumed or known to have drug-susceptible TB, the recommended 
treatment is a 6-month regimen made up of two months intensive phase with 
HRZE, followed by 4 months continuation phase with HR (2HRZE/4 HR). Drugs are 
to be taken daily but could be given three times a week if daily doses are not 
possible (WHO 2009). The intensive phase of retreatment regimen with first line 
drugs is made up of two months of SHRZE, followed by another month with HRZE. 
This initial 3-month treatment is followed by 5 months of HRE. Treatment duration 
is 8 months (2HRZES/1HRZE/5HRE). Different successful models of treatment for 
multi-drug resistant (MDR) TB exist: using a standardised regimen for all patients or 
tailor-made treatments for individuals based on drug susceptibility test patterns 
(Wells et al. 2007).  
2.3 IMPACT OF HIV INFECTION ON TB 
HIV is a sexually transmitted infection, but can also be spread through blood and 
blood products. The virus affects the lymphocytes which mediate immune 
responses and therefore an infected person progressively loses the capacity to 
protect the body from pathogens. AIDS occurs when the infection progresses to a 
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stage where physical symptoms manifest. HIV infection damages the lymphocytes 
and alveolar macrophages responsible for mediating immunity against TB by 
progressively depleting them or making them dysfunctional (Iseman 2000). A 
patient with HIV infection, especially with advancing disease, may therefore not be 
able to mount adequate immune response to a TB infection so they are more likely 
to progress to TB disease, or have the reactivation of latent infection.  
 However, research also suggests that HIV-positive TB patients may be less 
infectious because they remain infectious for a shorter period, due to rapid 
progression of the disease and higher mortality (Reid et al. 2006; Corbett et al. 
2006). Therefore impact of HIV on TB is mainly on the incidence of TB disease and 
deaths but much less through increased transmission or new infections (Corbett et 
al. 2006). As demonstrated in figure 1, HIV infection increases the likelihood of a 
primary lesion progressing to TB disease or reactivation of a latent infection. The 
interaction between TB and HIV acts both ways because the immune response to 
TB bacilli also leads to accelerated HIV replication. It is therefore likely to have 
increased HIV viral load at anatomical sites of TB and within the systemic 
circulation (Lawn 2009). 
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Figure 1: Impact of HIV on TB transmission cycle (adapted from Iseman 2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1 TB/HIV EPIDEMIOLOGY 
People living with HIV are about 20 – 40 times more likely to develop TB during 
their lifetime (WHO 2010a). High HIV prevalence has persistently been associated 
with high TB prevalence rates in Africa. In 2009, out of 9.4 million new TB cases 
worldwide, 12% (1.1 million) were also HIV positive, as compared to 37% in the 
Africa region (WHO 2010a). And within Africa itself, TB incidences are much higher 
in the countries with high HIV prevalence (WHO 2006).  
2.3. 2 PRESENTATION AND DIAGNOSIS OF HIV-ASSOCIATED TB 
Clinical presentation of HIV-associated TB is altered because immunity is 
progressively impaired as the HIV infection advances. Anergy and EPTB are more 
Transmission 
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Protective cellular and tissue-damaging immune responses occur 
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Inhalation of infection, proliferation & dissemination 
Bacilli survive and proliferate in macrophages 
Macrophage is killed and bacilli released 
More macrophages ingest bacilli and are killed 
Bacilli proliferate  and spread locally, to lymph nodes, and 
systemically 
Host fails to mount effective response 
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May spread to extra-pulmonary sites 
Patient expectorates bacilli 
Bacteria killed or proliferation limited 
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Latent infection for life HIV impact  
HIV impact  
16 
 
frequent in HIV infection. Other signs and symptoms are prominent fever, weight 
loss and multifocal EPTB. There is also a reduced likelihood of the development of 
cavitations due to the inadequate tissue-damaging immune response. Sputum 
smears are therefore increasingly likely to be falsely negative with advancing HIV 
infection because there will be fewer bacilli in expectoration resulting in increasing 
numbers of smear negative PTB (Getahun et al. 2007; Iseman 2000). Culture 
though could be positive where smears are falsely negative but may need a longer 
incubation period because of lower levels of bacilli (Getahun et al. 2007).  
 TST becomes even less sensitive due to the diminishing immune response. 
Chest x-ray findings are also atypical: confluent pneumonia, lower zone infiltration, 
hilar or paratracheal adenopathy, pleural effusions, miliary shadowing, or even 
normal x-rays (Lawn 2009). Accurate diagnosis of TB in HIV positive patients is 
therefore delayed (Havlir et al. 2008; Getahun et al. 2007; Iseman 2000).  
2.3.3 TREATMENT OF HIV-ASSOCIATED TB 
Many uncertainties exist about when to initiate treatment of HIV-associated TB 
disease because of the interaction between TB and HIV drugs, and the idiopathic 
immune reconstitution syndrome (IRIS) that may occur. However current 
recommendations are that newly diagnosed HIV cases should start TB treatment 
first, followed by antiretroviral therapy (ART) as soon as possible and within the 
first 8 weeks (WHO 2009). The choice of ART should include those with minimal 
interactions with TB drugs as recommended.  If patients are already on ART, TB 
treatment should still be as soon as possible, and ART modified (WHO 2009). 
 For HIV-associated TB the dosing has to be daily and not three times a 
week, because intermittent TB therapy in HIV-positive patients has been associated 
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with higher incidence of relapse and failure (Khan et al. 2010). Co-trimoxazole 
preventive therapy (CPT) is initiated as soon as possible as well, and continued 
throughout to reduce mortality (WHO 2009).  Isoniazid preventive therapy (IPT) is 
recommended to reduce illness and death among HIV-positive patients  (Balcells et 
al. 2006). HIV-positive TB patients may therefore have a large number of drugs, 
may experience more side effects, and this may adversely affect compliance. 
 The impact of HIV on TB is also reflected on the treatment outcomes, and 
this impact is more prominent in Africa where HIV incidence is high. Although Banu 
Rekha et al. (2007) suggest that there does not seem to be any significant 
difference in sputum conversion rates between HIV-positive and HIV-negative TB 
cases, HIV-positive cases have been associated with increased risk of failure and 
relapse (Khan et al. 2010). Mortality among HIV-positive TB patients is higher than 
in HIV-negative ones, but this could even be higher because death may occur 
before diagnosis or registration (Reid et al. 2006). Elliot et al. (1995) observed that 
HIV-positive TB patients were 5 times more likely to die than HIV-negative cases.  
2.4 RATIONALE FOR TB/HIV INTEGRATION 
The interaction between TB and HIV has had a profound impact on the control of 
both diseases, especially in TB endemic areas with concomitant high HIV 
prevalence rates as in sub-Saharan Africa (WHO 2010 a, b; Getahun et al. 2007). As 
described in the preceding sections, this interaction impedes the host’s capacity to 
mount adequate immune response, resulting in more cases of TB disease, atypical 
clinical presentations, diagnostic challenges, increased likelihood of adverse 
outcomes, and increased transmission of drug-resistant TB strains among HIV-
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positive patients (Johnson and Catherine 2006; Valadas and Antunes 2005; WHO 
2004c). Effective control therefore requires more appropriate and effective 
diagnostic techniques and management strategies.  
 TB and HIV programmes generally have some structural and philosophical 
differences (Table 1) that have limited their interaction in the past. 
Table 1:Differences in TB and HIV Programmes (Anderson and Maher 2001) 
TB HIV 
Structural differences 
 Managerially vertical with personnel 
at national, regional and district 
levels 
 TB care accessible in institutional 
and community health facilities  
 
 Centralised strategic planning 
departments with fewer but 
growing staff 
 Comprehensive HIV care mainly 
accessibly in health institutions and 
not communities 
Cultural and Philosophical differences 
 Long history of a well-researched 
treatable disease 
 Strong public health focus to deliver 
medical solutions 
 
 Short history of an emerging 
disease, preventable but not curable 
 Stronger focus on human rights, 
confidentiality, and involvement of 
infected and affected people. 
Initially promoted behavioural 
interventions 
Focus 
 Implementing DOTS strategy 
 
 Prevention and control 
 
Both programmes had initially focussed on implementing their individual core 
activities but the changing epidemiologies of both diseases which resulted from 
their interaction has compelled a broader approach and better interaction between 
the two programmes. Integration of TB and HIV services has therefore been seen 
as a mechanism to transcend these programmatic differences to  facilitate the 
changes needed to address current TB and HIV challenges (WHO 2008a).  
19 
 
Integration as an organisational concept is believed to improve responsiveness, 
increase efficiency and thereby enhance performance through: 
 Facilitation of the co-ordination of activities and reduction of errors leading 
to improved quality, and 
 Greater effectiveness through higher innovation, and improved inter-
functional communication and synergies (Barki and Pinsonneault 2005). 
Integrated care, as detailed in Chapter 3 (p. 62), involves changing care processes 
and multidisciplinary collaborations that ensure continuity of care, enhanced 
coordination, and makes care more patient-centred (Grol et al. 2007). The 
integration of health services has been defined by the WHO as the organisation and 
management of health services so that people get the care they need, when they 
need it, in ways that are user-friendly, achieve the desired results and provide 
value for money (WHO 2008a). The integration of TB and HIV care has therefore 
been promoted for these reasons: 
 Integration is a mechanism for identifying those in need of care through 
screening, especially in low income countries where large-scale screening is 
not possible due to resource constraints, 
 Resources are used more efficiently by using existing infrastructure and 
staff with improved communication, and the minimisation and possible 
elimination of duplication, and 
 Integration provides entry points and access to comprehensive care which 
improves quality of care and health outcomes for both TB and HIV (WHO 
2008a). 
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2.5 TB/HIV POLICY FRAMEWORK  
The WHO has provided leadership in the development and implementation of 
TB/HIV policies globally. Globally, the goal of the TB/HIV policy is to decrease the 
burden of TB and HIV in populations affected by both diseases: the objectives are 
to establish the mechanisms for collaboration, to decrease the burden of TB in 
PLHIV and to decrease the burden of HIV in TB patients (WHO 2004c). Policies are 
therefore intended to be implemented in conjunction with the existing core 
activities of TB and HIV control, rather than creating an independent control 
programme. For each policy objective there are recommended collaborative 
activities and strategies through which the objectives can be achieved, and these 
are to: 
 Establish the mechanisms for collaboration 
o Set up a coordinating body for TB/HIV activities effective at all levels 
o Conduct surveillance of HIV prevalence among TB patients 
o Carry out joint planning 
o Conduct monitoring and evaluation 
 Decrease the burden of TB in PLHIV 
o Establish intensified TB case finding 
o Introduce isoniazid preventive therapy 
o Ensure TB infection control in health care and congregate settings 
 Decrease the burden of HIV in TB patients 
o Provide HIV testing and counselling 
o Introduce HIV prevention methods 
o Introduce co-trimoxazole preventive therapy 
o Ensure HIV/AIDS care and support 
o Introduce antiretroviral therapy 
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Individual nations therefore develop their policies and collaborative activities based 
on WHO guidelines, in order to effectively address TB/HIV challenges. Although a 
detailed discussion of this policy is beyond this thesis, there have been suggestions 
for review of the policy to promote aggressive uptake of effective strategies 
because they have remained below global targets. Secondly the preventive role of 
ART, and the management of HIV-positive TB suspects have not been adequately 
addressed (Harries et al. 2010).  
2.6 TB/HIV INTEGRATION IN SUB-SAHARAN AFRICA 
2.6.1 INTRODUCTION 
Sub-Saharan Africa (SSA) bears the greatest burden of both TB and HIV pandemics 
(WHO 2010a, b; WHO 2006). Of the 33.3 million people living with HIV worldwide, 
67% (22.5 million) live in SSA, and 72% of the 1.8 million HIV deaths globally 
occurred in SSA. The prevalence of HIV in adults aged 15 - 49 years in SSA is 5% as 
compared to 0.8% worldwide. 2.3 million children below 15 years live with AIDS, 
and 230,000 children die of AIDS each year in SSA (UNAIDS 2010).  Of the 22 
countries with the greatest TB burden globally, 9 are in SSA, and therefore many 
sub-Saharan African countries have embraced the challenge and developed TB/HIV 
policies based on WHO recommendations.  
Southern Africa for instance remains the epicentre of the TB/HIV epidemic: 
almost 50% of all global cases of HIV-associated TB occur here (WHO 2010b; 
Harries et al. 2010). However implementation has been challenging and uptake has 
been low because there is no general research evidence of effectiveness of 
integrating strategies, and the best delivery models for TB/HIV activities are not 
known (WHO 2010c; Briggs and Garner 2006). Resources are limited, health 
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systems are weak, and human resource capacity for health is still a challenge in 
most countries. Sub-Saharan African countries therefore need to use existing 
strategies with innovation and more aggressively, and examine potential strategies 
to curb the TB/HIV. This review is therefore intended to use comparative analysis 
of TB/HIV practice in SSA to answer the following research questions: 
 What are the TB/HIV activities implemented, and the service delivery 
models used in SSA? 
 What are the barriers and facilitators of TB/HIV integration in SSA?  
2.6.2 METHODS 
A literature search was performed in different databases using different search 
terms to identify relevant articles (Appendix I, p. 254). Articles identified through 
the literature search were browsed and relevant ones selected, and further 
selection was done by reading through the abstracts of papers retrieved. 
References of selected articles were browsed for more articles and other relevant 
grey literature. A final selection of articles was made based on these inclusion 
criteria:  articles based in SSA, and involves only TB and HIV integration. Articles 
reviewing different programmes with no detailed descriptions were not included 
(Table 2).  
Table 2: Literature search inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Based in sub-Saharan Africa 
Involves only TB and HIV 
Involved general population 
Included TB and HIV diagnosis and 
management 
Only participants with XDR- or MDR-TB  
Specific population groups or ages 
Involved only single TB/HIV 
interventions 
Did not report on TB/HIV indicators 
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2.6.3 RESULTS 
The literature search methods identified 8 articles based on  different TB/HIV 
integration programmes across SSA (Table 3). In all 10774 articles were identified 
through the various search terms in the different databases, and after looking at 
the topics and reading abstract this number was reduced to 21. The 21 articles 
were further reduced after reading through and applying the inclusion criteria, and 
finally 5 articles were selected. Three more articles were included from references 
and other unpublished literature, and a final selection of 8 was made (Figure 2). 
These included one each from Kenya, Mozambique, Rwanda and Uganda, and two 
each from South Africa and Zambia.  The studies included 3 in which HIV services 
were added to existing TB service, another 3 in which both TB and HIV services 
were introduced into existing care. The remaining two studies involved the 
addition of TB service on to existing HIV services.  
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Figure 2: Flow diagram of article selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of articles identified 
with search terms 
n = 10774 
Selection through titles & abstracts  
n = 21 
Articles included in review n = 8 
Hand selection of references and 
other literature n = 3 
Did not meet inclusion criteria 
n = 12 
Irrelevant & repeated titles and 
abstracts n = 10753 
 
Articles identified from Medline 
OVIDSP with search terms 
n = 1031 
 
Articles identified from Science 
direct with search terms 
n = 8986 
 
Articles identified from Web of 
Knowledge with search terms 
n = 757 
Selection after reading abstracts  
n = 9 
Removal of duplicates n = 4 
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Table 3: Reviewed articles 
Author 
(s) 
Objective/Title Design / Methods Setting/ Participants Intervention Findings 
S. Miti et 
al 2003, 
Zambia 
 
 
To evaluate 
implementation of 
DOTS strategy as part 
of an existing 
HIV/AIDS home care 
programme  
Controlled post-
intervention study, 
observational. Data 
collected over 23 
months 
Poor, urban townships 
Introducing TB services 
into home care HIV 
programme in health 
centres. Involved all new 
TB cases 
Taking TB treatment at home 
for 1st 2 months in HIV 
programme 
HCP providing medical, 
nursing, welfare, 
psychological, spiritual & 
pastoral.  
Cure rate higher at intervention site, but not 
treatment success 
Better  follow up 
Default lower at intervention site 
No difference in transfer rates 
Micek 
2005, 
Moz’biqu
e 
To describe a strategy 
of integrating TB & 
HIV care 
Tuberculosis/HIV case 
study Descriptive 
Data collected over 14 
months 
Beira, provincial capital 
 
 
Adding TB screening &  
management to HIV 
programme 
 
Reduced morbidity and mortality in HIV 
patients but Low utilisation, Poor referrals by 
staff, High mortality & High loss to follow up 
MSF 
2005, S. 
Africa 
Report on the 
integration of TB and 
HIV services in Site B 
Khayelitsha 
Case  report Ubuntu clinic in 
Khayelitsha,  a poor, per-
urban, sub-district 
 
Upgrade HIV clinic to one-stop 
shop. 
 
Integration of services feasible 
Context-specific flexibility is important. 
Uptake of services increased  
M. 
Gasana 
et al 
2008, 
Rwanda 
To report on the 
results of integrated 
TB and HIV activities 
at a rural health care 
site 
Case study/report, 
before-and-after, 1yr 
before & after, 
Uncontrolled 
Rural district hospital and 
health centre located  
adjacent to each other 
 
Introducing strategies to 
improve referral between TB  
& HIV centres: TB/HIV focal 
person, Joint meetings, Staff 
training, PICT & patient 
support  
Increasing uptake of PICT & TB case 
detection. TB-HIV focuses services for 
patient benefit 
J.B. Harris 
et al 
2008, 
Zambia 
To report  the 
integration of TB and 
HIV services in 
primary care 
Uncontrolled before-
and-after study 
Phased 
implementation  
 7 Public primary care 
centres  in Lusaka, mainly 
urban 
 
 
Introduce strategies to 
implement TB/HIV 
integration: TB/HIV 
coordinating committee, 
guidelines, modified patient 
records 
 
Increased case detection, Improved 
referral, communication & follow-up. 
Increased access to ART among co-infected 
patients 
Improved yet low enrolment at HIV clinic, 
low utilisation 
N.R. 
Gandhi et 
al 2009, 
S. Africa 
To demonstrate 
feasibility, 
effectiveness & 
safety of TB/HIV 
integration in a rural, 
Prospective 
operational research 
Follow up for 1 year 
Rural district hospital 
with home-based care. 
Poor  rural area 
 
 
Concomitant TB & ART 
treatment by modified DOTS 
With transition to self-
administered ART after TB 
treatment 
Median of 67 days to ART initiation after 
TB treatment started 
Increased CD4, reduced viral loads. 
Improved TB treatment outcomes.   
Integration of TB and HIV treatment is safe 
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resource-limited 
setting 
 and effective 
R. Okot-
Chono et 
al 2009, 
Uganda 
To identify health 
provider, facility, 
patient & community 
barriers affecting 
implementation of 
TB/HIV activities 
Mixed methods 
FGDs, in-depth 
interviews, secondary 
data. Purposive 
sampling 
5 districts in 3 of 4 
regions, peri-urban or 
rural. Involved TB, HIV & 
TB/HIV patients, 
providers & community 
members. 
 
Referral between services 
8 months TB treatment 
ART started within 2 – 8 
weeks of TB treatment 
 
Low utilisation of services 
No TB/HIV data at HIV clinics 
Poor uptake of integration 
Barriers to TB/HIV implementation arise 
from health system e.g.  staff shortages, 
increasing workload, lack or irregular 
supply of drugs   
H. 
Huerga et 
al 2010, 
Kenya 
To evaluate short- & 
medium- term 
impact of an 
integrated TB/HIV 
programme on 
patient care and TB 
outcomes 
Retrospective, before 
– and- after study, 
uncontrolled, record-
based.  
Rural area. HIV care 
integration into a TB 
clinic,  
 
 
 
Increased uptake of services 
EPTB increased slightly 
Improved TB outcomes 
No difference in default or failure 
No difference in outcomes of HIV- & HIV+ 
on ART. Success & death rates worse in 
HIV+ /no ART & unknown HIV status 
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The articles involved 1 controlled post-intervention study (Miti et al. 2003), 3 
uncontrolled before-and-after studies (Huerga et al. 2010; Harris et al. 2008; 
Gasana et al. 2008), 1 prospective study (Gandhi et al. 2009), and 3 cross-sectional 
studies (Okot-Chono et al. 2009; MSF 2005; Micek 2005). The controlled post-
intervention study involved 72 patients at the intervention site and 96 at the 
control site (Miti et al. 2003). The two sites had similar socio-economic 
backgrounds. The mean age of participants was 32 years at both the intervention 
and control sites. Sex ratio (male: female) was 1:2 at the intervention site and 1:1 
at the control site. The study demonstrated that integrating TB treatment and 
monitoring into a home-based HIV care programme may improve adherence but 
not death rates. 
The uncontrolled before-and-after studies were record-based evaluations 
on the impact of integration of different aspects of patient care. The common 
indicator in all 3 studies was HIV screening among TB patients. Huerga et al. (2010) 
examined the impact of integration by studying 3 periods: 6 months before 
implementation (before), 6 - 12 months after (short-term), and 18 - 30 months 
after implementation (medium term). It involved 1323 TB patients: 409 before, 437 
short-term after, and 477 medium-term after. There was no difference in TB 
treatment success rates between HIV-negative TB patients (82%) and HIV-positive 
patients on ART (76%) at p < 0.27. Death rates were also not different between the 
two groups: no death in HIV negative patients and a single death in the HIV-positive 
patients on ART (p < 0.60). However treatment success rates in HIV-positive TB 
patients not on ART (66%) and those with unknown HIV status (52%) were 
significantly worse (p < 0.01). The findings of the study suggest that integration 
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improves case detection and management of HIV among TB patients, and thereby 
improve TB treatment outcomes.   
Gasana et al. (2008) also studied records 12 months after integration and 
compared indicators before and after integration. Uptake of provider-initiated 
counselling and testing (PICT), and case detection of HIV among TB patients as well 
as TB among HIV patients increased. Harris et al. (2008) on the other hand reported 
only on HIV screening in TB patients, and how many enrolled in the ART 
department. There was a phased implementation of integration in 7 primary care 
centres over 20 months. Data was collected 3 months before and 3 months after 
implementation. 1983 patients with unknown HIV status were counselled. 
Although integration increased detection of HIV cases, uptake of PICT and the 
enrolment for HIV care were relatively low.  
There was one prospective evaluation of the feasibility, effectiveness and 
safety of adding once-daily dose of anti-retroviral (ARV) to a home-based TB 
treatment programme (Gandhi et al. 2009). 119 patients were enrolled and 
monitored over 12 months. Median increase in CD4 cell count was 151 cells/mm3 
at 6 months and 211 cells/mm3 at 12 months. Patient weight also increased by an 
average of 6.5 kg at 6 months and 10.5 kg at 12 months. 93% of patients also 
attended follow up within 1 day of scheduled visits. In this study using existing TB 
(DOTS) structures to deliver ART was found to be feasible, effective and safe. 
The review included 3 retrospective evaluations made up of one mixed 
methods study (Okot-Chono et al. 2009), and two case reports (MSF 2005; Micek  
2005). Okot-Chono et al. (2009) conducted an operational research to identify 
provider, facility, patient and community barriers to implementation of integration. 
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Because of lack of efavirenz-based types which can be given with rifamycin-based 
anti-TB regimens, patients had to wait till intensive phase is completed before 
starting ART. For patients already on ART, it has to be suspended for the 2 months 
of intensive phase of TB treatment. If screening referred to health providers using a 
screening tool to determine which patient to test sputum for AFBs, then patient 
opinion may not be a valid way of assessing screening.  
The first case report (MSF 2005) involved the integration of TB services into 
an HIV clinic but reported only on HIV screening among TB patients and partially on 
the impact of ART. There were many missed opportunities for testing TB patients 
for HIV. There were no results on TB treatment outcome and TB screening among 
HIV patients. Micek (2005) reported on integration after collecting data covering 14 
months after integration. ART was not universally accessible, and capacity to give 
CPT was limited. There were no comments on HIV screening actually done, and no 
references to the TB treatment outcomes of other TB patients because the report 
appears to be restricted to findings from the HIV clinic that introduced TB 
screening.  
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Table 4: Quality of evidence 
Author (s) Design Results Quality characteristics Grade of 
evidence 
A B C D E F 
S. Miti et al 
2003, 
Zambia 
 
Controlled post-
intervention study 
Cure rates 54.1% at intervention site and 20.8% at control site. 
No difference in treatment success and deaths 
Lower default rates at intervention site (8.3%) as opposed to 22% in control site 
√ √ √ √ X √ ++++ 
H. Huerga 
et al 2010, 
Kenya 
Uncontrolled 
before-and-after 
study 
Changes in indicators seen before to short term and medium term after integration: 
HIV screening increased from 79% in short term to 91% in the medium term. 
CPT increased from 49% to 93% and to 86%  
ART increased from 9% to 46% and to 41%  
Treatment success increased from 56%, to 58% and to 71%. 
Death rate changed from 8% to 10% and 3% 
No difference in outcomes of HIV-negative cases and HIV-positive cases on ART  
√ √ X √ X √ 
+++0 
M. Gasana 
et al 2008, 
Rwanda 
Uncontrolled 
before-and-after 
study 
87% HIV screening, 72% on CPT and 42% on ART. 
Proportion of TB patients with known HIV status increased from 82% before to 93% 
after integration. 
48% of HIV cases screened for TB, 26.7% tested 
√ √ X √ √ √ 
+++0 
J.B. Harris 
et al 2008, 
Zambia 
Uncontrolled 
before-and-after 
study 
77% HIV screening and 59% enrolled at ART unit. 
Enrolment at ART unit increased by 38% 
√ √ X X X √ 
+++0 
N.R. 
Gandhi et 
al 2009, S. 
Africa 
Prospective  
study 
Treatment success was 84%, 9% died, 4% defaulted and 3% failed due to MDR and 
XDR TB. 
Viral load undetectable in 83% and 88% at 6 and 12 months respectively 
2 cases of IRIS at 56 and 63 days after ART initiation, but not severe enough to stop 
ART. 
√ √ X X X √ 
++00 
R. Okot- Mixed methods:  56% of 333 patients screened for HIV, 52% put on CPT and 12% on ART. 36% not on √ √ X X X √ ++00 
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Chono et al 
2009, 
Uganda 
descriptive 
quantitative 
study with focus 
group discussions 
and in-depth 
interviews 
CPT or ART. 
83% of patients not screened for HIV were not offered VCT 
CPT and ART shortages. 
No routine screening of HIV patients for TB. 
Health system barriers cause poor implementation and low utilisation. 
Micek 
2005, 
Moz’bique 
Descriptive study 141 TB cases identified from 1755 clinical visits. 24% died, and 41% defaulted. 
Only 141 out of expected 1663 co-infected patients seen at the HIV clinic. 
√ √ X √ X X 
+000 
MSF 2005, 
S. Africa 
Descriptive study 47% of 770 TB patients screened for HIV, 315 (40.9%) accepted. 
Viral load suppression in 93% in the 1st year. 
√ √ X X √ X 
+000 
 
 
Key: 
A – Clear focus 
B – Appropriate methods (appropriate design, acceptable recruitment, 
adequate sample size) 
C – Control group 
D – P-values 
E – Confidence intervals (CI) 
F – Valid results 
 
 
 
 
 
 
 
 
 
 
 
 
Grades of evidence (Dudley and Garner, 2011): 
++++  High: confident that true effect lies close to that of the estimate of 
the effect  
+++0  Moderate: true effect is likely to be close to that of the estimate of 
the effect 
++00  Low: true effect may be substantially different from the estimate of 
the effect 
+000  Very low: Any estimate of the effect is very uncertain  
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2.6.3.1 HIV SCREENING AMONG TB PATIENTS 
Five (5) out of the 8 articles reported on this indicator. Three of these (Huerga et al. 
2010; Harris et al. 2008; Gasana et al. 2008) reported screening rates between 77% 
and 91%, only Huerga et al. demonstrated a significant increase above levels before 
integration. Gasana et al. (2008) however observed a significant increase in 
proportion of TB patients with known HIV status, which was associated with a 38% 
increase in number of TB/HIV patient enrolment in the HIV clinic.  According to 
Micek (2005), only 8% of the estimated 1663 HIV-associated TB patients were seen 
at the HIV clinic. Lower screening levels of 56% (Okot-Chono et al. 2009) and 40.9% 
(MSF 2005) were also reported, signifying a lot of missed opportunities for 
screening: as many as 37% of eligible TB patients were offered no counselling and 
testing services at all, and 36% of those screened were not on CPT or ART (Okot-
Chono et al. 2009).  
A challenge in comparing these results however is the fact that Gasana et al. 
(2008), Harris et al. (2008)  and MSF (2005) reported on HIV screening among TB 
patients with unknown HIV status as compared to Heurga et al (2010) and Okot-
Chono et al. (2009) who referred to HIV testing among all TB patients. The 
numerators and denominators for these two groups of patients were therefore 
different and hence the cases. The first group referred to the proportion of patients 
with unknown HIV status who are screened, while the second would be the 
proportion of all registered patients who had a record of evidence of their HIV 
status.  
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2.6.3.2 CPT FOR HIV-POSITIVE TB PATIENTS 
This indicator was reported on by 3 articles. Huerga et al. (2010) demonstrated a 
significant increase in the proportion of HIV-positive TB patients put on this 
prophylaxis from 47% before to 93% after integration. Gasana et al. (2008) 
reported 72% of patients on CPT but Okot-Chono et al. (2009) reported only 52% 
due to lack of regular supply and the lack of human capacity. 
2.6.3.3 ART FOR HIV-POSITIVE TB PATIENTS 
The number of HIV-positive TB patients on ART increased from 9% to over 40% in 
the study by Huerga et al. (2010), and this was comparable to the 42% observed by 
Gasana et al. (2008). However the 12% observed by Okot-Chono et al. (2009) was 
rather comparable to the pre-integration levels in the Huerga et al. (2010) study. 
Gandhi et al.  (2009) observed that ART initiation was around 9 weeks after the 
start of TB treatment, and that being on ART was associated with significant 
increases in CD4 counts, viral load suppression, and weight gain. While Gasana et 
al. (2008) reported that viral load was undetectable in 88% of patients at 12 month, 
MSF (2005) referred only to viral load suppression in 93% but not the magnitude. 
2.6.3.4 TB TREATMENT OUTCOMES 
Huerga et al. (2010) demonstrated an increase in TB treatment success rate to 71%, 
but this was lower than the 84% observed by Gandhi et al. (2009). There was 
however no difference in success rates between the intervention and control sites 
in the Miti et al. (2003) study, although default rate was lower at the intervention 
site. Huerga et al. (2010) also observed no difference in TB treatment outcomes of 
HIV-negative TB patients and HIV-positive TB patients on ART. Micek (2005) 
reported on TB treatment outcomes for only the 141 TB patients managed at the 
HIV clinic: 24% died and 41% were lost to follow up. However no reasons for these 
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outcomes were available.  Resistant TB was responsible for all 3 failed TB 
treatments and 6 of the 13 deaths in the study by Gandhi et al. (2009). Four of the 
other 7 deaths were also suspected cases of resistant TB which were not confirmed 
prior to patient death. 
2.6.3.5 TB SCREENING AMONG HIV PATIENTS 
Gasana et al. (2008) established that only 48% of HIV patients were screened for TB 
and 3.7% of the 300 patients screened had active TB; lower than the 8% observed 
by Micek (2005).  
2.6.3.6 BARRIERS TO INTEGRATION 
In the TB/HIV programmes included in this review, most barriers described relate 
to the components of the programmes and implementation of the TB/HIV 
collaborative activities. Accordingly, these barriers are described here in relation to 
the health system components, namely leadership and governance, financing, 
information system, service delivery and barriers from other sources. 
Leadership and Governance 
Two out of the interventions cited lack of leadership in coordinating and 
supervising TB/HIV activities as barriers (Okot-Chono et al. 2009; MSF 2005). There 
was also reference to inadequate knowledge of the policy and the role of the 
provider. Providers did not display enough knowledge about the TB/HIV policy and 
seemed not to appreciate their roles and responsibilities in the success or 
otherwise of the integration. Patients were also not involved in planning (Okot-
Chono et al. 2009). 
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Financing 
The initial cost of integration remains high because of the capital required in 
training, infrastructure, supplies and drugs among other programme monitoring 
and evaluation systems. The cost of care to patients is also high and resource 
allocation for TB/HIV activities was not appropriately prioritised (Okot-Chono et al. 
2009; Gasana et al. 2008).  
Health Information Systems 
Difficulties associated with poor or too much documentation due to the separate 
information systems of the two programmes were the commonest complaints. 
Okot-Chono et al. (2009) also identified the lack of tools for recording TB/HIV 
activities in HIV units as a barrier to implementation. Also they observed that data 
collected was not adequately used in planning or given as feedback to communities 
to enhance coordination and compliance. 
Service delivery 
The commonest barriers were inadequate infrastructure and long waiting times 
due to increasing caseloads (Okot-Chono et al. 2009; Harris et al. 2008; MSF 2005). 
There is pressure on existing infrastructure, preventing expansion. In Uganda, this 
lack of infrastructure was the main hindrance to one-stop services (Okot-Chono et 
al. 2009). There was also the problem of privacy for HIV services, especially where 
existing TB services are to be used. Some TB services operated in open air spaces, 
not suitable for HIV services (Harris et al. 2008). Two programmes (Harris et al. 
2008; MSF 2005) also alluded to challenges with the diagnosis of TB in HIV patients 
due to atypical presentations. There were poor inter-clinic referrals, and patients 
complained of having to make too many visits (Okot-Chono et al. 2009). There 
were also problems with shortage of staff, and not enough trained staff. Coupled 
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with high staff attrition rates and increasing caseloads, staff become overburdened 
and de-motivated (Okot-Chono et al. 2009; Harris et al. 2008; Micek 2005). 
Medical Products 
In the Ugandan case there were frequent shortages of drugs and other supplies 
sometimes because procurement estimates were inaccurate or the process was 
delayed (Okot-Chono et al. 2009). Gandhi et al. (2009) also observed that drug-
resistant TB poses a challenge due to increased adverse outcomes.  
The above health system challenges presented as barriers to implementing 
integration irrespective of the degree. 
Cultural Beliefs 
In the Ndola (Zambia) case there was a high rate of loss to follow up because 
patients suddenly moved away without informing community volunteers or nurses. 
It is believed they do so for various cultural reasons. When family members think 
the patient may not survive the illness, they put pressure on the patient to move to 
the village where access to alternative care is greater, and funerals are cheaper. 
And then there was the belief that if an illness is caused by a spell cast by a 
neighbour, if the patient relocates the spell is broken (Miti et al. 2003). According 
to Harris et al. (2008), stigma may also pose a challenge for TB patients. Community 
members described ‘old TB’ which was believed to be curable, and ‘new TB’ 
referring to HIV-associated TB which was believed to be associated with immoral 
behaviour and incurable. Community members who are therefore perceived to 
have ‘new TB’ were more likely to be stigmatised. 
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2.6.4 DISCUSSION 
The articles and reports included in this study are from Eastern and Southern 
Africa, with none from Central and West Africa. This may be due to the fact that 
Central and West Africa bear a lower TB and HIV burden relative to the Eastern and 
Southern Africa (WHO 2010b). HIV prevalence in West and Central Africa range 
from 1.7% to 5.3% as compared to 5% to 28% in Southern and Eastern Africa. A lot 
of TB/HIV research has therefore been based in Southern Africa especially. More 
research from SSA countries with low HIV prevalence are required to provide a 
more comprehensive view of the burden and control of the twin epidemic. 
The studies reported  variable increases in key TB/HIV indicators, however the 
diversity in the study designs and other methodological considerations made it 
difficult to combine these and draw conclusions on these indicators. One of the 
sources of diversity was the types of indicators used. More than 12 different 
indicators were used in reference to different aspects of TB/HIV care, and there 
was no one indicator used by all studies. The commonest of the indicators used 
were HIV screening among TB patients (5 studies), death rates (4 studies), 
proportion of HIV-positive TB patients on ART (4 studies), proportion of HIV-
positive TB patients on CPT (3 studies), and TB treatment success rates (3 studies). 
Other indicators included TB treatment default and cure rates, proportion of TB 
patients with known HIV status, enrolment at ART units, patient weight gain and 
viral load. 
A second source of heterogeneity was the different samples used in the 
different studies. Five out of the papers included all cases of TB or HIV registered 
during the selected period of study while one used only HIV-associated TB cases. Of 
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the remaining 2 articles, one used all new TB cases while the other included only 
new smear-positive TB cases. There was also a wide variation in how long after 
integration the studies occurred and the study periods. The controlled post-
intervention study was conducted over 20 months after about 4 years of 
integration, while the 3 descriptive studies were conducted over 13 months 
immediately after integration, over 5 months after a year of integration, and over 9 
months after 2 years of integration. The 3 un-controlled before-and-after studies 
were also conducted  from 3 - 12 months before integration to 3 - 30 months after 
integration. These different time periods with different impacts of maturation and 
statistical regression (p. 122), made the results less comparable across study sites.   
Therefore multi-site studies with a common group of indicators are needed to 
facilitate comparison of TB/HIV services, and add to the knowledge to improve 
policy and practice.  
2.6.4.1 TEMPORAL INFLUENCE ON TB/HIV 
It was observed that the studies conducted earlier from 2003 to 2005 (MSF 2005; 
Micek 2005; Miti et al. 2003) generally had poorer indicator values compared to 
those conducted later. With respect to TB treatment outcomes Miti et al. (2003) 
reported an average of 55% treatment success rate, 20% deaths and 15% default. 
Death and default rates observed by Micek (2005) were 24% and 41% respectively. 
In comparison, treatment success rates for the later studies ranged between 76 – 
82% (Huerga et al. 2010; Gandhi et al. 2009, Harris et al., 2008, Gasana et al., 
2008), death rates 3 – 9% (Huerga et al. 2010; Gandhi et al. 2009), and default rate 
of 3% (Gandhi et al. 2009). 
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HIV screening among TB patients was 41% (MSF 2005) in the earlier years with no 
record of how many were on CPT or ART. From the later studies on the other hand, 
HIV screening ranged from 72% to 91% (Huerga et al. 2010; Gasana et al. 2008), 
and CPT and ART rates were 72 – 93% and 41 - 46% respectively (Huerga et al. 
2010; Gasana et al. 2008). Enrolment at HIV clinics was 8.5% (Micek 2005) earlier as 
compared to 59% (Harris et al. 2008).    
The studies span the 8 years from 2003 to 2010 inclusive. This period 
coincided with a season of global promotion of TB and HIV programmes 
collaboration through increasing awareness of their interaction, as well as the 
provision of resources and technical support. This resulted in a heightened level of 
commitment and goodwill that led to the introduction of many national TB/HIV 
policies and interventions. Consequently, as observed by the WHO, indicators for 
TB/HIV activities have steadily improved over these 8 years (WHO 2010a).  
The number of countries reporting on HIV screening among TB patients 
increased from 92 in 2002 to 143 in 2009. And the percentage of notified TB cases 
with known HIV status  also rose from 4.2% to 26% over the same period (WHO 
2010a). The number of HIV-associated TB cases on CPT or ART has also risen 
steadily to 75% and 37% respectively by the end of 2009. In the Africa region 53% 
of TB patients knew their HIV status by the end of 2009 with 15 countries reporting 
rates of 75% or more (WHO 2010a). CPT and ART rates among HIV-positive TB 
patients were 76% and 36% in 2009 in the Africa region. 
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Therefore the differences in the impact of integration observed between the two 
groups of studies have also been influenced by these global political and historical 
activities outside the study settings as well as the effect of maturation.    
2.6.4.2 TB/HIV ACTIVITIES 
Recognised TB/HIV activities include establishing mechanisms for collaboration 
between TB and HIV programmes, HIV testing of TB patients with CPT and ART for 
those who are HIV positive, intensified TB case-finding among HIV patients 
followed by IPT for those without active TB, and infection control in health care and 
congregate settings (WHO 2010a, b). These activities are intended to promote early 
detection, provide access to comprehensive care (WHO 2008a; Ghana Health 
Service 2007), reduce morbidity, improve survival and reduce transmission (WHO 
2010a; WHO 2004c). The TB/HIV programmes included in the review together 
involved HIV screening for TB patients, CPT for HIV positive TB cases, and ART for 
eligible TB patients.  
Uptake of these activities, although increasing, has however been 
persistently low globally (WHO 2010a, b). For HIV screening among TB patients, 
and CPT with or without ART for co-infected patients, uptake has been increasing 
since 2005: in 2009 26% of TB cases were tested for HIV globally, up from 8.5% in 
2005, 75% of HIV-positive TB cases were put on CPT and 37% (140,000 cases) on 
ART (WHO 2010b). In 2009 143 countries reported on HIV testing among TB 
patients as compared to 92 in 2003 (ibid). In the Africa region 53% of TB patients 
were tested for HIV, and 76% and 36% of co-infected cases respectively put on CPT 
and ART in 2009 (WHO 2010b). These are below global targets which were to test 
85% of TB patients for HIV; put 95% of co-infected cases on CPT, and 300,000 HIV-
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positive TB cases on ART by 2010 (WHO 2010a). Findings in this review also support 
this low intervention rates, with just one (Huerga et al. 2010) testing between 86% 
and 91% of TB cases for HIV after integration.   
Major bottlenecks to HIV screening among TB patients have been 
availability and utilisation (WHO 2010d). PICT is intended to ensure that every TB 
patient is offered counselling and testing but uptake has been below global targets  
due to many missed opportunities as a result of health workers not offering the 
service, patients not accepting to test, lack of trained staff, disconnected services, 
and poor referral systems leading to high loss to follow-up (WHO 2010c; Tribble et 
al. 2009; Okot-Chono et al. 2009).  These challenges, in addition to drug shortages 
and the lack of human capacity to deliver and monitor CPT, also affected CPT rates 
(WHO 2010c; Okot-Chono et al. 2009).  
The barriers to ART in SSA include lack of capacity for rapid decentralisation 
to improve access, determining eligibility for ART, drug-drug interaction and 
overlapping toxicities with anti-TB agents, and IRIS (TBCTA  2009; Havlir et al. 2008; 
McIlleron et al. 2007). ART has been proven to reduce morbidity and mortality in 
HIV patients, and to reduce TB transmission (Howard and El-Sadr 2010; Granich et 
al. 2009; Corbett et al. 2006). The improvement of survival was corroborated by the 
Huerga et al. (2010) study that demonstrated that there were no differences in 
treatment outcomes between HIV-negative TB patients and HIV-positive TB 
patients on ART. Kwange and Budambula (2010) also demonstrated that there was 
no significant difference in sputum conversion rates at 2- and 5-months between 
HIV-negative TB patients and HIV-positive TB patients on ART. Current research 
suggests that ART should be started early (Howard and El-Sadr 2010; Granich et al. 
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2009; Corbett et al. 2006), preferably as soon as a person tests positive for HIV 
(WHO 2010a; Granich et al. 2009), as opposed to current recommendations to use 
CD4 count of 350 cells/mm3 or less, or clinical staging of disease to determine who 
was eligible for ART (TBCTA 2009).  
Therefore as more and more HIV-positive patients are put on ART, more 
and more of them are going to have to take ART and anti-TB drugs together. This 
may mean more cases of IRIS which typically occurs within 6 weeks of ART 
initiation but may take up to months (McIlleron et al. 2007). On the other hand 
rifampicin therapy of 6 months or more, with daily therapy in intensive phase has 
been identified to be associated with lower risk of failure and relapse in HIV-
positive patients (Khan et al. 2010). Current research priorities therefore are the 
need to identify best models to deliver ART in hospitals and community level (WHO 
2010c), and how to provide adherence support and monitor adverse reactions 
(Howard and El-Sadr 2010).  
Screening HIV patients for TB was another activity, but in 3 of the studies 
(Okot-Chono et al. 2009; Harris et al. 2008; Gasana et al. 2008), it was not routinely 
done for all cases during clinical care but only for those who reported symptoms. 
This is as opposed to the intensified case finding promoted because  early diagnosis 
and treatment of TB is still an effective control strategy (Havlir et al. 2008). Only 
about 5% of PLHIV were screened for TB globally in 2009 (WHO 2010b), far below 
the 100% screening target (WHO 2010a). Challenges include the availability of 
sensitive screening tools and how often to screen (Howard and El-Sadr 2010). 
Improving uptake in SSA requires that barriers to these TB/HIV activities are 
addressed and best practices identified and replicated.  
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None of the review articles included IPT or reported on infection control as part of 
TB/HIV integration. IPT has been proven to be a safe, feasible and cheap way of 
reducing morbidity and mortality in HIV patients (Howard and El-Sadr 2010; 
Churchyard et al. 2007; Balcells et al. 2006; Grant et al. 2005), but uptake has been 
low (Howard and El-Sadr 2010; Harries et al. 2010). Combination of IPT and ART 
results in a significantly greater reduction in TB risk than does either treatment 
alone (Churchyard et al. 2007), however, globally less than 1% of PLHIV were on IPT 
by 2009 (WHO 2010b) as compared to the 10% target (WHO 2010a). Many reasons 
have been given for this low uptake of IPT by national programmes including the 
difficulty in diagnosing latent TB in PLHIV before IPT initiation (Reid and Shah 2009), 
and waiting to conduct local research on effectiveness and feasibility (Ghana 
Health Service 2007). Other concerns have been the fear that this may enhance the 
development of resistance to Isoniazid, and therefore reduce its effectiveness as a 
first line drug in treating new TB cases (Howard and El-Sadr 2010).  More advocacy 
and research is needed to improve IPT uptake by national programmes. 
Although infection control in congregate settings is an essential component of 
TB/HIV integration, it has not been accorded the same attention as other activities. 
Even though SSA bears the greatest burden of both diseases (WHO 2010a, b; WHO 
2006), none of the articles made any reference to that. More advocacy and political 
will is needed to give this activity the required support for uptake.  Delays in 
diagnosis facilitate nosocomial infections (Howard and El-Sadr 2010). Other 
challenges to infection control include overburdened clinics, crowded OPDs, long 
waiting times and lack of technological interventions (Howard and El-Sadr 2010, 
Chamie et al. 2010). 
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2.6.4.3 SERVICE DELIVERY MODELS 
The theory of integrated care proposes that improvement in patient care results 
from three key strategies namely patient-centred care, organizing the care 
continuum through multidisciplinary collaboration, and process improvement 
(Murray 2009; Grol et al. 2007). Care continuum is a reflection of the extent to 
which services are experienced as part of a coherent, coordinated and 
uninterrupted succession of events consistent with the patient’s medical needs and 
personal context (Haggerty et al. 2003; Shortell 1976). Continuity of care is 
achieved by bridging  the discrete  elements in the care pathway (Haggerty et al. 
2003) and it is strongly believed to be essential to high quality care  (van Walraven 
et al. 2010). Although there is strong evidence suggesting that continuity improves 
utilisation and patient satisfaction, evidence to support improved outcomes is 
more uncertain (ibid). Integrated services should therefore be organised in order to 
achieve the three main types of continuity, i.e. informational, management and 
relational as detailed in the theoretical review chapter (p. 67).  
Models of service delivery in TB and HIV integration refer to how 
collaborative activities are organised around existing services. These models are 
generally related to the continuum of integration, namely linkage, coordination or 
collaboration, and full integration [(Ahgren and Axelsson 2005; Glendinning 2003; 
Leutz 1999), Figure 3]. In this regard three main models of service delivery have 
been associated with TB and HIV integration based on the level of integration 
between the two units at the point of service delivery; namely referral, partially 
integrated or fully integrated (or one-stop shop) [(WHO 2010; Kachiza et al. 2010; 
Ghana Health Service 2007; Corbett et al. 2006), Figure 3]. On this basis the 8 
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programmes described in this review includes 2 referral models (Gasana et al. 
2008; Miti et al. 2003), 4 partially integrated models (Okot-Chono et al. 2009; 
Gandhi et al. 2009; Harris et al. 2008; Micek 2005), and 2 fully integrated models 
(Huerga et al. 2010; MSF 2005). 
Figure 3: Relation of TB/HIV service delivery models to continuum of integration 
 
 
 
 
 
Referral Model 
In the referral models no HIV activity occurs at the TB unit or vice versa. Patients 
are simply referred to the other unit to have screening done for either TB or HIV 
where applicable. The 2 referral programmes in this study used variants of the 
basic model. In the Zambian case at Ndola, there was a Home Care Programme 
(HCP) which is a part of the Catholic Church’s Integrated AIDS Programme (IAP) 
[(Fikansa 2005), Figure 4].  
Figure 4: Referral model variant 1 
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Administration and monitoring of TB treatment and ART was done in the 
community or patient’s home by the many volunteers and few nurses. The HCP 
also supervised sputum collection and transportation for testing.  
The other variant of the referral model was described in the Rwandan study 
by Gasana et al. (2008). They described a 3-unit referral system where the VCT 
centre for HIV was separate from the HIV clinical care and management unit 
(Figure 5). In this modified referral model the TB and HIV clinical care units were 
located in the District Hospital while the VCT centre was located in the Health 
Centre adjacent to the District Hospital. VCT is done at the health centre and not at 
the HIV clinical care unit in the hospital.  
Figure 5: Referral model variant 2 
   
 
 
 
TB screening and diagnostic services were also available at the health centre 
through the VCT centre. Diagnosed cases are therefore referred to the TB and HIV 
care units for the appropriate care. HIV cases that end up in the HIV clinical care 
unit from other VCT centres are all referred to the TB unit in the hospital where 
they can be screened for TB. And also TB suspects and cases from other sources 
that have not been screened for HIV are sent to the health centre for HIV 
screening. Referral models use ‘linkage’ where TB and HIV units relate through a 
referral system. TB and HIV centres are separate units in different locations or 
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within the same institution run by different staff referring cases one to the other. 
Patients have to attend two clinics, probably on different days, increasing both 
direct and indirect costs of care to patients (Friedland et al. 2007). The Malawi 
National TB/HIV Plan adopts this model for delivering TB/HIV services through the 
general health system (Friedland et al. 2007; Chimzizi et al. 2004). 
Recommendations for overcoming the challenges of this model are to synchronise 
clinics so they are held on same day for easy access by patients, and to administer 
anti-TB drugs and ARVs from the same point (Table 5). Other suggestions include 
decentralisation of ART from hospitals to health centres (Friedland et al. 2007).  
Table 5: Comparison of service delivery models 
Model Advantages Disadvantages/Barriers 
Referral Relatively low start-up cost and 
resource requirement 
Staff specialised in a particular care 
process 
Lower risk of infection from open TB 
cases  
Increased cost and inconvenience to patients 
Numerous visits required for needed care 
Disconnection of services 
Higher loss to follow up 
Higher case fatality rate & delays to ART 
initiation 
Partial 
Integration 
More convenient for patients 
Strong and effective communication 
between different units 
Discontinuities still exist 
Loss to follow up 
Different visits required for needed care 
Full 
Integration 
Better access to continuum of care 
Multi-tasked staff 
Most convenient to patients 
Fewer visits to access needed care  
Initial set-up very costly 
Patient overload and overworked staff 
Cross infection from open TB cases at the OPD 
 
Referral models offer low levels of all the three types of continuity because service 
experience is more likely to be incoherent and inconsistent due to the above 
challenges. Effective referral systems are critical to the success of these models. 
The referral system in the Rwandan model successfully increased TB and HIV case 
detection, but may have greater challenges for achieving continuity (Gasana et al. 
2008).  
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Partially integrated model 
The partially integrated models include all the programmes in which some HIV care 
activities occur at the TB unit or vice versa (Figure 6). HIV diagnosis and 
management therefore begins at the TB unit (Okot-Chono et al. 2009; Gandhi et al. 
2009), TB diagnosis is also initiated or done at the HIV centre (Micek 2005), or both 
(Harris et al. 2008). Patients are subsequently referred to the appropriate unit for 
further management. It therefore represents a wide range of models based on 
different levels of coordination and collaboration between TB and HIV services. 
Figure 6: Partially integrated model 
 
 
 
The differences between the partially integrated models are based on how much of 
HIV care takes place at the TB unit or vice versa. An increasing level of integration is 
reflected in how much of treatment of one condition occurs at the other unit, or to 
what extent synchronization of both clinics occur to improve access to both 
services. Kachiza et al. (2010) also described a partially integrated service as one in 
which services are separate but synchronized so patients receive services for both 
conditions on same day. Partially integrated model is expected to be more 
coherent and offer more continuity than a referral model because establishing 
informational and management continuity is expected to be relatively easier as 
compared to the referral model. However the challenges of relational continuity as 
described in the next chapter (p. 67) persist. 
TB Unit HIV Unit 
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In the Ugandan model only HIV pre-test counselling is integrated into the TB care. 
Patients are then referred to the HIV unit for testing and care if needed (Okot-
Chono et al. 2009). Gandhi et al.  (2009) also describe a model where HIV 
counselling and testing are incorporated into TB care at the TB unit. Another 
component of this particular programme was the integration of daily ART into the 
home-based directly observed TB treatment programme. Treatment monitoring 
was done at home by volunteers or family members. The case from Mozambique 
involves the integration of TB screening into an existing HIV care programme 
(Micek 2005). In Zambia, Harris et al. (2008) describe a ‘separate but linked’ 
integration programme. HIV counselling and testing is done at the TB centre, and 
blood samples for CD4 evaluation are forwarded if the patient is HIV positive. At 
the HIV centre TB screening is also done and positive cases referred for treatment. 
The more integrated these services are, the more likely they are to achieve 
continuity, and the more patient-centred care is likely to be. 
Fully integrated model 
This model is usually called a ‘one-stop’ service (Kachiza et al. 2010; Ghana Health 
Service 2007). In this model all TB and HIV services are provided in the same 
location by a team of providers. The programme from Kenya describes the 
integration of all HIV care into a TB service. HIV providers were brought in to make 
up a TB/HIV team which was trained in co-infection management (Huerga et al. 
2010). In the Khayelitsha model in South Africa, TB diagnosis and management was 
integrated into an HIV clinic. Here, existing staff were trained in TB and TB/HIV co-
infection management (MSF 2005). It was observed that the most integrated of TB 
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and HIV services are more commonly found in primary care (Huerga et al. 2010; 
Harris et al. 2008; MSF 2005).  
  The term ‘full integration’ of TB/HIV services has been used to describe 
various service delivery configurations. Leutz (1999) defines full integration as the 
pooling together of resources from the collaborating units to create new services 
with a single and common information system, and Shigayeva (2010) also refers to 
it as a merger of the two programmes.  However, integration in TB and HIV is not 
about creating a new programme out of the two but to identify effective ways of 
delivering their services together. Full integration in TB/HIV therefore refers to the 
provision of TB and HIV services under one roof, usually referred to as ‘one-stop 
shop or service’ and therefore this model has the greatest potential to provide 
continuity of care for TB/HIV co-infected patients and be more patient-centred.  
But it is also not without challenges (Table 5).  
The TB/HIV integration in Khayelitsha, South Africa (MSF 2005) and rural 
Kenya (Huerga et al. 2010) are examples of this and they demonstrated increased 
case detection and improved outcomes by offering a comprehensive package of 
care to the patient anytime they visit the facility but indicators were still below 
targets. Kachiza et al. (2010) suggested that this model was more effective at 
improving patient outcomes but had not provided adequate information on their 
methods to evaluate the validity of their findings.  
French et al. (2006) describe three variants of this fully integrated service: 
patient may be seen by one provider for all needs, or same provider but different 
sessions, or different providers in the same building (Figure 7). In Swaziland 
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proposed innovations at a regional TB diagnostic and treatment facility to address 
the risk of TB transmission included physical separation of confirmed and 
unconfirmed TB cases among HIV patients at the outpatients’ (Humphreys et al. 
2007). However none of the two articles with the one-stop shop delivery model 
made any references to how this may impact transmission of TB among patients or 
infection control. 
Figure 7: Variant models of one-stop shop 
 
Some authors suggest that the higher the level of integration, the better the 
service delivery (Kachiza et al. 2010; Friedland et al. 2007; French et al. 2006), and 
therefore the one-stop shop has been recommended or identified as the ultimate 
goal in many national policies (Okot-Chono et al. 2009; Ghana Health Service 2007; 
WHO 2004c).  
However Greenhalgh et al. (2004) propose that the success or otherwise of an 
intervention like integration is determined not just by the effectiveness of the 
intervention. Success of integration is influenced also by the multiple interactions 
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between the context within which it is introduced, and their impact on how the 
intervention is implemented.  
This review does not only demonstrate the paucity of research that compares 
different service delivery models but also does not provide any evidence to support 
that greater integration resulted in better indicators and outcomes. The different 
settings and study periods in the articles make comparison of results impractical: 
the articles range from 2003 to 2010 and major changes in practice occurred over 
that period (WHO 2010a, b; WHO 2009).  These studies therefore coincided with a 
time when there was global goodwill in addition to technical and financial support 
for TB/HIV research. These may therefore have contributed to the improvement in 
the indicators observed, making it erroneous to attribute the change to the 
integration itself. Therefore although the articles demonstrated varying degrees of 
improvement in indicators post-integration, it is not possible to compare findings 
and identify which model is most effective.  
2.6.4.4 BARRIERS OF INTEGRATION 
Barriers to integration arise from the differentiation or specialisation that accounts 
for the structural and cultural differences in the two programmes, and the political 
aspects of integration that may result in loss of territory, loss of influence and 
resources (p. 79). Barriers may also be encountered during  delivery of service. 
These implementation barriers arise from operationalising the intervention, and 
are a reflection on programme components and the general health system. The 
barriers are mainly staff shortages and high turnover, increasing workload, 
inadequate infrastructure, lack of or irregular supply of drugs and equipment, poor 
documentation, lack of resources (Harries et al. 2010). The findings of this review 
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are in line with general health system barriers, and they mainly affect availability 
and utilisation, but have no direct relationship with integration itself. Patients also 
complained of the high cost of accessing services, long waiting times and lack of 
prescribed drugs. Other barriers included the high adverse outcomes,  atypical 
presentations complicating diagnosis, and stigma.  
2.6.4.5 FACILITATORS OF INTEGRATION 
Highly differentiated systems require high degrees of integration in order to 
achieve organisational effectiveness in the face of differentiation (Glouberman and 
Mintzberg 2001a). Mechanisms of coordination are employed to enhance 
coordination to reduce the effect of differentiation (Sobczak 2002) and these are 
direct supervision, standardisation and mutual adjustment. Mutual adjustment is 
the most direct form of coordination: people involved simply adapt as work 
progresses through informal meetings, networking and quasi-formal arrangements 
like teams, task forces and work groups. In direct supervision, a manager or 
supervisor is appointed to ensure coordination occurs.  
Standardisation is used to define common procedures, tasks and results to be 
used by all collaborating partners. In TB/HIV integration this would be expected to 
be done by the national programme which develops guidelines and sets national 
standards. Standardisation of skills and knowledge is achieved by training different 
people in different skills, but each one knows what to expect from the other. 
Weingarten et al. (2002) for instance found that provider and patient education, 
reminders and feedback improved provider adherence to guidelines and protocols, 
and patient adherence to treatment. Standardisation of norms involves socialising 
people to work towards common expectations. A common culture is promoted so 
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that externalized controls are replaced by internalized attitudes. All the 
participants can therefore co-ordinate their effort because they just know what to 
do. Some of these mechanisms were identified in the review articles as portrayed 
in table 6. 
Table 6: Facilitators of integration 
Facilitating mechanisms Activities / strategies identified in review 
Direct supervision: hierarchy of 
authority created by appointing a 
manager /supervisor to ensure 
coordination occurs  
Home Care programme (Miti et al. 2003) 
Clinic manager  (MSF 2005) 
Electronic monitoring of follow-ups (MSF 2005) 
Coordinating committees (Harris et al. 2008) 
Standardisation of work: common 
tasks and procedures are specified 
through joint planning, protocols 
and guidelines 
National guidelines (Harris et al. 2008, Gasana et al. 2008) 
TB screening tool (Gasana et al. 2008) 
Modified TB patient cards to include TB/HIV activities 
(Harris et al. 2008) 
Standardisation of output: results 
or outcomes are standardised by 
setting performance targets. 
National and regional targets 
Standardisation of skills and 
knowledge: training different 
people in different relevant skills 
to knows what is expected of them 
and of others 
Training of providers (Harris et al. 2008, Miti et al. 2003)  
Education of patients, volunteers and family members (Miti 
et al. 2003, Harris et al. 2008, Gandhi et al. 2009, Huerga et 
al. 2010)  
Standardisation of norms: 
socialization is used to establish 
common values and beliefs to 
ensure that people work towards 
a common expectation 
Welfare and psychological support, spiritual and pastoral 
care (Miti et al. 2003) 
Mutual adjustment: involves 
flexible communication with peers 
to deal with problems adaptively 
and collaboratively as they work 
Same day HIV results and request of CD4 test for positive 
cases to reduce number of visits (Harris et al. 2008)  
Patients escorted by TB staff to enrol at HIV centre, or HIV 
nurses enrol patients at TB centre to reduce loss to follow-
up (Gasana et al. 2008) 
Travel money to reduce patient costs (Gandhi et al. 2009) 
Patient participation: Patients choose their supporter. 
Medication calendar used to facilitate / monitor patient 
adherence (Gandhi et al. 2009) 
2.6.5 LIMITATIONS 
The inclusion of only articles that described interventions which involved ART may 
have excluded other articles which described other innovative models, limiting the 
findings of this review. Another limitation is the fact that TB/HIV is usually 
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implemented concurrently with other TB and HIV programme activities and 
accounting for the effect of these individually can be problematic.  
These articles refer to studies conducted in an era where there was global 
emphasis on TB and HIV interaction and collaboration, leading a surge in political 
will for TB and HIV collaboration. These events would therefore influence TB/HIV 
integration and implementation, and serve as confounders to the study findings as 
these had not been accounted for. 
2.7 CONCLUSION 
The integration of TB and HIV services globally and in SSA as well is feasible with 
varying degrees of successes due to variations in policies and other local contexts. 
The commonest TB/HIV activities include HIV screening among TB patients, CPT 
and ART for those who are HIV-positive cases, and TB screening among HIV 
patients. However uptake of these has been low due to missed opportunities, lack 
of capacity to deliver and monitor interventions, as well as other health system 
barriers. IPT and infection control are less common activities, although they are 
feasible and safe. 
Three service delivery models of TB/HIV activities with varying degrees of 
modification and effectiveness are identified. Differences in resources, capacities 
and other local factors contribute to the adoption of which service delivery model 
is used and how these can be adapted to suit the local settings. Although many 
health system barriers to integration exist, training, education and other types of 
support are used to enhance integration. 
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2.7.1 LITERATURE AND RESEARCH GAPS 
This review identifies some knowledge gaps which present opportunities for more 
research to expand the frontiers of knowledge in this academic discipline. 
 Most TB/HIV studies have been based in Eastern and Southern Africa. 
However local context is an important determinant of successful 
integration, and therefore more research from other parts of SSA like West 
and Central Africa where HIV incidence rates are relatively lower are 
required. These would give a more balanced outlook of the twin epidemic in 
the region,  
 Research suggests that key TB/HIV interventions should be based on better 
implementation of existing policies, more widespread implementation of 
additional effective interventions, and rapid assessment of promising new 
approaches (Granich et al. 2009; Corbett et al. 2006). In recognition of the 
above, research is needed to explore the determinants of success or 
otherwise of TB/HIV integration in different contexts,  
 No best service delivery model currently exists, and therefore best 
strategies and optimal models to integrate and deliver joint TB/HIV 
activities should be a research priority as well (WHO 2010c),  
 This review suggests that innovations and adaptations of existing TB/HIV 
strategies can be effectively used to deliver TB and HIV services in resource-
limited settings. Most research in health service integration and TB/HIV 
integration in particular have been focussed on the providers with very few 
conducted to examine service user perspectives and experiences, and 
therefore there is limited knowledge on user-based factors promoting or 
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inhibiting integration (Gebrekristos et al. 2009; Corneli et al. 2008; Levin et 
al. 2006; Briggs and Garner 2006; Porter et al. 2002). It is recommended 
that operational research should be conducted to understand barriers to 
accessing services from both user and provider perspectives (WHO 2010c), 
 Other areas recommended for research to improve TB/HIV integration are 
various ways of up-scaling laboratory services, the impact of MDR and XDR 
on service delivery, and improving monitoring and surveillance (WHO 
2010c). 
In view of these knowledge gaps and research priorities, a thesis like this aimed at 
examining the service delivery models and impact of TB/HIV integration in West 
Africa is very relevant as well as timely. It will not only inform policy and practice in 
Ghana where the study will be based, but it will also be relevant to other nations 
with similar contextual factors and will provide new knowledge to add to the 
existing body of literature.    
In the next chapter, there is a discussion of integrated care as a concept and 
its theoretical underpinnings, as well as other related concepts. These are then 
used to develop a conceptual framework with which TB/HIV was studied.  
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3 THEORETICAL REVIEW 
3.1 INTRODUCTION 
Improving services is an objective of all health systems, and even more so in 
current times when research and technology, demographic changes and 
epidemiologic transitions are rapidly transforming health care (WHO 2007b). 
Service improvement may mean different things to the different types of providers 
and patients but however it is interpreted it involves change (Maher and Penny 
2005). Changing clinical practice is challenging, especially if it involves complex 
routines, better collaboration or the organisation of care. Theories are useful in 
understanding the interaction of factors at multiple levels that may influence the 
success or failure of the change intervention (Grol et al. 2007). The purpose of this 
chapter is therefore to review the relevant theories of TB and HIV services 
integration, and to use them to develop a conceptual framework for this study. 
 This chapter opens with a review of theories on changing health care, and 
then the theory of integrated care is discussed with reference to the underlying 
assumptions and the strategies used to achieve its impact. Subsequent sections 
address the dimensions of integration, and the application of integration in health 
systems. A conceptual framework used to analyse TB/HIV integration and inform 
the methodology is then described in the concluding section. 
3.2 THEORIES OF CHANGE IN HEALTH CARE 
Patient care is a primary function of all health systems. In today’s world, rapid 
technological development, and an overwhelming amount of research evidence, as 
well as the ever-changing needs of patients demands that patient care also changes 
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appropriately to match available knowledge and evidence. The effectiveness of any 
organisation depends on how successfully these change transitions are achieved 
(Hayes 2007). Change is therefore required to maintain or improve the 
effectiveness of health systems. There are four main categories of theories of 
change in health care, with each category made up of different types of theoretical 
approaches (Table 7). The four main categories are theories on factors related to 
individuals, theories on social context and social interaction as it relates to change, 
theories related to change in the organisational context, and theories related to the 
political and economic context of change.  
Table 7: Theories of change in health care (Grol et al. 2007) 
Category Types 
Theories on factors related to individual 
professions that influence change in 
performance 
- Cognitive theories 
- Educational theories 
- Motivational theories 
Theories on influence of the social context  
and social interaction on the change process  
- Theories of communication 
- Social learning theory 
- Social network and influence theories 
- Theories related to teamwork 
- Theories on professional development 
- Theories on leadership 
Theories on factors related to the 
organisational context 
- Theories of innovative organisations 
- Theory of quality management 
- Theory of integrated care 
- Complexity theory 
- Organisational learning theory 
- Theories of organisational culture 
Theories on factors related to the political or 
economic context 
- Reimbursement theories 
- Theory of contracting 
 
The empirical evidence of the effectiveness and feasibility of most theoretical 
approaches to produce intended change in health care is limited so conclusions 
about the relative superiority of any theory based on evidence from healthcare is 
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not easy to come by. However some theories seem to be more suitable and 
effective for particular changes and innovations (Grol et al. 2007). 
The theory of integrated care is an example of the theories related to the 
organisational context. This group of theories target changing patient care through 
structural and organisational conditions and reforms e.g. more efficient processes 
of organising care, different division of tasks and roles, change in culture of work 
setting or the collaboration among professionals. Other types of theories in this 
category are identified in table 8 below.  
 Table 8: Organisational context theories 
Types Underlying assumptions/focus 
Theories of innovative 
organisations 
Implementation should take into account the type of 
organisation; decentralised decision making  (teams) 
about innovation is important  
Theory of quality management Improvement is a continuous cyclic process, with plans for 
change continually adapted on the basis of previous 
experience; organisation-wide measures are aimed at 
improving culture, collaboration, customer focus, and 
processes 
Theory of integrated care Change multidisciplinary care processes and collaboration 
instead of individual decision making 
Complexity theory Focus on system as a whole, find patterns in behaviour 
(attractors) and link change plan to these, and test and 
improve plan 
Theory of organisational 
learning 
The creation or availability  of conditions in the 
organisation for continuous learning at all levels can lead 
to successful changes 
Theories on organisational 
culture 
Changes in the culture can stimulate changes in 
performance, particularly a culture of teamwork, 
flexibility, and external orientation 
 
Theories of innovative organisations suggest that some organisations adopt 
innovations more quickly and easily than others. These theories therefore focus on 
the characteristics of an organisation that determines whether, and to what extent 
61 
 
 
they are able to take up innovations. Greenhalgh et al. (2004) suggest that the 
ability of health service organisations to be innovative depend on the system 
antecedents (e.g. structure, absorptive capacity for knowledge, and receptive 
context for change), the readiness for innovation, adoption and assimilation 
characteristics (e.g. needs, motivation, values and goals, and complex, non-linear 
processes), and the implementation process. 
The emphasis of total quality management (TQM) is the continuous 
improvement of processes in health care to address patient needs more effectively 
(Grol et al. 2007). Inadequate performance is attributed to a system failure and not 
perceived as an individual problem. Basic principles of TQM include comprehensive 
and organisational efforts to improve quality, a people-centred focus, continuous 
improvement and re-design of care processes, management by facts and on-going 
training (Grol et al. 2007).  
 In complexity theory the underlying assumption is that health care is 
becoming increasingly complex and therefore improving health systems should 
involve the whole system as opposed to breaking the system into components. 
Hospitals, primary care teams and disease management programmes are seen as 
complex adaptive systems i.e. interconnected individual components whose 
actions change the context for other agents (Plsek and Greenhalgh 2001). Change is 
therefore focussed on the system as a unit. 
 Organisational learning is a critical component of organisational 
development, which is a long-term process for initiating and implementing planned 
change (Senior 2002). A learning organisation does not only identify and solve 
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problems; it emphasises why the problem occurred, and therefore enables the 
organisation to anticipate change by proactively embedding learning processes into 
the culture (Hardacre and Peck 2005). Central to organisational learning is 
individual learning, and therefore favourable conditions for individual learning 
must exist to improve organisational learning ability (Lähteenmäki, Toivonen and 
Mattila 2001). Learning organisations are characterised by an experimental mind-
set, curiosity about trying new things, a climate of openness, acceptance of debate 
and conflict, an ongoing commitment to education, as well as growth and 
development at all levels (Lähteenmäki, Toivonen and Mattila 2001). 
Organisational learning theories are therefore focussed on how health 
organisations can become learning organisations that are continually and 
effectively responding to internal and external triggers of change.  
The basis of theories about organisational culture is that an organisation’s 
culture can be altered to change performance. Whether it is seen as an attribute or 
as defining the whole character and experience of organisational life, the culture of 
an organisation means the group learns to address its challenges, and also 
successfully transfers their values and underlying assumptions to new members 
(Grol et al. 2007). Based on this theory, health care organisations seeking to 
improve quality need to develop a quality culture that emphasises learning, 
teamwork and customer focus (Ferlie and Shortell 2001). 
3.3 THEORY OF INTEGRATED CARE 
Integration refers to the coordination of various tasks, functions and divisions so 
that they work together to achieve organisational goals, or the extent to which 
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distinct and interdependent organisational components constitute a unified whole 
(Barki and Pinsonneault 2005). One of the main reasons for integration is the need 
for coordination that arises from differentiation (Lawrence and Lorsch 1986). 
Integrated care is a response to modern day health care problems: access 
concerns, fragmented services, disjointed care, less than optimal quality, system 
inefficiencies, and difficult-to-control costs. Demographic changes and chronic 
conditions have resulted in complex needs which health systems seem unable to 
meet (Kodner 2009).  
Integration therefore bonds the different units or organisations together to 
achieve common goals and optimal results (Kodner and Spreeuwenberg 2002). 
Integration is believed to improve responsiveness, increase efficiency and thereby 
enhance performance through greater efficiency, greater productivity and 
improved competitiveness, strengthening of strategic advantages and greater 
effectiveness. Integrated care, as a type of theory on factors related to the 
organisational context, focuses on changing multidisciplinary care processes and 
collaboration. It encompasses two main concepts which are change of the process 
of care and multidisciplinary collaboration (Kodner 2009; Grol et al. 2007). 
 Integrated care involves the radical or gradual redesign of the steps in 
providing care. Models for changing processes focus on improving the organising 
and managing of care for specific categories of patients to meet their needs and 
reduce costs. The mechanism of change therefore is primarily the redesign of 
multidisciplinary care processes and not by influencing professional decision 
making (Grol et al. 2007). Changing processes of care include organising new 
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collaborations of care providers, allocating tasks differently, transferring 
information more efficiently, and using new types of health professionals (Grol et 
al. 2007).  
Multidisciplinary collaboration is crucial in integrated care. Successful 
integrated care approaches often use strategies like case management, 
performance feedback to providers, explicit protocols and pathways, use of disease 
registers, electronic follow-up systems and reorganisation of services to better 
meet patient needs (Grol et al. 2007). Multidisciplinary collaborations and 
coordination are essential to play down traditional boundaries between disciplines 
and reduce fragmentation. Care is therefore experienced as a series of related 
actions performed by different professionals (Grol et al. 2007). The impact of these 
two concepts is to make care more patient-centred, ensure continuity of care, and 
enhance coordination. 
3.3.1 PATIENT-CENTRED CARE 
Patient-centred care is a means of focussing care on efforts to optimise patient 
understanding of, and participation in the care process (Murray 2009). It 
strengthens the role of patients in managing their health problems i.e. they move 
from being passive recipients of care to being active decision-makers (WHO 2005). 
Patient perceptions of patient-centred care have been found to be directly related 
to improved patient health status, increased efficiency of care (Stewart et al. 2000), 
and have also been used as a predictor of health outcomes (Stewart 2001). 
Pelzang (2010) identifies two models of patient-centred care: the systems 
approach and the process approach. A systems approach to patient-centred care 
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focuses on providing a patient-centred environment which is central for providing 
patient-centred care. Essential components would therefore be providing a 
structure with healthcare professional attributes like professional competence, 
interpersonal skills, commitment, and personal characteristics; organisational 
preparedness in terms of time, the health worker’s role, shared decision-making; 
and patient attributes of perception of care, participation in care, perspectives on 
illness, cooperation and culture (Pelzang 2010). A process model of patient-centred 
care on the other hand describes the dimensions of patient-centred care which are 
a range of activities essential for patient-centred care: respect for patients’ values, 
preferences and needs, coordination of care, information, physical comfort, 
emotional support and alleviation of fear, involvement of family and friends, and 
transition and continuity of care (Pelzang 2010).  
Effective patient-centred care necessary for successful integration requires 
the strengthening of the role of patients from being passive recipients to active 
decision-makers (WHO 2005). Mead and Bower (2000) define five distinct 
dimensions of patient-centred care. The first dimension reflects the use of the 
biopsychosocial perspective to explain illness, acknowledging the role of health 
promotion and help-seeking behaviour modification. The second dimension relates 
to the management of a patient as a person in order to fully understand the 
patient’s illness experience which differs from person to person. In the third 
dimension Mead and Bower (2000) refer to the asymmetrical relationship between 
provider and patient whereby authority lies with the provider. They criticise this as 
paternalistic, as opposed to the preferred relationship which involves the sharing of 
power and responsibility in a mutual partnership. The fourth dimension of patient 
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centred care according to Mead and Bower (ibid), recognises the significance of a 
therapeutic alliance between provider and patient based not just on the decision-
making and procedural issues of diagnosis and treatment alone, but also on the 
personal relationship. The fifth dimension concerns the influence of the personal 
qualities of the provider in terms of how these can affect patient behaviour and 
provide insights for therapeutic purposes (ibid).  
Patient-provider communication should therefore be characterised by 
exploring the disease and illness experience, understanding the whole person, 
finding common ground, enhancing prevention and health promotion, and 
enhancing continuity relationship (Stewart 2001; Stewart et al. 2000). As a result of 
patient-centeredness of care, the provider’s understanding of the patient’s illness 
experience is enhanced, and allows providers to offer individualised support for 
patient needs leading to fewer complications (Holmström and Röing 2010). 
However the establishment of patient-centred care has to overcome barriers 
including lack of a clear definition of what it is, inadequate educational emphasis 
on it, shortage of staff, lack of continuity, absence of good teaching models and 
curricula on patient-centred care, and the dominance of the biomedical model in 
healthcare (Pelzang 2010). 
Patient empowerment has been acknowledged as an alternative to the 
compliance-oriented approach which can support patients in dealing with health-
related challenges outside the healthcare setting. Unlike patient-centred care 
which is the goal of an encounter between the patient and the provider, and 
therefore bound by the context of clinical health care settings, patient 
empowerment makes patients responsible for their choices and the consequences 
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of these choices (Holmström and Röing 2010; Aujoulat, D’Hoore, and Deccache 
2007). It involves facilitating and supporting patients to reflect on their experiences 
of living with a chronic illness, think critically and make informed decisions 
(Anderson and Funnell 2010). Patient empowerment has been shown to facilitate 
coping and well-being in patients, and increased patient knowledge and personal 
development. It allows self-management of the disease, treatment, their health 
and their own life or personal changes (Holmström and Röing 2010). A necessary 
skill for patients in the empowerment approach is the ability to reflect on the 
benefits of behaviour change in their lives (Holmström and Röing 2010). Although 
most of the practice of patient empowerment has been based in resource-rich 
settings a lot of research has been conducted among medically underserved 
minority patients to suggest that while the resources available for the management 
of chronic illnesses may be limited, the ability for patients to assume responsibility 
and make informed decisions is not (Anderson and Funnell 2010).  
3.3.2 CONTINUITY OF CARE 
Continuity of care is the degree to which a series of discrete healthcare events is 
experienced as coherent, connected and consistent with the patient’s medical 
needs and personal context (Haggerty et al. 2003) i.e. patients’ experience of the 
cohesiveness and connectedness of the health system. It is recommended to 
address fragmented and uncoordinated health and social services systems (Kodner 
2009). Continuity of care reflects  how individuals experience the coordinated 
nature of health care, and therefore it is not an attribute of health providers or 
organisations. Continuity is necessary for better coordination (Haggerty et al. 
2003). Although few studies clearly demonstrate that increasing continuity 
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improves quality, literature suggests that continuity of care improves patient 
satisfaction, early diagnosis of patient condition, and compliance to medical 
treatment (van Walraven et al. 2010). However, the effect of continuity on patient 
satisfaction is variable because although patient perception of it is consistently and 
significantly improved, quantitative measures were not (Adler, Vasiliadis and Bickell 
2010). 
Continuity of care is achieved by bridging discrete elements in the care 
pathway i.e. different episodes, interventions by different providers, or changes in 
illness status (Haggerty et al. 2003). There are three main types of continuity: 
informational, management and relational.  Informational continuity refers to the 
use of information on past events and personal circumstances to make current care 
appropriate for each individual. It links care from one provider or health care event 
to another (Haggerty et al. 2003). Management continuity represents the 
consistent and coherent approach to the management of a health condition that is 
responsive to a patient’s changing needs. It is particularly relevant where the 
management of the disease condition requires multiple providers. Continuity is 
achieved when services are complementary and timely. Tools used include shared 
management plans and care protocols. For long term care and chronic conditions, 
flexibility and consistency are critical for management continuity (Haggerty et al. 
2003).  
Relational or interpersonal continuity refers to an on-going relationship 
between a patient and one or more providers (Saultz and Lochner 2005; Haggerty 
et al. 2003). It bridges the past to the current care, provides a link to future care, 
and also provides the patient with a sense of predictability and coherence. 
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Relational continuity improves uptake of preventive care and adherence to 
treatment, and also improves health utilisation and satisfaction (van Walraven et 
al. 2010; Gray et al. 2003). The evidence on outcomes of chronic disease is however 
less clear cut.  Relational continuity seems to be associated with improvements in 
delivery of preventive services, lower hospitalisation rates and lower costs (Saultz 
and Lochner 2005). Most patients value relational continuity because of the value 
they place on their relationship with the provider, their physician’s knowledge 
about them, the ability to communicate their concerns, and the development of 
trust and confidence with the provider (Pandhi and Saultz 2006).   
3.3.3 ENHANCED COORDINATION 
Coordination of care is the deliberate integration of patient care activities between 
two or more participants involved in a patient’s care to facilitate the appropriate 
delivery of health care services (McDonald et al. 2007). Care must be coordinated 
in all aspects: between different providers, and between providers and patients 
and their families (Bodenheimer 2008). Continuity of care is frequently used 
interchangeably with coordinated care although they are different: the presence of 
continuity facilitates better coordination of care (Haggerty et al. 2003). 
Coordination is the mechanism or operational component of integration. Services 
are fragmented because there is inadequate coordination in the presence of 
differentiation. Enhancing coordination therefore is an integral component of 
integrated care. 
 Highly differentiated systems like health care systems therefore require 
high degrees of integration (Glouberman and Mintzberg 2001). Mechanisms of 
integration are employed to reduce the effect of differentiation (Sobczak 2002). 
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Glouberman and Mintzberg (2001a) identify a number of mechanisms by which  
coordination can be strengthened in health care organisations: direct supervision, 
mutual adjustment and standardisation.  Mutual adjustment is the most direct 
form of coordination. The people involved simply adapt as work progresses 
through informal communication. It thus involves flexible communication with 
peers to deal with problems adaptively and collaboratively through informal 
meetings, networking and quasi-formal arrangements like teams, task forces and 
work groups. In direct supervision a manager or supervisor is appointed to ensure 
coordination occurs. This appointee does not actually do the work but issues 
directives to those doing it. Hierarchy of authority is therefore created 
(Glouberman and Mintzberg 2001a). 
Standardisation of work occurs where common procedures and tasks are 
clearly specified through the use of protocols and guidelines; coordination 
therefore takes place in the design of work. This also includes joint planning to 
establish schedules governing activities of different units (Glouberman and 
Mintzberg 2001a). Standardisation of output refers to the use of standardised 
results or outcomes. The focus of coordination is therefore on the interface of 
services provided by different health providers. This can be done by setting 
performance or productivity targets.  Standardisation of skills and knowledge is 
achieved by training different people in different skills, but each one knows what to 
expect from the other. Co-ordination is by specialization. This type of co-ordination 
is particularly favoured in the health systems because of the ease with which co-
ordination is done as long as each participant does what is expected (Glouberman 
and Mintzberg 2001a).  
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In standardisation of norms socialization is used to establish common values and 
believes to ensure that people work towards common expectations. A common 
culture is promoted so that externalized controls are replaced by internalized 
attitudes (Glouberman and Mintzberg 2001a). All the participants can therefore co-
ordinate their effort because they just know what to do. It is the most powerful 
way to enhance mutual adjustment. Standardisation of norms and mutual 
adjustment are the most effective ways for overcoming cultural and political 
barriers of integration. 
Kodner (2009) also identifies a number of strategies for strengthening 
coordination as shown in table 9. Depending on the target of integration, a number 
of methods or tools can be used to operationalise integration. Due to the 
complexity of health systems integrated care interventions like TB/HIV integration 
usually encompass more than one target and therefore utilise a combination of 
these tools and methods. 
Table 9: Methods and tools of integrated care  
Target of integration Methods/Tools of operation 
Funding Pools of funds  
Prepaid capitation at various levels 
Administrative Consolidation of responsibilities/functions 
Inter-sectoral planning 
Needs assessment/allocation chain  
Joint purchasing or commissioning 
Organisational Co-location of services 
Discharge and transfer agreements 
Inter-agency planning and/or budgeting  
Service affiliation or contracting 
Jointly managed programs/services  
Strategic alliances or care networks 
Consolidation or common ownership or merger 
Service delivery Joint training  
Centralised information 
Intake and referral  
Case management 
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Interdisciplinary teamwork 
Integrated information systems 
Clinical Standard diagnosing criteria 
Uniform, comprehensive assessment procedures 
Joint care planning 
Shared clinical record(s) 
Continuous patient monitoring 
Common decision support tools (guidelines & protocols) 
Regular patient/family contact 
On-going support 
 
3.4 DIMENSIONS OF INTEGRATION 
Integration is designed to create coherence and synergy between different parts of 
healthcare to enhance system efficiency, quality of care, quality of life and 
consumer satisfaction (Kodner 2009). Integration can be described in terms of what 
the focus is, the breadth, types, and degree. Integration efforts can be focussed on 
entire communities or populations irrespective of health status, vulnerable client 
subgroups, and patients with complex illnesses (Kodner 2009). Linking of 
organisations to provide clinical and functional services is done in two main ways: 
horizontal integration occurs when similar organisations/units at the same level of 
care join, while vertical integration combines different organisations at different 
levels (Kodner 2009; Criel, Brouwere and Dugas  1997). 
Different types of integration have been described. Functional integration is 
the degree to which back-office and non-clinical support functions are coordinated 
across all units (Kodner 2009). Organisational integration represents the 
relationships between health care organisations to address the needs of 
coordination arising from differentiation (Lawrence and Lorsch 1986). Service and 
clinical integration on the other hand refer to coordination of services and the 
integration of care in a single process across time, place and discipline. Kodner 
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(2009) additionally describes normative integration which refers to the shared 
mission, work values and organisational or professional culture, and systemic 
integration that is about the alignment of policies and incentives at the 
organisational level. 
The degrees of integration are often described on a continuum: from full 
segregation to full integration [(Ahgren and Axelsson 2005; Glendinning 2003; 
Leutz 1999), Figure 8]. Full segregation exists where there is no form of integration, 
but complete separation and autonomy of organisations and functions. Segregation 
develops when differentiation is allowed to progress without the necessary 
integration. Units become fragmented.  Linkage occurs between existing 
organisational units. Different units and professionals understand and stick to the 
services they are responsible for. There is good communication between units. In 
health care it is aimed at effective referral of patients to the right unit at the right 
time to ensure continuity of care (Leutz 1999).  
Figure 8: Continuum of Integration 
         
Collaboration involves integrating existing units in a more structured form. The aim 
is to coordinate different services or processes, share information and to manage 
interfaces between these services. In health care, chains of care and other forms of 
health care networks are included in this form of integration. Integrating units still 
operate through separate structures but various strategies like appointing 
individual managers are used to achieve coordination and collaboration (Leutz 
1999). Full Integration refers to a degree of collaboration so high that the separate 
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units no longer see their separate identities as significant (Glendinning 2003). 
Resources of different organisational units are pooled together to create a new 
organisation with new benefits, processes or services (Leutz 1999). Other 
characteristics are joint arrangements encompassing strategic and operational 
issues, shared or single management arrangements and joint commissioning at 
macro- and micro- levels (Glendinning 2003). In health care this may result in a new 
organisation which manages the comprehensive services that have been developed 
to address the needs of a specific patient group.  
3.5 INTEGRATION AND HEALTH SYSTEMS 
3.5.1 RELEVANCE OF INTEGRATION IN HEALTH CARE 
A health system includes all the activities whose primary purpose is to promote, 
restore and maintain health, and the overall goals are to improve the health of the 
people served, be responsive to their expectations, and to provide mechanisms for 
fair health financing [(WHO 2007c; WHO 2000), Figure 9]. 
Figure 9: The WHO Health System Framework: building blocks and goals/outcomes   
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packages, delivery models, infrastructure, management, safety and quality, and the 
demand for care (WHO 2007c). When the Alma-Ata Declaration on Primary Health 
Care was made (WHO 1978), it was described as an integral part of a nation’s 
health system. The health system was identified as the engine for achieving health 
for all.  
Health for all has been pursued by national health systems, but over the years 
the different interpretations of the concept have resulted in health services that 
lack equity and social justice, and have failed to improve health outcomes as 
expected. Health systems have also been challenged by demographic changes, new 
epidemics, epidemiologic transitions and escalating costs of health (WHO 2007c). 
They have thus become characterised by disproportionate emphasis on specialized 
curative care, fragmented service, and unregulated commercialisation (WHO 
2008b). There has subsequently been global discontentment with health systems 
and what they have evolved into, resulting in calls for sustainable systems that 
deliver comprehensive care. Most countries are dissatisfied with the current state 
of their health systems. Different kinds of reforms are being introduced to make 
the system more responsive to user needs, yet most are really designed to bring its 
component parts under control—particularly financial control (Glouberman and 
Mintzberg, 2001). It is in the light of these challenges that the calls for reforms 
based on primary health care have arisen (WHO 2007c; WHO 2008a).  
The integration of health care is promoted because it has the potential to 
address fragmentation and reduce inequity, making access to that comprehensive 
essential care a reality (WHO 2008a). There have been calls for a comprehensive, 
integrated approach to service delivery in order to tackle the impact of 
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fragmentation (WHO 2007b). This is a call for another look at this not-so-new 
concept of primary health care for the following reasons (WHO 2008a). 
  Rapid technological developments have led to increasing specialisation 
which in turn leads to fragmentation of services. Integration is used to 
increase internal coordination to reduce discontinuities, 
 There has been a dramatic increase in the funding for single-disease and 
population or group-specific programmes leading to concerns that this 
adversely affects less well-funded health priorities, 
 Health systems have been faced with resources constraints, especially 
human resource shortages in low-income countries. Integration is one of 
the strategies for using resources as efficiently as possible, 
 Some of the constraints to effective service delivery are common to several 
technical programmes and integration offers a way of tackling some of 
these challenges and achieving goals together, 
 Integration is a means of organising health systems to offer universal access 
to a broad range of services as proposed through primary health care. 
3.5.2 INTEGRATION OF HEALTH SERVICES 
Integration of health services is defined as ‘the organisation and management of 
health services so that people get the care they need, when they need it, in ways 
that are user-friendly, achieve the desired results and provide value for money’ 
(WHO 2008a). The aim here is to enhance quality of care and life, improve 
consumer satisfaction and system efficiency for patients with problems that cut 
across multiple services, providers and settings. According to Kodner and 
Spreeuwwenger (2002) integration is a step in the process of health systems and 
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health care delivery becoming more complete and comprehensive. Briggs and 
Garner (2006) also define integration of health services as a variety of managerial 
and operational changes to health systems to bring together inputs, delivery, 
management and organisation of particular service functions. And they suggest 
that strategies to promote integration would ensure these services are managed 
together to maximise efficiency, and that they are also delivered together to 
increase service quality and opportunities for accessing these services. 
Although many authors agree that integration in health care holds a great 
promise, there is a caution against unrealistic expectations (Vondeling 2004), 
because the complexity of health care systems and the many factors influencing 
integration make it very difficult to achieve and sustain (Sobczak 2002). Practical 
issues that need to be considered include the following (WHO 2008a): 
  Integration of health services may not be appropriate but rather too risky if 
it is to change a working vertical programme in a wider health system that 
does not function well, 
 The current streams of funding of health usually focus on specific interests 
over short time frames. Integration may not be able to demonstrate the 
reduction in specific diseases to attract funding, 
 Integration does not mean everything has to be a part of one package and 
delivered in one place, 
 Integration is not a cure for inadequate resources or a non-functioning 
system. Underlying health system problems have to be addressed, 
 A lot of policies in favour of integration exist, but actual implementation has 
received less attention. 
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3.5.3 SCOPE OF INTEGRATION IN HEALTH SERVICES 
The scope of integration describes the various elements and components of the 
integration. It describes the extent and boundaries of the integration within the 
different targets of integration. The scope of integration can therefore be of service 
tasks, management and support function, or of organisational components (Table 
10). 
Table 10: Scope of integration in health services (WHO 1996) 
Scope Description 
Integration of 
service tasks  
 multipurpose clinics instead of special-purpose clinics 
 multipurpose staff instead of specialised staff for each function 
 integration of certain service functions previously confined to specific 
service facilities or levels. 
Integration of 
management and 
support functions  
 intersectoral planning and development of programmes 
 budgetary and financial processes that allocate resources to 
multipurpose programmes 
 information systems which report on all the services delivered, and 
which are used as management tools 
 in-service training of staff to upgrade skills in several areas of service 
responsibility 
 multipurpose supervisory visits that deal with all elements of the 
services 
 research plans that cover the overall health systems needs. 
Integration of 
organisational 
components 
 integration of the efforts of different resource providers through 
coordinating mechanisms 
 integration of health and other development efforts across several 
sectors 
 integration of health care into community and family activities. 
 
3.5.3.1 Integration of services tasks 
This refers to the integration at the point of service delivery and it advocates the 
establishment of multipurpose clinics manned by staff trained with different skills 
to perform multipurpose functions. The health workers are therefore able to offer 
a wide range of services but no specialised care in any specific area. Where 
specialised care is needed, patients are referred to the appropriate places. This 
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ensures that a comprehensive service is delivered with each visit, especially for 
patients who need different services. It also maximises the use of health staff, and 
uses resources more efficiently and effectively because tasks are not duplicated. In 
the integration of TB and HIV for instance it is mainly of service delivery tasks 
between the two programmes.  
3.5.3.2 Integration of management and support functions 
This type of integration refers to the planning and development of inter-sectoral 
health programmes. It involves designing budgetary and financial processes to 
allocate resources to multipurpose programmes. It may also be the installation of 
information systems that would report on all services and not a multitude of 
systems each reporting on only one service. In this kind of integration staff 
development planning and supervisory visits targets all the different elements of 
the services.  
3.5.3.3 Integration of organisational components 
Here the main focus is integrating health services with other health or non-health 
services like social care, and the management of this interface. Health care may be 
integrated with other developmental efforts, or into community or family activities. 
Care therefore becomes continuous and holistic, especially for people with chronic 
conditions requiring different services. 
3.5.4 BARRIERS TO INTEGRATION IN HEALTH  
The barriers to organisational integration may be political or as a result of the level 
of differentiation and specialisation, and these barriers can be in reference to 
individual members of the organisation or the organisation itself as an entity [(Barki 
and Pinsonneault 2005), Table 11]. 
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Table 11: Barriers to integration of health services  
Type Individual Organisational 
Structural Number of staff or patients 
Calibre of staff 
Number of patients / workload 
Individual resources 
Administrative systems, processes and 
boundaries in the health system 
Rules and regulations 
Organisational structure of facilities 
Organisational processes 
Available Resources 
Cultural Professional values and interests 
Individual staff commitments 
Patient beliefs, attitudes and 
commitments 
Shared cultures, expertise and norms 
Differing goals among units  
Political Loss of power base 
Lack of interest 
Loss of functional territory 
Perceived exclusion 
Loss of resources 
Loss of power 
Inequity 
Operational Impact of drug treatment 
Mode of delivery 
Process of care 
Preparedness of the health system/facility 
Adequacy of monitoring and feedback 
systems 
Guidelines and protocols availability 
 
Differentiation and specialisation, although necessary for the functioning of a 
health system, result in differences in goals and frames of reference that promote 
the development of a local focus, shared culture, shared expertise and 
expectations (Glouberman and Mintzberg 2001). This then leads to disconnection 
due to unreconciled values, incompatible structures and intransigent attitudes 
(ibid). The barriers to integration arising from differentiation are often cultural or 
structural ( Axelsson and Axelsson 2006; Barki and Pinsonneault 2005). Structural 
barriers arise from the differences in administrative boundaries, laws, rules, 
regulations, budget and financial streams, information systems and databases that 
develop within the organisation making it difficult for units to coordinate or 
collaborate (Barki and Pinsonneault 2005).  Structural barriers may also be due to 
the lack of adequate number of qualified staff, especially at the point of service 
delivery. Structural barriers can be overcome by formal agreements, rules, 
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regulations and financial support (Glendinning 2003), as well as with 
standardisation of work, output, skills and knowledge.  
Cultural barriers arise from the differences in professional and 
organisational cultures, values and interests, as well as commitment of individuals 
and groups within the organisation (Glendinning 2003). Differentiation leads to the 
development of local focus and shared expertise within units, therefore members 
in these units develop specialised skills and core competencies in specific areas. 
There may therefore be a perceived lack of skill and the fear of moving into new 
territories that will be expressed as resistance to the change that integration 
brings. Cultural barriers are the most difficult to overcome (Dong et al. 2007). 
Standardisation of norms is useful in creating new values and cultures to facilitate 
change and so integration is by courting support from all stakeholders to do things 
differently and create new lived experiences (Anderson-Wallace and Blantern 
2005). 
Political barriers are a result of the fear of loss of resources, loss of power 
due to shared information, and the loss of functional territories (Barki and 
Pinsonneault 2005). This engenders resistance to change and lack of cooperation 
from the members of the units or organisations being integrated. External political 
decision-making concerning financing and resource allocation may lead to inequity 
and therefore lack of adequate resources to support or sustain integration.  
Operational barriers include the model of service delivery, and the impact of 
treatment. The one-stop shop as described in Chapter 2 (p. 37) is more user-
friendly and hence leads to improved access as well as utilisation. However this 
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results in high attendance at these clinics making waiting times even longer. On the 
other hand, the referral system is usually more costly to users in terms of time and 
money, increasing the risk of attrition and default. Other operational barriers arise 
from the implications of being managed for both TB and HIV. First of all TB 
treatment lasts between 6 and 8 months (NTP & NACP 2007), while HIV is classified 
as a chronic condition requiring lifelong management; and therefore a high level of 
personal commitment and resolve is required for successful TB/HIV integration.  
Secondly, unwanted effects of drug treatment like adverse drug reactions, 
immune reconstitution inflammatory syndrome (IRIS), or drug-drug interaction 
between TB and HIV impact directly on the outcome of TB/HIV collaborative 
activities (Lawn et al. 2007). Lack of a health system’s preparedness for integration 
in terms of adequate resources, infrastructure, treatment guidelines and 
appropriate monitoring and feedback mechanisms are major barriers to integration 
of TB and HIV services (Kodner and Spreeuwenberg 2002). 
3.6 TB/HIV INTEGRATION AS A COMPLEX INTERVENTION 
A complex intervention is defined as one that has several interacting components. 
The complexity may be with respect to the number of and interactions between 
the components, the number of groups or organisational levels targeted, or the 
number and variability of outcomes (Craig et al. 2008). These complexities have 
implications for the development and evaluation of these interventions as outlined 
below: 
 A good theoretical understanding of how change occurs is necessary, 
 Implementation failure can be misconstrued as ineffectiveness, 
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 Variability in individual level outcomes may be as a result of higher level 
processes, 
 A range of outcome measures is required, and  
 Local adaptation may be required. 
Therefore for successful development and effective evaluation, the new Medical 
Research Council (MRC) guidance proposes four main stages: development, 
feasibility or piloting, evaluation, and implementation (Figure 10).  The first stage is 
development of the intervention which is intended to identify the evidence base, 
identify or develop the relevant theory, and model the processes or outcomes. This 
stage ensures that the intervention can reasonably be expected to result in a 
worthwhile effect (Craig et al. 2008).  
Figure 10: Development-evaluation-implementation process of complex 
interventions (Craig et al. 2008) 
 
 
 
 
 
In the second stage the feasibility of the intervention can be assessed and the 
methods piloted: acceptability of procedures is tested, recruitment or retention 
rates can be estimated, and sample size can be determined. This stage can 
therefore be used to address any uncertainties identified in the previous stage and 
anticipate issues that can undermine the next (Craig et al. 2008). After feasibility 
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and piloting appropriate study designs can be used to assess effectiveness, 
understand the change process through process evaluation, and assess cost 
effectiveness in the evaluation stage (Craig et al. 2008). Implementation, the next 
stage, involves two main components. The first is dissemination to get evidence 
into practice. The second component involves surveillance and monitoring to 
observe unwanted side effects and long term outcomes, which then feeds back 
into the development. This is therefore a cyclical rather than a linear process. (Craig 
et al. 2008).  
 TB/HIV integration is a complex intervention because of the different 
components and their interactions, the different target populations, and the 
variety of outputs and outcomes. On account of its aim and objectives, this study 
can therefore be located in the feasibility/piloting stage in the development-
evaluation-implementation process in figure 10 above. Specifically this study 
involves a piloting of methods of evaluation as well as a study of factors influencing 
the delivery of the intervention.   
3.7 CONCEPTUAL FRAMEWORK 
The conceptual framework of this study is an expansion on the input-process-
outcome logic model for monitoring and evaluating programmes (Figure 11) as 
recommended by the WHO.  
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Figure 11:Framework for programme monitoring and evaluation (WHO 2004a) 
 
 
 
 
 
                        Process Evaluation                                                            Outcome/Impact Evaluation 
The WHO framework (Figure 11) describes the elements of health programmes in 
terms of  inputs, processes, outputs, outcomes and impact. Inputs refer to the core 
ingredients like human and financial resources, physical facilities, equipment, 
clinical guidelines, and operational policies. Processes refer to the multiple 
activities that are carried out to achieve the objectives of the program. It includes 
both what is done and how well it is done. Outputs are the results of program-level 
efforts, such as the number of activities conducted. Service delivery outputs may 
measure the volume of services provided to the target population, as well as access 
and quality of care. Outcomes measure changes at the population level, some or all 
of which may be the result of a given program or intervention. Impact refers to 
program results achieved among the target population and to what extent these 
achievements can be attributed to the intervention. (WHO 2004a, b). 
As stated earlier, the conceptual framework for this study (Figure 12) is based 
on the model in figure 11 above. The elaboration on the model to develop the 
conceptual framework is based upon the strategies to achieve integrated care, as 
well as the anticipated results of integrated care. Inputs in integration are intended 
to establish multidisciplinary collaboration and provide the guidelines for change of 
CONTEXT: environmental, cultural, political, and socioeconomic factors external to the 
programme 
INPUT 
Basic 
resources 
necessary 
IMPACT 
Ultimate 
effect of 
project in 
long term 
OUTCOME 
Results at 
level of 
target 
population 
OUTPUT 
Results at 
the 
programme 
level 
PROCESS 
Programme 
activities 
86 
 
 
the care pathways. In integrated care the emphasis of the redesign of the 
processes is to make care more patient-centred, to enhance coordination, and to 
establish continuity of care. These are the underlying assumptions of integration 
that are anticipated to achieve the results which are described in the form of 
outputs, outcomes and impact. 
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                 Figure 12: Conceptual framework of integrated care 
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Outputs of integrated care are improved resource utilisation, improved efficiency, 
improved access (Kodner 2009; WHO 2008a) and greater patient involvement 
(Pelzang 2010). These are all essential anticipated benefits of integrated care as 
they directly influence the programme outcomes which are improved clinical 
outcomes, reduced costs and patient satisfaction with care. Long term outcomes 
(or impact) of integrated care as a health improvement intervention include 
improved quality of life and the reduced disease burden in the population.  
The strategies of integrated care are multidisciplinary collaboration and 
change of the care process, and these make care more patient-centred, improve 
continuity of care, and enhance coordination. The effects of these are then 
represented as the results of integrated care as related to the outputs, outcomes 
and the impact of integration. The conceptual framework of the study therefore 
depicts integration as a strategy for improving health care, showing the 
mechanisms by which the strategy is expected to achieve results, and relating 
these to the existing model for evaluating TB/HIV integration as defined by the 
WHO.  
The conceptual framework of integrated care described above forms the 
basis upon which the appropriate study methods are identified. These methods are 
described in the next chapter.   
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4 STUDY METHODS 
4.1 INTRODUCTION 
Research in medicine and health has predominantly used quantitative methods of 
data collection based on positivism, but increasingly health researchers are using 
qualitative methods. This has been in response to the fact that lifestyle is a major 
determinant of health, and problems in public health especially are those of human 
behaviour rather than  the challenges of developing new technical interventions 
(Green and Thorogood 2009). Health researchers are therefore  turning to 
qualitative methods of social inquiry in addition to the traditional quantitative 
methods so as to better understand health, health behaviour and health services, 
and to improve the management and provision of health services (Green and 
Thorogood 2009).  
It is however important that health research methods are theoretically sound 
and able to achieve the research objectives. This chapter and the next have 
therefore been used to address the methods and research settings of this study. On 
this basis, this chapter has been written to demonstrate how the methods of this 
research have been informed by the theoretical framework in the previous chapter, 
and how it will answer the research objectives and questions stated in Chapter 1. 
This chapter therefore identifies the research approach used and why, followed by 
a discussion on the specific research designs and data collection methods. 
Subsequent sections discuss data analysis and the methods and procedures used 
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for this purpose. The last two sections describe the rigour of the study, the ethical 
considerations and the limitations of the methods used. 
4.2 RESEARCH APPROACH 
A mixed method approach was used in this study and the paradigm of this 
approach is pragmatism. In pragmatism the main focus is solving problems so the 
emphasis is on 'what works' or drawing on 'subtle realism' which accommodates 
both qualitative and quantitative methods (O'Cathain and Thomas 2006). Research 
methods in pragmatism are therefore not predefined but depend on the problem 
and the research objectives (Creswell 2008a). Pragmatism is therefore about 
freedom of choice to draw on different approaches and procedures for what best 
serves the purpose of the research. Mixed methods research draws its strength 
from the theoretical and methodological differences of qualitative and quantitative 
approaches to generate more insight from one study than can be achieved by using 
either one on its own (O'Cathain and Thomas 2006). I therefore used mixed 
methods research and the pragmatic approach for the following reasons: 
 This research is a problem-oriented one that seeks to address specific 
problems arising from public health practice and programme 
implementation. The choice of methods was therefore driven by the 
research objectives arising from the theoretical framework to provide a 
more holistic and meaningful picture of TB and HIV integration, 
 A mixed methods approach is useful to explore and understand barriers to 
the implementation of complex interventions like TB/HIV integration in 
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order to refine evaluation designs as part of the feasibility and piloting 
phase identified in figure 10 above (p. 83), 
 The approach provided the flexibility to broaden the scope of my research 
questions to understand  the factors underlying programme outputs and 
outcomes to enhance the relevance of this research to policy (O'Cathain 
and Thomas 2006), 
 The significance of the role of a patient in the management of chronic 
conditions is well established (WHO 2005). Mixed methods approach 
provides a means to better understand the role of the HIV-associated TB 
patient in their management so as to inform and design appropriate 
strategies to empower them to effectively fulfil this role, 
 This approach also enabled me to choose from different methods and 
procedures (Creswell 2008a), and to decide when to integrate the data from 
the different methods used in order to provide a comprehensive 
understanding of the TB and HIV integration (Tashakkori and Teddlie 2009),  
 Quantitative methods alone cannot accurately capture the diversity of 
goals, objectives and service inputs which contribute to health care 
outcomes (Bowling 2009). Therefore, the use of this approach is a means of 
achieving more relevant evidence. 
4.3 MIXED METHODS DEBATES  
There are two major debates about mixed methods as an approach to research. 
The first relates to its legitimacy as a research approach, and the second is about 
defining it.  
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4.3.1 LEGITIMACY OF MIXED METHODS RESEARCH 
According to Lincoln and Guba (2000) different research paradigms and 
philosophies are not commensurable and therefore cannot be integrated. They are 
therefore of the opinion that methods can be mixed only within paradigms. Green 
and Thorogood (2009) also state that qualitative research is often rooted in rather 
different epistemological traditions which depart from one or more tenets of 
positivism and quantitative research. The opinion is that qualitative and 
quantitative researches originate from two different ontologies and 
epistemologies, and therefore cannot be used together. These seemingly 
‘opposing’ paradigms have resulted in a qualitative-quantitative divide which has in 
turn fuelled a lot of methodological debates (Bergman 2008).  
However another school of thought is that there is a qualitative-quantitative 
continuum of research approaches determined by the degree of inductive-
deductive logic, subjectivity and value-addedness (Tashakkori and Teddlie 2009). 
Bergman (2008) suggests that the major source of the qualitative-quantitative 
debates is the linking of qualitative and quantitative methods with 
interpretive/constructivism and positivism respectively. And Onwuegbuzie and 
Teddlie (2003) are also of the opinion that the qualitative-quantitative debates 
arise from the confusion of the logic of justification with research methods. The 
research process is a complex and compromise-laden one that makes a clear 
distinction of qualitative and quantitative research too simplistic (Bergman, 2008). 
Johnson and Onwuegbuzie (2004) categorically reject an incompatibilistic either/or 
approach in favour of a more pluralistic or compatibilist approach. 
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Contemporary research is applied and problem-oriented: funded research is done 
more for the answers they provide for specific problems than for the sake of the 
knowledge itself. Under such circumstances these distinctly defined and exclusive 
paradigms become a constraint, and often mixed methods researchers ‘have to 
maintain a strangely schizophrenic position towards the division of labor between 
qualitative and quantitative methods.’ (Bergman 2008, p. 14). Pragmatists do not 
allow paradigmatic boundaries to constrain them, but rather see qualitative and 
quantitative methods as a large and heterogeneous family of methods (Bergman 
2008). Pragmatism challenges the very way in which we perceive research. Mixed 
methods approaches offer a useful philosophical and methodological middle 
position, they offer a practical outcome-oriented method of enquiry, as well as a 
method for selecting methodological mixes that can help researchers better 
answer research questions (Johnson and Onwuegbuzie 2004). Bergman (2008) 
therefore advocates for a rethink of the qualitative-quantitative divide for a better 
understanding and utility of these methods and justifies mixed methods research 
as follows: 
 Nature of reality should be delimited only by the specifics of the research 
goals, 
 Defining research approaches as paradigms is restrictive and misleading as 
researchers then tend to associate specific data collection and analysis 
methods with certain paradigms, 
 The division between qualitative and quantitative methods is problematic, 
and based on questionable premises, 
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 Many assumptions behind qualitative and quantitative methods limit the 
application of the individual data collection and analysis techniques, 
 Qualitative and quantitative methods should be regarded as a large and 
heterogeneous resource to unravel complex research aims and objectives, 
 Mixed methods should not be about justifying ‘inconsistent’ research 
designs but should be an opportunity to explore the possibilities and limits 
of qualitative and quantitative methods. 
4.3.2 DEFINING MIXED METHODS RESEARCH 
The debate about the definition of mixed methods research centres on what is 
done and how it is done. Tashakkori and Teddlie (2009) define mixed methods 
research as one in which the investigator collects data, integrates findings and 
draws references using both qualitative and quantitative approaches or methods in 
a single study or program of inquiry. Most definitions refer to the use of both 
qualitative and quantitative approaches, data collection and analysis methods 
(Creswell 2008a; Johnson, Onwuegbuzie, and Turner 2007; O'Cathain and Thomas 
2006). Some theorists are of the opinion that using different qualitative or 
quantitative methods should also qualify as mixed methods research (Brannen 
2008; Johnson, Onwuegbuzie, and Turner 2007; O'Cathain and Thomas 2006).  
Another key issue is the integration of these methods, and the level at 
which this is done. Some identify mixed methods as only those studies in which 
integration occurs throughout the study, and not just during interpretation: in 
which case it may be described as multiple methods or quasi-mixed methods 
(Tashakkori and Teddlie 2009; Johnson, Onwuegbuzie, and Turner 2007). 
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For this research mixed methods research is defined as one that uses both 
qualitative and quantitative methods which may be integrated throughout or 
during interpretation to address different research questions targeted at providing 
different types of evidence to achieve the study objectives. 
4.4 RESEARCH DESIGN 
4.4.1 INTRODUCTION 
The aim of the study is to gather evidence for the improvement of the integration 
of TB and HIV services in Ghana so as to facilitate effective implementation and 
nation-wide scale-up. The objectives are to explore the effect of integration on TB 
and HIV service delivery, to compare the impact of different delivery models on 
TB/HIV integration, and to explore the influences of provider- and patient-related 
factors on the outputs and outcomes of TB/HIV services integration. A mixed 
methods approach has been chosen to address these objectives. This section of the 
chapter describes the mixed methods design used and explains the rationale 
behind the choice.  
4.4.2 CHOICE OF RESEARCH DESIGN       
The pragmatic approach to this research has been driven primarily by the aim and 
objectives, as well as the anticipated application of findings in Ghana and their 
transferability. The research is an embedded mixed methods study made up of a 
natural experiment composed of before-and-after studies at three study sites, and 
a qualitative study at each of the sites as well. This design has been used based on 
appropriateness, feasibility and practicality.  
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 An embedded design (Figure 13) is used because different research 
questions require the different data sets to produce knowledge on different 
aspects of TB/HIV integration over a relatively shorter time (Creswell and 
Clark 2007), 
 An embedded design provided the opportunity to collect the data 
concurrently to interrogate the different aspects of the theoretical 
framework, and also use qualitative data to explore some of the early 
quantitative findings. I did not use an explanatory or exploratory design 
because there was not sufficient time and resource for a sequential study, 
i.e. doing the quantitative study followed by a qualitative one, or vice versa,  
 A natural experiment was appropriate because the study was being latched 
on to a service delivery intervention that was already on-going. Achieving 
randomisation and standardisation was not a primary design objective 
because this study was intended to explore the factors influencing the 
delivery of the intervention, and to pilot methods of evaluation A 
randomised controlled trial was therefore not appropriate,  
 A quasi-experimental before-and-after design was used at the individual 
study sites. This design cannot be used to draw causal conclusion because 
of the presence of confounders and the lack of randomisation. However as 
a pilot study, the findings will inform and further improve the intervention 
and evaluation. Also hypotheses could be generated to direct future 
research, 
 Interrupted time series was also not done because although there were 
sufficient data points, the intervention included a number of components, 
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and was still on-going. Secondly the resources required to use such a design 
were not available to the student at the time of the research,  
 Prospective or retrospective controlled studies were not done because 
there was not enough time available for identifying appropriate controls 
and then monitor effects of the intervention over extended periods in order 
to draw conclusions on the causal associations between the variables, 
 Even though descriptive study designs are usually cheaper to do and can be 
done over a short time period, the designs are not as robust as the before-
and-after study.  
Figure 13: Diagram of mixed methods study design as applied (adapted from 
Creswell and Plano Clark 2007) 
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deliver primary care services as well as serve as referral centres for primary care in 
Ghana. Also currently the decentralisation of HIV care, especially ART, is at the level 
of the district hospital. Therefore it is only at this level that all the models of 
delivery being studied can be described. The main inclusion criteria were thus the 
presence of a TB centre, the use of the new TB register, and the availability of ART 
services at the HIV centre.  
Out of the 7 district hospitals in the region which had both TB and HIV 
services with ART. The three selected sites were the only sites that described the 
three models of service delivery to be studied and had started using the modified 
TB register. Matching of the sites were as follows: they had TB units, they had HIV 
units providing ART, had started using the new TB register, were hospitals that 
delivered both primary care, and specialised clinical and diagnostic care. Other 
inclusion criteria were having staff who had undergone training in TB/HIV co-
infection and management, urban locations, and the use of the national guidelines 
on the management of TB and HIV.  
4.5.1.2 STUDY POPULATION & PARTICIPANT SELECTION 
Participants of the quantitative study included all TB patients registered at all the 3 
study sites from January 2006 to December 2008. As the target of the study was 
service delivery processes and how these were reflected in outputs and outcomes, 
individual participant characteristics were not of primary interest in selection. And 
therefore all registered patients were included. 
4.5.1.3 QUALITATIVE STUDY PARTICIPANT SELECTION 
All TB/HIV patients who were registered at the 3 sites as well as providers working 
during May – July 2009 when the interviews were done were included in the 
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sampling frame. Purposive sampling was then used here too to identify eligible 
participants based on the inclusion criteria in table 12.   The intention was to get a 
good mix of male and female patients in both phases of treatment. This sampling 
approach provides the flexibility to focus on participants critical to answering the 
research questions (Denscombe 2007). Though it does not give representative 
samples it provides rich data that is not otherwise available through other sampling 
methods, and data may be transferable to other relevant sites.  
Table 12: Interview participants 
Type of 
participant 
Number 
Inclusion criteria Exclusion Criteria 
Service 
providers 
8 
Facility TB/HIV co-ordinator 
DOTS centre treatment room nurse 
HIV centre nurse/physician 
Trained in TB treatment or HIV clinical 
care 
Training on TB/HIV co-infection  
Not currently 
active in clinics 
Patients 18 
TB patients who are: 
- HIV positive 
- Male or Female 
- Completed at least a month of 
the intensive phase or in the 
continuation phase 
Critically ill 
patients 
 
National 
Leadership 
3 
Programme Manager, NTP 
Programme Manager Rep, NACP 
National TB/HIV Coordinator 
None 
 
At each site eligible patient participants identified from the TB registers were 
approached to participate through their telephone contacts or during a scheduled 
visit. This initial contact was made by one of the TB/HIV team members because 
recruitment to participate would have been adversely affected if patients were 
approached by ‘strangers’ to talk about confidential and personal experiences with 
TB and HIV both of which are highly stigmatised. During this initial contact the 
study was introduced to them and they were invited to participate. Once an initial 
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verbal consent was achieved a date for the interview was scheduled. On the 
scheduled interview date a more detailed introduction and explanation of the 
study was done by the researcher and informed consent obtained by signature or 
thumbprint before each interview. For the referral site this initial contact was made 
during a weekly trip with the hospital outreach team to visit patients. These trips 
are part of the activities involved in the monitoring of community-based care. I 
therefore travelled with this team as they went on their trips. For those who 
agreed to participate, the interviews were held the same day, but in the absence of 
the members of the outreach team.  
Twenty nine (29) interviews were held with three categories of participants 
(Table 12). There was a category of key informants from the national leadership. 
This included the Programme Manager of the NTP, the National TB/HIV Co-
ordinator, and a senior official from the NACP. A second group of interviewees 
comprised TB/HIV team members in the three districts. The 8 members 
interviewed included one district TB coordinator, 3 TB team leaders, 2 VCT centre 
leaders and 2 other TB centre nurses. A total of 18 TB/HIV patients made up the 
third category: 5 were in the intensive phase of TB treatment and 13 in the 
continuation phase. There were 8 females and 10 males. 
4.5.2 INTERVENTION 
As noted in the preceding section, this study involved all TB patients registered at 
the TB treatment centres of each of the study sites 17 months before and 19 
months after the intervention, as well as the facility TB/HIV team members and the 
national managers. The research studied integrated TB/HIV care as delivered from 
TB treatment centres in the three study sites. The  TB/HIV intervention in this 
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research is defined as follows: fixed dose combination (FDC) therapy for all 
registered TB cases, provider-initiated counselling and testing (PICT) of all 
registered TB cases for HIV, initiation of co-trimoxazole preventive therapy (CPT) 
and antiretroviral therapy (ART) for all eligible HIV-positive TB cases, as well as the 
use of the modified TB register.  
At the three sites therefore, the different service delivery models had 
different implications for the delivery of the intervention defined above. All three 
sites had already started using the new and modified TB registers which recorded 
the TB/HIV activities. Table 13 below describes how the other TB/HIV care 
components in the intervention were delivered according to the different service 
delivery models and showing where the different components of the TB/HIV 
intervention can be assessed.   
Table 13: TB/HIV intervention delivery at TB treatment centres at study sites 
Characteristic One-stop shop Partial integration Referral 
HIV Pre-test counselling Available Available  Available 
HIV testing Available Referral to HIV unit Referral to HIV unit 
CPT initiation and/or 
continuation 
Available Available Referral to HIV unit 
ART initiation and/or 
continuation 
Available Referral to HIV unit Referral to HIV unit 
 
4.5.3 DATA COLLECTION METHODS 
Secondary data was recorded from patient records in the hospitals, and semi-
structured interviews were conducted with both providers and patients. 
Anonymous data collected from routine programme data was used as secondary 
data because it provided readily accessible data so that a lot of information was 
collected over a short period of time. Direct observation and measurement could 
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have been done prospectively and in real time but this would mean more time and 
money than was available for the PhD. Secondary data was therefore most 
appropriate for the quantitative study. The major disadvantages of this choice are 
associated with the quality of the data, its completeness, its relevance to the 
purpose of the study, and then accessing the data. These problems were addressed 
by tracing the individual patient folders where possible and using them to complete 
entries, restricting data collection to only relevant portions of what was available, 
and establishing relationships with providers at the national, regional, district and 
facility levels.  
One-on-one semi-structured in-depth interviews were used as the tool for 
qualitative data collection. Interviews are an effective way of generating target-
specific data, especially where key informants are used. The interviews will 
therefore give me the patient’s perspective of TB and HIV integration, although it 
only tells what people say they do and not what they actually do. Also it may be 
flawed by poor recall on the part of participants, or biased if questions are poorly 
constructed.   
Focus group discussions (FGDs) were not included because there is no 
obvious advantage in terms of additional information. This is because both TB and 
HIV are highly stigmatised conditions and therefore the usefulness of FGDs with 
patients would be limited by unwillingness to disclose in a group. Among the 
providers, the above would not be a hindrance, but the challenge would be getting 
all team members in such a discussion for a useful length of time because they 
tend to be few and very busy. This busy schedule of providers however did not 
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prevent one-on-one interviews with them as the interviews were arranged at their 
individual convenience and availability. 
4.5.2 PREPARATION 
In order to enhance the relevance of the study and promote uptake of findings by 
the national programmes the TB and HIV control programme managers, and the 
national TB/HIV coordinator had been consulted and included in the study as much 
as possible from the very beginning. A visit was paid to the National TB/HIV 
coordinator and the NTP manager to discuss the TB/HIV programme in order to 
identify the needs of the programmes, to establish a collaborative relationship, and 
to engender a sense of ownership on their part.  
Preparing for the actual data collection involved identifying a sampling frame 
and visiting all possible study sites and getting approval and access to conduct the 
study. The National TB-HIV co-ordinator, was contacted for a comprehensive list of 
all health facilities in Ghana providing both ART and TB services. Seven of the 
hospitals on this list were in the region of interest, namely the Eastern Region. All 
seven hospitals were then visited in May - June 2008 for an informal interaction 
that was to help identify which specific facilities would be suitable: 3 sites were 
selected. Approval to conduct the study was then sought from each facility through 
the Regional Deputy Director of Health, after which ethical approval from the 
Ghana Health Service was also applied for and granted. Subsequently I visited all 
the three sites again to interact with the individual TB/HIV team members to 
introduce the study and notify them of the data collection. 
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4.5.4 QUANTITATIVE DATA COLLECTION  
4.5.4.2 QUANTITATIVE DATA INDICATORS 
There were 5 indicators (Table 14) used in this study: 3 output and 2 outcome 
indicators. These indicators were identified from the set of indicators developed by 
the WHO and selected for use in Ghana’s  TB/HIV collaborative activities policy 
guidelines (Ghana Health Service 2007; WHO 2004a, b). The output indicators of 
this study relate to screening of TB patients for HIV, co-trimoxazole prophylaxis for 
those found to be positive, and how many go on ART (Table 14). The outcome 
indicators used in this study are TB treatment success rate in all cases and in HIV 
positive cases.  
Treatment success measures a program’s capacity to retain patients through 
a complete course of chemotherapy with a favourable clinical result. It is useful 
because it is the only outcome indicator that can be used at all levels (e.g., from 
operational level to international level). There is a direct and immediate link 
between this outcome of treatment success and the impact of reduced TB 
mortality. For new smear-positive cases, there is a target of 85% treatment success, 
based on what can be reasonably achieved assuming the baseline proportion of 
adverse outcomes (including death, failure and default) to be about 15%. The 85% 
level formally became a global target via the World Health Assembly resolution of 
1991 but has been revised in the Global Plan to Stop TB 2011 - 2015  (WHO 2010a). 
105 
 
 
Table 14: Quantitative indicators 
Indicator Definition Numerator Denominator Relevance 
Proportion of TB 
patients with known 
HIV status  
Percentage of TB patients who had 
an HIV test result recorded in the 
TB register. 
Number of TB patients 
registered during the 
reporting period who had 
HIV test result recorded in 
the TB register. 
Total number of TB 
patients registered 
during the reporting 
period. 
Measures HIV status of TB patients. 
Knowledge of HIV status enables HIV-
positive TB patients to access 
appropriate HIV care and support 
services.  
Proportion of HIV-
positive TB patients 
who receive CPT 
Number of HIV-positive TB patients 
who are started on or continue 
previously initiated CPT, during TB 
treatment, expressed as a 
proportion of all HIV-positive TB 
patients registered over the 
reporting period. 
Number of HIV-positive TB 
patients, registered over the 
reporting period, starting or 
continuing CPT treatment 
during their TB treatment. 
Total number of HIV-
positive TB patients 
registered during the 
reporting period. 
To monitor commitment and capacity 
of programmes to provide CPT to HIV-
positive TB patients.  
 
Proportion of HIV-
positive registered TB 
patients given ART 
during TB treatment 
Number of HIV-positive TB patients 
who are started on or continue 
previously initiated ART during 
their TB treatment, expressed as a 
proportion of all HIV-positive TB 
patients registered over the 
reporting period. 
All HIV-positive TB patients, 
registered over the reporting 
period, who receive ART (are 
started on or continue 
previously initiated ART). 
Total number of HIV-
positive TB patients 
registered during the 
reporting period. 
Outcome indicator to measure 
commitment and capacity of TB services 
to ensure that HIV-positive TB patients 
are able to access ART. 
Treatment success 
rate (in all cases and in 
HIV-positive cases 
The percentage of a cohort of TB 
cases registered in a specified 
period that were cured or 
completed treatment.  
Number of TB cases 
registered in a specified 
period that were cured plus 
the number that completed 
treatment 
Total number of TB 
cases registered in the 
same period 
Measures a program’s capacity to retain 
patients through a complete course of 
chemotherapy with a favourable clinical 
result.  
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Output indicators measure what is actually done in giving and receiving care and so 
result from inputs and processes of the intervention. Output measures are useful 
for explaining differences in outcomes for particular providers. The main 
advantages of these measures are that they are more sensitive to small differences 
in service delivery, and they can be used in a short time frame (Mainz 2003; Mant 
2001).  
Outcome indicators measure changes in health status that can be attributed 
to care (Mainz 2003; Donabedian 1978). Broader perspectives include health-
related knowledge, attitudes and behaviour of clients, and patient satisfaction with 
care. Outcome measures are useful for studying whole system performance and for 
detecting problems in the implementation of processes of care. They are 
advantageous because their validity as dimensions of quality are well established 
and they can be precisely measured (Donabedian 1966). The major disadvantage of 
outcome measures is that they are unable to distinguish between health care-
related influences and others. They are described as having a low signal to noise 
ratio, i.e. they are likely to be affected by factors other than health-care related 
factors (Lilford, Brown and Nicholl 2007). 
4.5.4.3 DATA COLLECTION PROCESS 
The quantitative data collection involved creating a data set in Microsoft Excel of all 
TB cases registered at each of the study sites between January 2006 and December 
2008 using the relevant variables in the facility TB registers. For the purposes of 
this study the point of reference of TB/HIV integration was June 2007 when the 
new register to monitor TB and HIV activities was introduced at each of the three 
facilities. The specific point to describe the introduction of the intervention was a 
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particular challenge. This is because as a complex intervention different activities 
including staff training had taken place prior to this study, and the use of the new 
registers which started in June 2007 was one activity directly related to programme 
outputs and outcomes. The use of June 2007 as the point of reference was 
therefore a choice appropriate for use with secondary data collection and for 
matching. Therefore the target coverage of data collection was 17 month before, 
and 19 months after integration. 
4.5.5 QUALITATIVE DATA COLLECTION 
4.5.5.1 PILOTING OF TOOLS 
Piloting of the patient and TB/HIV-provider consent forms and interview guides 
was done in Legon Hospital which is also an urban-based district hospital with TB 
and HIV services located in the Greater Accra Region which is adjacent to the 
Eastern Region where the study was based.  The pilot study was primarily intended 
to test the clarity and appropriateness of the questions. It involved 2 female TB/HIV 
providers, and 4 TB/HIV patients made up of two males and two females. The 
patients were identified from the TB register and approached to participate during 
their scheduled visits. One-on-one audio-recorded interviews were held at the 
hospital. The pilot study was used to refine the consent form and interview guides 
prior to data collection.  
4.5.5.3 DATA COLLECTION PROCESS 
During each interview, the aims and objectives of the study were explained again 
to all participants and written consent obtained after the information sheet had 
been read or translated to participants in their preferred language. Particular 
attention was given to explaining to the patient participants that they were not 
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obliged to participate. This was done to mitigate the impact of the recruitment 
process which may have inadvertently coerced some patients to participate. 
Further clarification and emphasis was made on the use of the information, as well 
as measures instituted to preserve the privacy and confidentiality of participants. 
Consent was also sought for each interview to be audio-recorded. 
Managers: All the interviews with the managers were pre-arranged by telephone 
and appointments booked. The interviews were all held in English and they took 
place in the offices of the participants. The three interviews lasted about an hour 
each and they were all audio-recorded after they had each approved of that. These 
interviews were held after those with users and TB/HIV team members. The main 
aim was therefore to bring to their attention issues that had been raised in 
previous interviews, and seek their perspectives on resolving them. I also inquired 
about barriers of integration at the management level, as well as the future 
directions of the programme. 
TB/HIV Team members: these interviews were also all held in English and they 
took place in the TB or HIV centres for the partially integrated and referral sites and 
in the nurses’ office in the one-stop shop. As noted earlier, in all cases informed 
consent was sought prior to the interview, and all of them were recorded using a 
voice recorder. To encourage an honest discourse from providers, I reiterated my 
role as a researcher and not there in a capacity to make judgements on their 
individual performance or personal opinions. I begun the interviews by asking 
participants to tell me a bit about themselves, and then about the team. These 
were then followed by questions about the services they deliver and their 
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experiences. Prompts and probes were used to clarify responses and to prevent 
straying from the topic. These also lasted between 30 and 60 minutes each. 
Patient Interviews: the interviews with the patients mostly occurred in the 
facilities in two sites, but in the homes of patients in the referral site. Most of these 
interviews were held in Twi my local language; with a few in Ga Dangme. An 
interpreter was used for the interviews in Ga dangme. There was some loss of 
meaning in translation because the local dialects lack the flexibility of the English 
language that makes it easy to express oneself in many ways. The word 
‘integration’ itself has no equivalent in the local dialects. The use of teachers of the 
languages to translate, and back translation were methods used to minimise this 
loss and retain context.  
Initial questions were general to explore the experiences of the participants 
during their care, and their interpretation of these experiences. Specific questions 
were then asked to elicit patient views on accessing TB and HIV services. Prompts 
were used here as well to probe and to prevent the interviewee from straying. The 
duration of these interviews also ranged from 11 to 45 minutes. Interviews were 
held after patients had completed their consultation or monitoring visits, and so 
hospital staff or outreach team members were excluded. 
4.6 DATA ANALYSIS 
4.6.1 QUANTITATIVE DATA ANALYSIS 
Data preparation was done to edit the raw data and transform it into a form that 
could be analysed to answer the research questions. In Microsoft Excel tables and 
figures were used to summarise the data for easy comparison. After ensuring that 
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all identifying data had been removed the data from all 3 sites was combined to 
create a data set in SPSS (PASW version 17) and new variables were added towards 
statistical analysis. These variables included those that categorised the data 
according to the year and quarters of each year, two more to represent the levels 
of integration and the intervention group (before or after integration), and another 
one that categorised age into 9 subgroups. The outcomes of TB treatment were 
also re-categorised as successful (cured or completed treatment) or adverse 
(defaulted, failure, relapse, and transferred out cases) in another variable.   
Using SPSS software, the raw data was also transformed into proportions 
and percentages to be used to compute the output and outcome indicators for 
each quarter and as before-and-after values for each site. Means, standard 
deviations and ranges of demographic variables were computed. The tables, 
figures, and the measures of central tendency and spread were used to describe 
the data on outputs and outcomes over the period of study to observe any trends 
and differences across sites. Chi-square (Χ2) tests were also used to identify any 
significant differences in demographic characteristics of participants before and 
after integration. 
In accordance with the objective of the study, Chi-square (Χ2) tests of 
significance were done not to test hypothesis of significant differences but to pilot 
the methods of evaluation. Statistical analyses were done in an attempt to assess 
the effect of integration on outputs and outcomes of TB treatment, and to 
determine the level of integration associated with the best outputs and outcomes. 
Chi-square tests and odds ratios (ORs) were used to determine whether or not 
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there were significant differences in outputs and outcomes before and after 
integration, or across the three sites. 
Finally, statistical testing was done to explore the existence of any significant 
influences of any of the demographic characteristics and TB treatment outcomes 
before and after integration. 
4.6.2 QUALITATIVE DATA ANALYSIS 
4.6.2.1 APPROACH TO QUALITATIVE ANALYSIS 
Qualitative research uses analytical categories to describe and explain phenomena 
(Pope et al., 2006) by  developing conceptual definitions, developing typologies and 
classifications, exploring associations between attitudes, behaviours and 
experiences, developing explanations of phenomena or generating new ideas and 
theories (Green and Thorogood 2009).  The different approaches to qualitative 
analysis fall on a continuum from completely inductive ones to mostly deductive 
styles. Lacey and Luff (2007) are of the opinion that irrespective of the approach 
used all qualitative data analysis goes through stages which may include 
familiarisation with the data, transcription, organisation and indexing of data, 
coding development of themes and categories, exploration of relationships, and 
development of theory. Framework analysis was the approach used in this study.  
4.6.2.2 FRAMEWORK ANALYSIS 
Framework is a structured thematic approach to analysis, with a well-defined 
procedure involving a number of distinct and interconnected stages, though not a 
mechanical process. It has been developed specifically for applied qualitative policy 
research in which objectives are set in advance, time scale is usually short, and 
there is often the need to link the analysis with quantitative findings. Framework 
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analysis has both inductive and deductive aspects. The individual accounts from 
interviews reflect the inductive component, but the pre-set aims and objectives 
mean that research starts deductively. It involves five key stages namely: 
familiarisation, identifying a thematic framework, indexing, charting, and mapping 
and interpretation(Lacey and Luff 2007; Pope, Ziebland and Mays 2006). This 
approach was therefore used for the following reasons:  
 it allows the use of a priori as well as emergent themes, and so research 
objectives can be analysed as themes and categories, 
 the research process can be planned and executed with specific scheduling, 
making it suitable for time-bound research like a PhD, 
 It can be executed in a linear fashion so that all data collection can be done 
prior to analysis, 
 It provides a systematic process that can inform third parties (e.g. funders 
and other stakeholders) of how results have been arrived at, 
 it provides the opportunity to reconsider and rework ideas because the 
analysis has been documented and therefore accessible,  
 Grounded theory was not appropriate because development of theories 
was not my objective, and there was not enough time to use that approach.  
4.6.2.3 QUALITATIVE ANALYSIS PROCESS 
All the recorded interviews were transcribed, and those not in English were 
translated and also transcribed into English. After this I read the transcripts and 
listened to the tapes to edit the transcripts and also to familiarise myself with the 
data to take note of key ideas and recurrent themes. The next stage was to develop 
a thematic framework by which the key issues, concepts and themes would be 
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examined and referenced. An initial framework was developed using all 29 
interviews, because my intention was to develop one framework for all 
respondents to make comparison across the groups easier. The codes used in this 
initial stage were both descriptive and interpretive using both sentences and 
paragraphs as units of analysis. 
The initial coding was done by writing the applicable codes in the margins of 
transcripts. Once all cases had been coded this way, the codes were combined into 
broader themes. These themes were derived from the research objectives, issues 
arising from the quantitative study, as well as those that emerged from the 
qualitative data itself. After coding the data, I had to go through again and again to 
recode and re categorise different codes. Afterwards I went back to the research 
objectives and questions in order to ensure that further analysis through charting, 
mapping and interpretation addressed the research objectives. During the charting 
and mapping I had to recode some areas and combine themes as the analysis 
progressed.  
During mapping I went through each sub theme to read through what each 
interviewee said concerning each one of them. I then summarised each code 
according to the main topics or the range of issues brought up on each code.. I had 
initially planned to use NVivo7 but once I started using it the laptop got frozen 
anytime I wanted to save what work had been done. Eventually I had to abandon 
its use and resort to Excel. The use of Excel instead of NVivo7 or other qualitative 
software meant this process was much more prolonged than anticipated. 
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4.7 RESEARCH FRAMEWORK 
The research framework (Table 15) is a schematic representation of the study 
showing the objectives of the study and how the research questions were 
addressed through the study methods. It is intended to provide a summary of this 
research and also to serve as a quick reference point with which to relate the 
subsequent chapters of the research. 
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Table 15 Research framework: summary of research objectives and methods 
Objectives Research Questions Methods Indicators/ Measures Analysis  
To explore the effects of  
integration on TB and HIV 
service on TB treatment 
outcomes 
Has the integration of TB and 
HIV services affected TB 
treatment outcomes? 
Natural experiment using 
before-and- after quasi- 
experiment and routine 
data at the individual 
study sites 
Outcome Indicators: TB 
treatment success rates 
Descriptive analysis using tables and graphs 
Comparison of outcomes before and after 
integration using odds ratios and chi-square 
(χ
2 
) tests  
Analysis of association between HIV status 
and treatment outcome using χ
2 
 
To compare the effect of 
different service delivery 
models on TB/HIV integration 
Does increasing degrees of 
integration improve TB/HIV 
outputs and outcomes? 
Output indicators : 
Proportions of TB patients 
who had VCT, CPT & ART 
Proportion of HIV patients 
screened for TB 
Descriptive analysis using tables and graphs 
Observing trends 
Comparison of outputs at all 3 sites using χ
2
 
contingency tables using the different levels 
of integration as 3 different exposures 
Use χ
2
 contingency tables to analyse the 
association between level of integration and 
outcome of TB treatment in all cases and 
among HIV positive cases 
What is the optimal TB/HIV 
service delivery model? 
Outcome Indicators:  
TB Treatment success rates in 
all cases and among HIV-
positive cases 
To explore the influences of 
provider and user behaviour 
and experiences on TB/HIV 
outputs and outcomes 
How does provider behaviour 
influence TB/HIV outputs and 
outcomes? 
 Semi-structured one-on-
one interviews with users 
and providers 
Coding (from objectives and 
emergent)  
 
Develop framework using 
priori  and emerging themes  
Charting, Mapping & Interpretation 
How does user experiences 
and behaviour influence 
TB/HIV outputs and 
outcomes? 
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4.8 STUDY RIGOUR 
4.8.1 RIGOUR IN QUANTITATIVE STUDY 
The following strategies were used in this study to address the threats to validity 
and reliability of the quantitative study. 
4.8.1.1 MATCHING 
Limited matching was used to make the three study sites as comparable as possible 
with respect to the these important characteristics: offering TB and HIV/ART 
services, using new and modified TB register, and staff trained on TB/HIV 
management. This was aimed at limiting the effect of non-random allocation and 
control for confounders as well  
4.8.1.2 STRATIFICATION 
Data was also analysed by stratification; data was disaggregated according to age, 
gender and the other participant attributes, and compared to explore the existence 
of any associations between these attributes and successful TB treatment 
outcomes. 
4.8.2 RIGOUR IN QUALITATIVE STUDY 
Rigour in qualitative research also involves validity and reliability but the criteria for 
definition and strategies to achieve these are different from those applicable in 
quantitative research because of the differences in the types of evidence provided 
by the two research approaches. The different types of measures used to ensure 
rigour in the qualitative component of the study are as follows:  
4.8.2.1 ENSURING METHODOLOGICAL COHERENCE 
The mixed methods approach used provided the opportunity to use both 
quantitative and qualitative methods appropriately to study the different research 
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questions developed from the conceptual framework (p. 87). The different types of 
data were then appropriately integrated to answer the questions.  
4.8.2.2 SAMPLING SUFFICIENCY 
The main stakeholders of integrated TB/HIV care are the policy makers, service 
providers, and the users of the service. The sampling strategy ensured that 
adequate data for all these stakeholders was obtained. Purposive sampling was 
used to identify key informants on TB/HIV services integration. 
4.8.2.3 THEORY DEVELOPMENT 
The interpretation and inferences drawn from the data were constantly related to 
the conceptual framework and its theoretical underpinnings. This enabled 
comparison with and further development of the theory of integrated care, 
although not the development of a new theory. 
4.8.2.4 TRIANGULATION 
Although a triangulation design was not used in the study, there was triangulation 
of data as qualitative findings were used to explain some of the quantitative 
findings. This would improve the accuracy and add to a more comprehensive 
understanding of TB/HIV integration.    
4.8.2.5 REFLEXIVITY 
Reflexivity concerns the relationship between the researcher and the social world, 
and the impact of the researcher on the research. The issues of reflexivity 
addressed here relate to methodological and theoretical openness, the awareness 
of the social context of the research, and the wider social and political contexts 
(Green and Thorogood 2009), all of which together influenced what data was 
acquired, and how it has been analysed. Steps taken in selecting and accessing 
study sites, data production and analysis have been explicitly outlined earlier in this 
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chapter. The theoretical starting point of this research is that integrated care 
improves health outcomes as depicted in the conceptual framework, and this 
informed the research questions, the choice of mixed methods approach as well as 
the methods of data collection and analysis. Findings of the study were therefore 
continually related to the conceptual framework to emphasis their theoretical 
relevance. 
Secondly, providers were aware of my background as a medical doctor and 
this influenced the interaction. All three managers are medical doctors by training 
as well, and were able to relate more at par in terms of power relations. The 
service providers on the other hand were all nurses and the interaction was 
influenced by the existing social context where nurses relate as subordinates to 
doctors. Some of them who felt I could help were more forthcoming with their 
experiences but some had doubts about this and were therefore more selective in 
their answers. My previous experience in the specific area also made it easier to 
share experiences and the freedom to use technical language in our 
communication. 
Patients were not aware that I am a medical doctor but from the introduction 
of the study in the first contact perceived me as a potential source of solution to 
some of their problems. A number of them therefore asked for financial or some 
other support. The use of service providers to assist in recruiting patients as 
described earlier on page  97 may have made patients feel they have no choice but 
to participate. This was avoided by taking time to explain to each participating 
patient the purpose of the study and assure them of confidentiality and privacy. I 
also actively assured them that participation or lack of it would not influence the 
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care they receive. On the other hand the stigma and social exclusion associated 
with both TB and HIV means patients hesitate to share their experiences as TB/HIV 
patients. Consultations are also too short to be able to share these with service 
providers. Some patients therefore used this unhurried time during the interview 
as a rare opportunity to talk about living with TB/HIV. 
In the wider social context TB/HIV integration enjoys a lot of political will at 
both national and programme level, and resources from the Global Fund. The study 
was therefore designed around the national TB/HIV policy so as to provide relevant 
and timely information to improve integration and its implementation. 
4.8.2.6 RELEVANCE 
The generalisability of findings is not in relation to the findings of this study but 
how this study informs the understanding of TB/HIV integration in similar contexts 
or similar issues in integrated care. The transferability of this research is 
demonstrated in identifying what was context specific and what would be more 
widely applicable within the findings. 
4.8.2.7 TRANSPARENCY 
A clear account of procedures used is provided as an audit trail for any audience. 
Additional measures taken to make analysis more rigorous were providing 
evidence from the data for each interpretation made, analysing the whole data set 
to maximise reliability, and comparing data between and within cases, as well as to 
other studies including the quantitative study.  
4.8.3 ETHICS 
Ethical approval for the study was sought from the University Of Leeds Faculty Of 
Medicine Research Ethics Committee as well as from the Ghana Health Service 
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Ethical Review Committee. The core ethical principles of this study have been 
respect for persons and communities, and beneficence and justice (Mack et al. 
2005). Ethical considerations in this study have therefore been based on avoiding 
deception or misrepresentation, protecting the identities and interests of 
participants, and guaranteeing confidentiality. 
4.8.3.1 CONFIDENTIALITY 
These steps were taken to ensure confidentiality of participants: 
 Keeping data secure by use of passwords and codes, and restriction of 
access to the data,  
 Storage of data and other related matters in locked safes, 
 Non-disclosure of embarrassing information in publications, 
 Signed consent forms kept separate from, and coded differently from 
corresponding interviews, and   
 Fair and unbiased analysis. 
4.8.3.2 PRIVACY 
Participant privacy has been ensured by instituting the following measures: 
 Conducting interviews in locations where minimal interference from other 
patients or health workers was encountered. In the hospitals interviews 
were held in a consulting room that would not be in use that period. 
Occasional interferences occurred where patients or other staff would 
knock and enter thinking there was on-going consultation. During such 
interferences the interviews were halted, 
 Patient records that were not relevant to the study objectives were not 
included in the data collection. Data was anonymised, 
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 No identifying characteristics will also be used in publications. 
4.8.3.3 BENEFITS  
 Immediate benefits to patients are the improved delivery based on 
reactivity i.e. provider behaviour is altered because of the awareness of 
ongoing research, 
 To providers the immediate benefit of motivation and stress release that 
comes with talking through achievements and problems. Secondly, their 
concerns and challenges were communicated directly to the policy makers 
at the national level, 
 To the facilities the study will also identify gaps in service delivery and 
effective ways of addressing these at the facility level, 
 In the medium to long term the study will result in improved patient 
outcomes, patient satisfaction, reduced cost and reduced disease burden, 
better quality of care and improved quality of life especially for TB/HIV 
patients. The findings of the study are intended to inform policy decisions 
that will improve working environment.  
4.8.3.4 REDUCING RISKS  
 Location and timing of interviews were chosen with safety of both 
researcher and participant in mind. A good balance of safety and privacy 
was pursued. Interviews were held during normal working hours and mostly 
in the clinics and offices. For those interviews held in the homes of 
participants I travelled with other health workers who stayed at a distance 
during the interview itself, 
 Questions were asked with participants’ sensitivity, feelings and other 
religious or cultural beliefs in mind. Local phrases that reflect the respect 
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for participants like ‘please’, ‘with all due respect’ and ‘thank you’ were 
used frequently. They helped in reducing any psychological difficulties of 
talking about much stigmatised health conditions, 
 Participants had the option to refuse to answer any question or to withdraw 
participation at any point in time, 
 Sensitive information will be handled in order not to result in victimisation 
or political embarrassment, particularly for the managers. 
4.8.4 LIMITATIONS OF STUDY 
This is a pilot study and therefore the findings are not statistically representative of 
TB/HIV programme in Ghana, but are intended to anticipate design and delivery 
issues that can undermine effective evaluation, so as to improve the intervention, 
its evaluation and implementation. The limitations of this study have been outlined 
in the subsections below. 
4.8.4.1 Study design 
 The concurrent approach used in the mixed methods design enabled the 
study to be conducted over a shorter period but prevented the use of the 
quantitative findings  to inform the qualitative study. The qualitative study 
would then have been used to explain or corroborate quantitative findings, 
 The quasi-experimental design is subject to a number of biases that prevent 
causative inferences to be drawn from the findings. The lack of 
randomisation and the absence of controls introduces a selection bias 
which makes the findings liable to confounders arising from differences in 
the individuals as well as the sites. And therefore the effects measured 
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could be due to these confounding characteristics either before or after 
integration, 
 Quasi-experimental studies are also liable to temporal effects like history.  
History in this context refers to other events in or outside the study setting 
which is not of interest but that could have accounted for the effects 
measured. In this study such events included the on-going activities by the 
TB and HIV national programmes,  
  Another relevant bias is statistical regression which describes the fact that 
dependent variables relating to any process naturally fluctuates around a 
mean. Changes in the TB/HIV output and outcome indicators of research 
interest could be falsely increased or decreased if the study coincided with 
an upward or downward trend of statistical regression respectively. 
4.8.4.2 Sampling   
 The use of purposive sampling and the recruitment process may have 
compounded the  selection bias, which implies the effects measured could 
be due to the differences in participants and the study sites which are not 
of research interest, 
 Only 3 study sites were used, which provides a low statistical power for 
inferences. And also the sample sizes of participants at each site used in 
determining outputs and outcomes were small, particularly the numbers 
used in the determination of treatment success rate in all cases and in HIV-
positive TB cases. Another source of bias from the samples was the 
differences in participant numbers at the three sites: the referral site had as 
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many participants as the two sites combined, leading to different statistical 
powers of the findings, 
 Cluster effect: this refers to the fact that individuals in a particular 
treatment group will tend to behave in a similar manner leading to a loss of 
independence in the participants at each site. This would result in errors in 
estimation of the effect of integration at each site. 
4.8.4.3 Reliability of Intervention Implementation 
Although national guidelines exist and training of staff are based on these 
guidelines, bias may arise from the differences in the implementation of 
integration (Cook and Campbell 1979). In this study the bias may arise as a result of 
the differences in the calibre of staff at the different sites. Bias may also be due to 
the variations in the aspects of the guidelines where providers exercise some 
discretion and make decisions about the specificities of the treatment e.g. 
counselling session,         
4.9 CONCLUSION 
I have used the above chapter to describe the methods used in this study. I 
introduced the mixed methods approach and then the study design. Subsequently 
the data collection and analysis methods are also described before the study 
methods are evaluated by reflecting on the strengths, challenges, and limitations of 
these methods.  
The effectiveness of study methods are influenced variably by the context 
within which the study occurs. Therefore the setting of this study is described in 
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the next chapter to provide an insight into Ghana’s health system and TB/HIV 
control in the country. 
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5 RESEARCH SETTING 
5.1 INTRODUCTION 
This chapter is intended to provide a description of the context within which this 
study was conducted for a better understanding of the study. There is a brief 
description of Ghana’s demographic profile, geography, history and the economy. 
This is followed by a narrative on Ghana’s health system, TB and HIV control in 
Ghana, as well as TB/HIV in Ghana. The chapter then concludes with an account of 
the study sites and the TB/HIV services they provide. 
5.2 GHANA 
5.2.1 DEMOGRAPHIC PROFILE 
Ghana’s population is 24,233,431  with a male to female sex ratio of 95 : 100 
(Ghana 2011). The proportion of the population under 15 years however has 
decreased from 47 percent in 1970 to 36.5%  percent in 2011. Population growth 
rate is 1.8% and life expectancy at birth is currently at 61 years.  
5.2.2 GEOGRAPHY  
The Republic of Ghana is centrally located on the West African coast and has a total 
land area of 238,537 square kilometres. Ghana is divided into ten regions (Figure 
14). Ghana can be divided into three ecological zones: the sandy coastline backed 
by a coastal plain; the middle belt and western parts which are forests; and a 
northern savannah, which is drained by the Black and White Volta Rivers. The Volta 
Lake, created by the hydroelectric dam in the east, is one of the largest artificial 
lakes in the world. Ghana has a tropical climate with temperatures and rainfall 
varying according to distance from the coast and elevation (USAID 2011).  
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Figure 14: Administrative Map of Ghana 
 
5.2.3 HISTORY  
Ghana gained independence from British rule on 6 March 1957, and became a 
republic in the British Commonwealth of Nations on 1 July 1960. Its administrative 
and political capital is Accra. There are 10 administrative regions sub-divided into 
170 districts to ensure equitable resource allocation and efficient and effective 
administration at the local levels (USAID 2011). The proportion of the population 
living in urban areas has been increasing over the years: changing from 30% in 1978 
to 45% in 2003 (Ministry of Health 2007). 
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5.2.4 ECONOMY 
Agriculture is still the most important area of economic activity, followed by 
services, and then industry. Agriculture contributes 34% of the gross domestic 
product (GDP) and it employs about 50% of the population.  The service sector, 
with a growth rate of 10%, is the fastest growing sector of the economy and it 
contributes one-third of the country’s GDP. The industrial sector contributes a little 
over one-quarter (26%) to the country’s GDP. The leading export commodities of 
the country are cocoa, gold, and timber. In recent times, the economy has 
diversified to include exports of non-traditional commodities such as pineapples, 
bananas, yams, and cashew nuts. Tourism is fast gaining prominence as a foreign 
exchange earner (USAID 2011). 
5.3 THE HEALTH SYSTEM IN GHANA 
5.3.1 MINISTRY OF HEALTH 
Ghana has in the last two decades pursued a health sector decentralisation 
programme as a means of improving the performance in the sector. This 
decentralisation has been aimed at transferring fiscal, administrative, ownership 
and/ or political authority for health service delivery from the central Ministry of 
Health (MOH) to alternate institutions (Figure 15). The MOH is therefore now 
primarily involved in policy formulation, setting standards, mobilizing resources, 
capacity development, technical support, coordination of health research, and 
overall monitoring and evaluation of performance in the sector (Ministry of Health 
2007).  
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Figure 15: Agencies under the Ministry of Health in Ghana 
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The Regional and District Health Administration ensure that services provided are in 
line with the national policies. Planned activities revolve around the 5 main objectives 
of the MOH, which are to increase geographical and financial accessibility in health, to 
provide better quality of care in all health facilities, to improve efficiency at all levels, 
to foster closer collaboration with communities and other partners, and to increase 
resources and ensure equitable and efficient resource distribution.  
The Ghana Health Service (GHS) was established in 1996 as an autonomous 
agency responsible for implementing national policies from the MOH. This was seen as 
a necessary step for achieving a more equitable, efficient, accessible and responsive 
health care system. Taking health care out of the civil service provided the 
management flexibility for a more efficient system (Ghana Health Service 2011a). 
Christian Health Association of Ghana (CHAG), on the other hand is a non-
governmental and not-for-profit organisation bringing together churches involved in 
the provision of health services. CHAG plays a complementary role to the MOH and 
the GHS, and is the second largest provider of health services in the country. CHAG’s 
182 member institutions provide about 42% of total health services in the country, and 
are predominantly located in rural, underserved areas (CHAG Ghana 2011).    
5.3.2 PUBLIC HEALTH SECTOR  
The public sector of the Ghana Health System is made up of the Ghana Health Service, 
Teaching Hospitals, Quasi-government facilities, and Faith-based organisations (FBOs) 
including CHAG. Service delivery organisations are graded into primary, secondary, and 
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tertiary care depending on the level of complexity of services and the administrative 
zones they serve (Table 16).  
Table 16: Organisation of health service delivery in Ghana (Ghana 2005) 
Level of Care Institution Services/Functions 
Tertiary Teaching Hospitals - Apex of care 
- Research & Training 
Secondary Regional Hospitals - 2
nd referral level 
- Specialised clinical & diagnostic care 
Primary District Hospitals 
- 1st referral point for primary health 
care 
- Clinical inpatient and outpatient care 
- Maternity services 
- Back-up for health centres 
 
The quasi-government health facilities are those that were initially established to 
address the health needs of staff of some public institutions, but have evolved and 
become integrated into the public sector. These are primary and secondary level 
facilities that may be involved in teaching, training and/or research. They include the 
37 Military Hospital under the Ministry of Defence, the University Hospitals under the 
Ministry of Education, and the Police Hospital under the Ministry of Interior. 
Health service at the district level is also subdivided into sub-districts and 
communities (Figure 16). The District Health Administration provides technical and 
administrative support to health service providers. These include resource 
mobilization and distribution, training and research programmes. There is a District 
Health Management Team (DHMT) responsible for providing leadership in service 
delivery.   
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Figure 16: Health services delivery at the district level (Ghana 2005) 
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Key: CHPS – Community-based Health Planning and Services 
5.4 TUBERCULOSIS (TB) IN GHANA 
5.4.1 EPIDEMIOLOGY 
The last TB survey in Ghana was carried out in 1957 and therefore the exact burden of 
the disease is unknown. Current estimates are from WHO annual reports which 
suggest that TB case detection in Ghana is about 30% of all existing cases (NTP 2009a). 
The WHO 2010 Global TB report puts TB incidence in Ghana at 201/100,000 
population, and case notification has increased from 7425 in 1996 to 14022 in 2008 
(NTP 2009a). National figures show that there has been a trend indicating improving 
control as demonstrated by increasing numbers of patients evaluated after treatment, 
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successful treatment outcomes, and decreasing numbers of default cases [(NTP 
2009b), Figure 17).  
Figure 17: Trend of TB treatment outcomes in Ghana: 1996 - 2008 
 
The overall male-female ratio among notified TB cases is 2:1; the peak age for women 
is 25 to 34 years, and 35 to 44 years for men. Multi-drug resistant (MDR) TB, a threat 
to global TB control, formed 0.9% and 14% of new TB and retreatment cases 
respectively (NTP 2009a).  
5.4.2 NATIONAL RESPONSE 
Tuberculosis control in Ghana started in the pre-independence era when the then 
colonial government recognized the need to combat the disease due to the threat it 
posed to the larger society. Therefore since the 1950s there has been a structure in 
place for the care of TB patients in all regional hospitals and the two Teaching 
Hospitals localised to the Chest Clinics. In addition most mission hospitals also run 
Chest Clinics which took care of TB patients. These clinics were supervised infrequently 
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by the Ministry of Health, and there were challenges such as late reporting of patients 
with advanced disease, no specific treatment guidelines, erratic drug supply and no 
proper evaluation systems (Ghana Health Service 2011b). In 1991 it was concluded 
that important measures were required to rectify the challenges of TB control, and a 
consensus was reached on the need for a control program followed by the drafting of 
a TB Control Program. The implementation of the program started in 1994 and in the 
same year, Ghana adopted the WHO DOTS (Directly observed therapy, short course) 
Strategy (Ghana Health Service 2011b) 
The National TB Control Programme (NTP) has since been implemented 
countrywide and involves ensuring regular drug supply, surveillance, building capacity 
for TB treatment and control, and directly supervising treatment among others. Ghana 
achieved 100% DOTS coverage in 2000. TB treatment is free in Ghana: the Government 
of Ghana supports the programme financially every year but the main funding for its 
activities is from the Global Fund which is set aside to support the control of Malaria, 
Tuberculosis and HIV/AIDS. The NTP is now implementing the new Stop TB Strategy of 
WHO which has six strategies: to pursue high-quality DOTS expansion and 
enhancement, address TB/HIV, MDR-TB and other challenges, contribute to health 
system strengthening, engage all care providers, empower people with TB and 
communities through partnerships, and to enable and promote research (WHO 
2010a). 
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5.4.3 CASE MANAGEMENT 
TB management has been mostly decentralized in the country such that primary TB 
services can be accessed in communities or health centres in every district in the 
country. Management of TB in Ghana currently lasts 6 months using fixed dose 
combinations (FDCs) for the appropriate categories, and the drugs used are Isoniazid 
(H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E) and Streptomycin (S) as indicated 
in table 17. Sputum smears are checked after the second and fifth months of 
treatment.  
Table 17: Recommended treatment regimens for TB in Ghana (NTP & NACP 2007) 
Patient 
Category 
Definition Initial Phase Treatment Continuation Phase 
Treatment 
Daily (28 doses/month) Daily (28 doses/month) 
I All New Cases 
New smear positive 
New smear negative PTB 
Concomitant HIV disease 
Extra-pulmonary TB 
2 (HRZE) 
= 56 doses of HRZE 
4 (HR) 
= 112 doses of HR 
II Previously treated sputum 
smear-positive PTB 
Relapse 
Treatment after 
interruption 
Treatment failure 
2 (HRZE)S 
+ 
1 (HRZE) 
= 84 doses of HRZE + 56 
doses of S 
5 (HRE) 
= 140 doses of HRE 
III Children under 12 years 2 (HRZ) 
= 56 doses of HRZ 
4 (HR) 
= 112 doses of HR 
 
Currently diagnosis and susceptibility testing of drug resistant TB cannot be done in 
Ghana and samples have to be sent to Egypt or South Africa. Once this has been done 
treatment of cases occurs in the Korle-Bu Teaching Hospital Chest Clinic. However 
there are plans to establish a diagnostic and treatment centre in the country in the 
near future.  
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The outcomes of TB treatment in Ghana are cured, completed treatment, died, 
defaulted, failure or transferred out. Cured cases refer to all sputum-smear positive 
cases who have negative sputum-smear at month 2, 3 or 5, complete the designated 
treatment, and still have negative sputum smear after completing treatment. 
‘Completed treatment’ is used to describe all smear-negative cases, EPTB cases, and 
children who successfully complete the treatment. It also includes all smear-positive 
cases who have sputum conversion at the end of the second, third or fifth month, 
complete treatment but are unable to do the final sputum smear at the end of 
treatment. Anyone who dies during TB treatment is counted as an adverse TB 
treatment outcome, irrespective of the cause of death.  
A person is described as a defaulter if after a month or more of treatment there 
is an interruption for more than a month. And transferred out cases represents all 
patients on TB treatment who after initiating treatment at one site, are referred to 
another treatment facility outside the district of the current treatment facility. If 
sputum conversion does not occur at the end of 5 months of treatment, a patient is 
said to have had a failure of treatment. ‘Cured’ and ‘completed treatment’ together 
constitute the successful outcomes while the rest are described as adverse outcomes.  
TB treatment success rate refers to the proportion of registered cases who were cured 
or completed treatment. 
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5.5 HIV IN GHANA 
5.5.1 EPIDEMIOLOGY 
The first HIV case was recorded in Ghana in 1986. HIV prevalence rate among adults 
(15 - 49 years) has decreased from 2.6% in 2000 and 3.1% in 2004 (GAC 2005a), to 
1.9% in 2009 (NACP, 2010a). The total HIV population estimate for 2009 is 267,069 
persons made up of 112,457 males and 154,612 females; 25,666 children were living 
with AIDS, and there were an estimated 20,313 deaths. AIDS orphans were 149,543 in 
total (NACP 2010a). Almost 40% of all new cases are due to unprotected paid sex, sex 
between men, and the use of contaminated drug-injecting equipment by two or more 
people on the same occasion (UNAIDS 2010).  
According to the 2009 HIV Sentinel Survey, the median national prevalence of 
HIV in adults between 15 and 49 years is on a downward trend from 2000 (Figure 18) 
but with peaks in 2003, 2006, and 2009 (NACP 2010b). The median prevalence varied 
from 0.7% in North Tongu in the Volta Region to 5.8% in Koforidua and Agomanya in 
the Eastern Region.  The prevalence in rural sites was 2.2% as compared to 3.6% in 
urban sites (NACP 2010b). 
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Figure 18: HIV Sentinel Sites survey in Ghana: 2000 - 2009 
 
5.5.2 NATIONAL RESPONSE 
The Government of Ghana established the National AIDS/STD Control Programme 
(NACP) in 1987 to coordinate the national response to the epidemic. NACP led in the 
development of a Short Term Plan (STP) for the prevention and control of HIV/AIDS 
that ran during 1987 and 1988. Subsequently, NACP developed the first Medium Term 
Plan (MTP-1) that guided HIV/AIDS prevention and control efforts between 1989 and 
1993.  
The Ministry of Health was primarily responsible for implementing the early 
programmes. However, over time, other public sector ministries, the private sector, 
non-governmental organizations (NGOs) and people living with HIV/AIDS (PLHIV) have 
become more involved in programme implementation. In 1997, NACP led the drafting 
of a policy document on HIV/AIDS. The purpose of the policy was to create a 
favourable environment for all HIV/AIDS control and prevention programmes, and to 
mitigate the social and personal consequences of HIV infection on those persons living 
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with the virus and on those persons who have already developed AIDS (NACP 2001). 
Following a review of the national response that stressed the importance of expanding 
a multi-sectoral approach to the epidemic the Ghana AIDS Commission (GAC) was 
established in 2000 to provide efficient and effective leadership, and to coordinate all 
programmes and activities of all stakeholders (GAC 2005b).  
The national response has resulted in the development of guidelines to 
standardize treatment and care, training of service providers, and the setting up of 
VCT and PMTCT centres nationwide. In 2003, Ghana began the process of delivering 
ART to all eligible HIV-positive patients in the country at four public health facilities, 
and in 2005/2006, the Government of Ghana’s HAART programme began to 
implement a scale-up plan, accompanied by ongoing efforts to scale up VCT and 
PMTCT services (Ghana Health Service 2007). At the end of 2009, there were 808 
counselling and testing sites (with or without PMTCT), and 138 ART sites (NACP 
2010a).   
5.5.3 CASE MANAGEMENT 
A heavily subsidised comprehensive HIV/AIDS care package with ART for eligible 
patients is currently hospital-based and can be accessed through acute medical 
services, referrals from testing and diagnostic centres, Reproductive and Child Health 
Clinics, PMTCT units, TB services, and other community- or home-based programmes 
(Ghana Health Service 2007). The mainstay of care includes prevention and 
management of opportunistic infections, provision of ART, and prevention of future 
spread. 
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5.6 TB/HIV IN GHANA 
5.6.1 EPIDEMIOLOGY 
According to estimates, 12% and 23% of all new TB cases were HIV positive in 2009 
(WHO 2010a) and 2010 (WHO 2011). No systematic, nationwide study on the 
prevalence of TB and HIV prevalence co-infection has been conducted yet, but it is 
estimated that HIV-associated TB cases have been increasing since 1989 (Ghana Health 
Service 2007). According to Adjei et al. (2005), sero-prevalence of HIV in all TB suspects 
in the Korle-Bu Teaching Hospital-based study of 277 subjects was 46.2%. In 2009, 
22.5% of all TB patients screened nationally for HIV were positive (NTP 2010).  
5.6.2 RATIONALE FOR INTEGRATION 
The main rationale for TB/HIV services integration is the recognition that the two 
diseases amplify one another’s impact. TB is recognized as the most important 
opportunistic infection in HIV. TB increases mortality and morbidity in HIV patients by 
speeding up the progression of HIV infection to clinical AIDS. By the same token, HIV is 
known to be fanning the flames of the TB epidemic in Ghana as in other parts of the 
world. Secondly, while the NACP HAART programme is relatively new, the NTP is well 
established in all districts with 100% DOTS coverage, and has strengths that can be 
synergistic with the national scale-up of the HAART programme. Closer collaboration 
will increase efficiencies, improve service delivery, eliminate overlap, and help reduce 
national health care costs: both patients and health workers will benefit (Ghana Health 
Service 2007). 
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5.6.3 TB/HIV POLICY 
A national policy for the ‘Implementation of TB and HIV Collaborative Activities in 
Ghana’ was launched in 2007 with the goals of strengthening the health system to 
respond to the TB/HIV dual epidemic, decreasing the burden of TB in people living with 
HIV/AIDS (PLHIV) and decreasing the burden of HIV among TB patients. The overall 
strategic framework consists of three linked sets of activities: effective implementation 
of the STOP TB Strategy for TB control, improved HIV prevention and care, and 
implementation of a set of additional collaborative TB/HIV activities for which both 
NTP and NACP are responsible (Ghana Health Service 2007).  
5.6.4 TB/HIV INTERVENTION 
The integration of TB and HIV services in Ghana has involved the introduction of 
collaborative activities into existing care processes, as well as new indicators for the 
management of TB and HIV, and the monitoring of their activities. Therefore in 
addition to the TB programme activities already in place, TB patients would also be 
routinely offered counselling and testing for HIV, Co-trimoxazole preventive therapy 
(CPT) for those found to be HIV positive, and if eligible Antiretroviral therapy (ART). 
HIV patients would also be routinely screened for TB on each visit. At the study sites, 
HIV screening, CPT and ART were routinely made available to patients through the TB 
centres and recorded in the new TB registers from June 2007, but the screening of HIV 
patients for TB had a much delayed and non-uniform start.  
Prior to the launching of the TB/HIV policy in 2007, a number of meetings and 
workshops had been held at the national level to initiate a national response. After a 
number of stakeholders’ meetings, a national TB/HIV coordinating body was 
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established in early 2005 to define the roles and responsibilities for TB/HIV 
collaborative activities by NACP and NTP. In allocating responsibilities, care was taken 
to minimize duplication of effort and to coordinate budgets. A major priority was to 
take advantage of the natural synergies and complementariness of the two 
programmes. Subsequently a focal person for joint TB/HIV collaboration was identified 
to coordinate and ensure joint TB/HIV activities (Ghana Health Service 2007).   
Anderson and Maher (2001) identified that at the national and district level, some 
mechanism promoted to enhance TB and HIV/AIDS programme collaboration include 
the following:  
 in-country high level political commitment, 
 joint planning meetings, 
 involvement of HIV and TB community groups on national interagency 
 co-ordination committees, 
 joint training of programme and general health service provider staff in TB and 
 HIV issues, 
 joint TB and HIV/AIDS programme reviews, 
 utilisation of existing organisational structures and the sharing of experience, 
 a strengthened referral system, 
 implementation of HIV care packages, including TB prevention and care, and 
 formulation of joint health education messages. 
The TB/HIV policy therefore defined how these mechanisms would be 
combined to  characterise the TB/HIV intervention. The different activities that have 
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been involved in the process of integration in Ghana have been outlined in table 18 
according to the goals of the national policy.  
Table 18: TB/HIV in Ghana 
Policy objective Related activities Implemented in integration 
Health System 
Strengthening 
Coordination of TB/HIV activities at all levels:   
- national TB/HIV focal person appointed 
- formation of coordinating partnerships at all levels to coordinate 
activities 
Joint TB/HIV Planning: 
- Developing partnership with national, community and private 
stakeholders 
-  resource mobilisation and deployment 
-  joint advocacy, communication and social mobilisation 
- support for operational research 
Health Infrastructure Development: 
- Human resource development and capacity building through joint 
training of health workers on TB/HIV i.e. pre-service, and  in-service; 
continuing professional development and specialisation courses being 
planned 
-  Health System Support: Capacity strengthening of laboratories to 
improve quality of diagnosis, supply of drugs, equipment and some 
infrastructure to TB/ART treatment centres, and improved 
partnership and linkages with other sectors of the health system 
- Strengthening  Programme Management at all levels: Appointment of 
central unit staff like data and drug managers, focal persons for 
human resource development and monitoring and evaluation, regular 
updates of field manuals, clinical forms, registers and cards; and 
sensitisation of all stakeholders and partners 
Building Partnerships 
- Use of NGOs, community volunteers and family supporters in patient 
management 
- Training of NGOs, CBOs and FBOs  
Surveillance 
- Baseline survey of TB/HIV burden yet to be done 
- Use of regular reporting and recording tools provided by both 
programmes 
Supervision, Monitoring and Evaluation 
- Use of core set of TB/HIV indicators, and regular review and reporting 
on the indicators at district, regional and national levels 
- External monitoring and evaluation yet to be done 
- Forms and data recording tools have been modified to capture joint 
TB/HIV data.  New TB/HIV specific forms not created 
Decreasing the 
burden of TB in 
PLHIV 
Prevention of TB infection in PLHIV 
- Active contact tracing for TB contacts of PLHIV 
- Operational research for more evidence on the feasibility of IPT yet to 
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be done 
Early diagnosis and treatment of HIV-associated TB 
- HIV patients are screened for TB but not suspects as in the policy 
- Sputum cultures are hardly done for sputum negative HIV-positive 
patients as stipulated in the policy  
Decreasing the 
burden of HIV 
in TB patients 
Prevention of HIV in TB patients 
- Provider initiated counselling and testing for all TB patients 
- Discussion of sexual issues, availability of condoms, and STI screening 
and treatment at TB centres are not routinely done 
- Reduction of occupational and nosocomial exposure to HIV 
Provision of ART 
- Strong links between TB and ART centres have been established to 
facilitate cross referrals 
HIV care and support during and after TB treatment 
- Involves clinical, nursing and home care 
- Professional psychosocial support lacking. NGOs provide supportive 
social network 
- Continuity after TB care mainly the responsibility of individual 
patients 
5.7 EASTERN REGION 
The Eastern Region (ER), where the study was conducted, is in the south-eastern part 
of Ghana and is the third most populated region with 11.5% (2.1 million) of Ghana’s 
population. It has Koforidua as its capital. Like all of the 10 regions in Ghana, it has one 
regional hospital and a network of district hospitals, health centres, mission hospitals, 
clinics and community facilities. Private clinics and maternity homes, chemical sellers, 
traditional healers, and traditional birth attendants are significant contributors to 
health care in the mostly rural population (Ghana Districts 2011).  
HIV prevalence in the ER was the highest nationwide in 2009 at 4.2%, with the 
highest site prevalence of 5.8% occurring in Koforidua and Agomanya (NACP 2010b). 
At the end of 2009, the region had the highest concentration (28.7%) of counselling 
and testing sites in any region, and had 17 ART hospitals (NACP 2010b). The ER has 
consistently contributed the highest number of reported AIDS cases nationwide 
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between 2007 and 2009: 50.8% in 2007, 30.0% in 2008 and 31.6% in 2009 (NACP 
2010a). Even though the ER has consistently had the highest HIV prevalence levels 
nationwide, the region is also experiencing a similar trend of reduction as observed 
nationwide albeit more dramatic (Figure 19). 
Figure 19: Trend of HIV Prevalence in the Eastern Region: 2003 -2009 
 
AIDS deaths was also highest in the region in 2007 (23.4%) and 2009 (38.9%), but was 
second to Greater Accra Region in 2008 at 26.1% (NACP 2010a). In 2009, HIV-
prevalence among TB patients nation-wide was also highest in the Eastern region 
(Figure 20) 
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Figure 20: TB/HIV burden by region in Ghana: 2009 
 
5.8 STUDY SITES  
The three study sites are all located in the Eastern region. St Dominic’s Hospital, the 
one-stop shop (OSS), is located in the Kwaebibirem District and is the biggest mission 
hospital in Ghana with 357 beds. As at 2005 the population density of the district was 
160 persons/km2, as compared to 109 persons/km2 for the region (KDA 2011). The 
commonest income-earning activities in the district are agriculture (76.8%) and 
industry (11%). The district has 2 hospitals, 4 health centres, and 3 community clinics, 
among other private health facilities. The St. Dominic’s Hospital is the one of the most 
well-equipped health institutions in the district with 10 medical doctors, 148 nurses, 
and 5 medical assistants. The Hospital is the only service delivery facility that supports 
PLHIV in the form of feeding, transportation costs and other social activities (KDA 
2011).  
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Atua Government Hospital is located in Agomanya in the Lower Manya Krobo which is 
one of the 21 districts in the Eastern Region. The population density in the 2000 census 
was 114 per square kilometre, greater than the regional figures of 109. The age 
dependency ratio is 1:07 (i.e. one active person to 0.7 inactive person) and the sex 
ratio is 95.2 males to 100 females, which is about the same as the national average of 
95:100. There are four hospitals, which serve as the first referral points namely: Atua 
Government Hospital, Akuse Hospital, St. Martin’s Hospital (Catholic) and Asesewa 
Hospital. The commonest economic activities are farming and trading (LMKDA 2006). 
The Atua Government Hospital is a 112-bed hospital established in 1977. Currently 
there are 2 permanent doctors and 72 nurses. It is the smallest of the three hospitals 
selected for this study. 
The New Juaben covers an estimated 0.57% (110 km2) of the total land area of 
the ER.  Females form 52% of the population. There are three main economic activities 
prevalent in New Juaben: service sector (44%), agricultural sector (28%), and industrial 
sector (27%). There are 2 hospitals in New Juaben: the Koforidua Central and the St. 
Joseph’s both in Koforidua. There are also 3 health centres and 2 community clinics 
(NJMA, 2011). The Koforidua Central Hospital was established in 1926 and currently 
doubles as a referral centre for the region. It has 323 beds with 48 doctors and 220 
nurses (Anim Boamah 2011). 
The TB/HIV activities at the 3 sites are described below and a description of how 
these are related are summarised in table 19.   
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Table 19: TB/HIV Activities at study sites 
Characteristic One-stop shop Partial integration Referral 
Location of DOTS  and 
HIV Clinics 
Co-located in a 
purpose-built 
building 
Different parts of 
same hospital 
Different parts of 
hospital & district 
HIV Pre-test 
counselling 
TB and HIV staff at 
centre 
TB and VCT staff  TB or HIV staff 
HIV testing TB or HIV staff HIV staff HIV staff 
Post-test counselling TB or HIV staff HIV staff HIV staff 
HIV treatment Same location Referred to HIV clinic Referred to HIV clinic 
HIV clinic staff TB/HIV team  TB &VCT team 
leaders 
HIV staff only 
CPT prescription TB or HIV staff TB & VCT team 
leaders 
HIV staff only 
ART prescription Team leader (doctor) TB &VCT (nurses) HIV staff only (nurses 
& doctor) 
 
5.8.1 TB SERVICES 
TB services in the OSS are mainly based in the Fevers’ Unit. Services are available on all 
days because of the in-patient component of the unit. In the partially integrated site, 
the TB centre is located in a room in the general OPD and is headed by a senior nursing 
officer. Counselling done prior to registration and initiation of TB treatment is done on 
all weekdays. The TB Unit at the referral site had initially been located outside Central 
Hospital at the beginning of this study but was later relocated within the hospital 
although it still remained separate from the HIV/VCT centre.  TB services are available 
all days of the week apart from the weekend.  
Common characteristics observed about the TB services in all three sites were 
that both suspected and confirmed cases are received from the OPD, other wards, or 
as referrals from other facilities without diagnostic or treatment services, and there 
were usually no queues. All sites also used the national treatment guidelines, the new 
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TB registers, and they all regularly sent quarterly reports through the district 
coordinators as required by the NTP. 
5.8.2 VCT FOR HIV AMONG TB PATIENTS 
The three study sites all comply with the national policy for active case finding (Ghana 
Health Service 2007). All TB patients at the OSS are counselled for HIV and then tested 
if they consent. Although there is a separate VCT unit in the hospital, the Fever’s unit 
has counselling and testing services available and patients do not have to be referred 
to the VCT centre. At the partially integrated and referral sites all new cases are 
referred to the VCT centre preferably before treatment is initiated. Privacy and the 
comfort of clients are well ensured and results are usually ready within an hour in all 
sites. VCT services are available all days including weekends and holidays at the OSS 
unlike the other two sites where the VCT centres are closed on weekends and public 
holidays. 
5.8.3 CPT 
Co-trimoxazole (CTX) prophylaxis is available through the HIV clinics for all HIV positive 
patients, including HIV-positive TB patients. The prescriptions are made out by the 
doctors and nurse prescribers at the HIV clinics. Patients who refuse to attend the HIV 
clinic are therefore not likely to receive CPT.  
5.8.4 HIV CLINICAL CARE 
The HIV clinics operate once a week at the OSS and the referral site (RS), and two 
times at the partially integrated site (PIS). The OSS and RS clinics are handled by 
doctors and nurses, but at the PIS the clinic is manned by two nurse prescribers. These 
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clinics are usually very heavy and often translate into long waiting times for patients, 
especially at the RS and PIS.  Patients are referred from the VCT centre, the DOTS 
centre and other testing facilities in the district or elsewhere. All the clinics follow the 
national guidelines for the management of cases. 
5.8.5 ART 
As part of the national ART scale-up programme, ARVs are available in all three study 
sites at a heavily subsidised rate. Due to the use of rifampicin throughout the 
treatment of TB in Ghana, efavirenz (antiretroviral) which has a relatively lower 
interaction with rifampicin has been made available for HIV-positive patients on TB 
treatment (Ghana Health Service, 2007). CD4 testing is done to assess the eligibility for 
ART for each new patient and thereafter every 3 or 6 months to monitor the CD4 
count. Currently a CD4 count value of 350 cells/mm3 or less (250 cells/mm3 prior to 
June 2008) is an indication for the initiation of ARVs. For co-infected patients who are 
eligible for ARVs, the guidelines suggest that the priority is to start TB treatment 
immediately.  
The timing of the initiation of ART is determined by the level of the CD4 count. If 
the count is more than 350 cells/mm3, then ART is started after completion of TB 
treatment. For values between 250 cells/mm3 and 350 cells/mm3 ART is started after 
the initial phase of TB treatment. When CD4 count is less than 250 cells/mm3, ART is 
started after 2 - 4 weeks of TB treatment when the therapy is tolerated. ARTs are 
started concomitantly with TB treatment in cases where the CD4 count is 50 cell/mm3 
or less (NTP & NACP 2007). 
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5.8.6 TB SCREENING AMONG HIV PATIENTS 
Active TB case finding using the TB screening tool had not yet started in any of the 3 
study sites although staff were aware of the screening tool. What currently pertains is 
the routine questioning of whether or not a patient has been treated for TB before. 
When complaints indicate it questions about cough lasting 2 weeks or more, fever and 
night sweats are asked to decide whether there is the need to do sputum AFBs.  
5.9 CONCURRENT TB AND HIV PROGRAMME ACTIVITIES  
The implementation of the TB/HIV policy in Ghana has not been in vacuum but was 
done in an enabling environment which had been created as a result of the 
effectiveness of previous TB and HIV control strategies, as well as other local and 
global factors. TB/HIV integration was therefore a component of broader nationwide 
strategies to improve effectiveness of and access to TB and HIV control programme 
activities (Ghana Health Service 2007). Other NTP objectives in addition to TB/HIV 
integration were to improve coverage and quality of DOTS expansion in Ghana, and to 
promote behavioural change communication (BCC) interventions in support of TB 
control activities.  
As part of the former objective, interventions introduced included expansion of 
Public-Private Mix DOTS, improving access to DOTS services through community-based 
TB care facilitated by the use of treatment supporters, and reducing TB transmission in 
the Ghana Prison System (Ghana Health Service 2007). Quality improvement activities 
in the form of monitoring, supervision, training and education were also introduced. 
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BCC activities were targeted at encouraging healthy behaviours and reducing stigma 
(Ghana Health Service 2007). 
On the HIV front, the main concurrent objective was the nationwide scale up of 
ART. And therefore in addition to existing activities of scaling up of counselling and 
testing, and PMTCT, the following activities were introduced in relation to the ART 
scale up: sensitization of communities and service providers, training of prescribers in 
ART and management of opportunistic infections, training of adherence counsellors 
and for VCT and PMTCT, ensuring linkages with support groups e.g. for PLHIV, and 
procurement and distribution of laboratory equipments (Ghana Health Service 2007). 
Other activities included refurbishment of clinical care sites, introducing an 
information management system, and strengthening of prevention and post-exposure 
prophylaxis (Ghana Health Service 2007). 
5.10 CONCLUSION 
In this chapter I have sought to provide a context for this study by giving a brief 
introduction to Ghana and the health system in the country. The chapter then 
continued with a background of TB/HIV in Ghana as well as the nation’s response to 
the dual epidemic, and then an introduction to the study sites.  
The next chapter is the first of three results chapters of this study and it reports 
the findings of the investigation into the impact of TB/HIV integration on TB treatment 
outcomes.  
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6 TB/HIV INTEGRATION AND TB TREATMENT 
OUTCOMES 
6. 1 INTRODUCTION 
The purpose of this chapter is to address the first objective of this study which is to 
assess the effect of integrated TB/HIV services on the outcome of TB treatment at 
each of the study sites. TB treatment success rate was used as the main outcome 
indicator in addition to other TB treatment outcomes because it is one of the key 
indicators described by the national TB/HIV policy document. The focus of analysis was 
to determine if there could be  any significant difference in TB treatment success 
before and after integration.  
As has been made known in earlier chapters, this study is intended to inform 
evaluation, implementation and nationwide scale-up of TB/HIV in Ghana. The 
intention is therefore not to make definitive statements and draw causal inferences 
about the effect of integration.  Therefore even though the results being presented in 
this and the next chapter have used chi-squares and odds ratios, the interpretation of 
these findings have been cautiously done as demonstrating how these methods can be 
used to assess the influence of TB/HIV integration in the Ghanaian setting and other 
similar contexts.. These two results chapters therefore present findings on the piloting 
of the methods of evaluating TB/HIV integration.  
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6.2 PARTICIPANT CHARACTERISTICS 
In all, a total of 1330 TB cases were registered between the three study sites from 
January 2006 to December 2008: 727 (55%) were registered before integration and 
603 (45%) after.  
Figure 21: Flow diagram of participants involved in analysis 
 
 
 
 
 
 
 
 
 
 
 
 
About 96% of these were evaluated and outcomes declared at the end of treatment, 
and among these there were different degrees of missing data with respect to the 
attributes of interest (Figure 21). The attribute with most missing data was sputum at 
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month 0 i.e. at registration: almost 11% of patients eligible for sputum smear had no 
recorded evidence of their sputum status (Figure 21, Table 20).  
Table 20: Demographic characteristics and stratified treatment success rates  
Characteristic 
Frequency  Treatment success rates 
Before (%) After (%) Before (%) After (%) Chi square 
(X2) 
p-value 
Gender  N = 1275 
           Female 
           Male 
N = 708 
38.3 
61.7 
N = 567 
39.8 
60.2 
 
57.2 
46.5 
 
68.3 
69.4 
 
6.461 
41.010 
 
0.011 
0.000 
Age  N=1269 
           Mean (SD) 
        Median (IQR) 
           Range 
N = 704 
40.5 (18.0) 
40 (22) 
1 - 97 
N = 565 
41.8 (18.4) 
39 (24) 
2 - 105 
50.6 69.0 43.958 0.000 
Age categories 
0 - 9 
10 - 19 
20 - 29 
30 - 39 
40 - 49 
50 - 59 
60 - 69 
70 - 79 
≥80 
 
5.7 
5.0 
15.6 
23.0 
22.4 
13.8 
5.8 
6.8 
1.8 
 
3.4 
5.8 
16.5 
24.1 
19.1 
13.1 
7.6 
7.8 
2.7 
 
50.0 
42.9 
50.0 
55.6 
51.9 
52.6 
41.5 
41.7 
38.5 
 
94.7 
81.8 
77.4 
64.7 
64.8 
62.2 
72.1 
65.9 
53.3 
 
11.246 
10.918 
16.176 
2.374 
4.370 
1.571 
8.040 
5.420 
0.619 
 
0.001 
0.001 
0.000 
0.109 
0.037 
0.210 
0.005 
0.020 
0.431 
Site of Disease 
           Pulmonary 
  Extra-pulmonary 
N = 708 
92.7 
7.3 
N = 567 
88.5 
11.5 
 
50.3 
53.8 
 
67.9 
76.9 
 
36.245 
6.923 
 
0.000 
0.009 
Sputum @ month 0  
           Positive            
           Negative 
N = 508 
60.4 
39.6 
N = 481 
53.4 
46.6 
 
54.7 
49.8 
 
69.4 
65.5 
 
12.650 
10.912 
 
0.000 
0.001 
Patient Type  
           New 
           Defaulter* 
           Failure* 
           Relapse* 
        Transferred * 
N = 702 
88.3 
4.7 
0.6 
5.6 
0.7 
N = 566 
90.5 
1.4 
3.5 
4.1 
0.5 
 
48.7 
- 
- 
- 
- 
 
69.7 
- 
- 
- 
- 
 
50.921 
- 
- 
- 
- 
 
0.000 
- 
- 
- 
- 
 
 Successful treatment outcomes data not included on account of the small 
sample sizes as compared to the new cases. 
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6.3 TB TREATMENT OUTCOMES 
Figure 22: Participants involved in treatment outcomes 
 
 
 
 
 
 
 
In all, about 96% of cases were evaluated at the end of TB treatment (Figure 22), which 
was comparable to the 97.6% national average for all TB cases evaluated over the 
period of study (NTP 2009b). Treatment success rose from 50.6% to 69% before and 
after integration respectively (Table 20). On the adverse outcomes before integration 
18.8% died, 14.3% defaulted and 15.3% of cases were transferred out after treatment 
had been initiated. Both cured and completed rates increased after integration while 
defaults, and cases transferred out decreased (Figure 23). Only 1.4% of cases defaulted 
after integration, and cases transferred out reduced to 9%. As with the cases before 
integration, deaths during treatment were high at 17.5% after integration. Failures 
were 1.3% before and 2.3% after integration. 
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Figure 23: TB treatment outcome of cases evaluated before and after integration 
 
Death rates reduced marginally from 18.8% before integration to 17.5%, but this was 
not statistically significant. The death rate among TB patients was much higher at the 
study sites than figures reported by the national programme corresponding to 9% in 
2006, 8.5% in 2007, and 7.5% in 2008. All the 3 sites had high death rates over the 
study period with no significant reductions after integration (Figure 24).  
 
 
 
 
 
 
 
 
 
0.0 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
35.0 
40.0 
45.0 
Fr
e
q
u
e
n
cy
 (
%
) 
Outcomes 
Outcomes of TB treatment 
Before (N = 708) 
After (N= 567) 
158 
 
 
Figure 24: Trend of death rates among TB patients  
 
 
With cases transferred out during treatment, there was marked difference between 
the one-stop shop (OSS) and the other two sites. The rates were generally higher at 
the OSS with peaks in 2006 and 2007 (Figure 25) and there seemed to be no difference 
after integration. The other two sites had lower transfer rates and demonstrated a 
reduction trend after integration (Figure 25, Table 21). 
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Figure 25: Trend of TB cases transferred out during treatment across study sites 
 
Defaulter rate fell from 14.3%, which was much higher than the national rate (6% for 
2006, and 3.2% for 2007), to 1.4% (NTP 2009b). Defaults reduced most significantly at 
the referral site. There was however no record of default at the PIS, suggesting either 
poor record keeping or misclassification of outcomes. Failure rates increased from 
1.3% before, to 2.3% after integration.  
Table 21: “Transferred out”  and “Defaulted” outcomes 
Study 
site 
Transferred out cases Defaulted cases 
Frequency  
N (% of all cases) X2 
 (p-value) 
Frequency  
N (% of all cases) X2 
(p-value) Before 
integration 
After 
integration  
Before 
integration 
After 
integration  
RS 41 (11.1%) 2 (0.8%) 
41.737 
 (0.000) 
84 (22.8%) 2 (0.8%) 
15.066 
(0.000) PIS 24 (14.7%) 1 (0.8%) - - 
OSS 43 (24.4%) 48 (24.1%) 17 (9.7%) 6 (3.0%) 
0.0 
10.0 
20.0 
30.0 
40.0 
50.0 
60.0 
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 
2006 2007 2008 
P
e
rc
e
n
ta
ge
 o
u
tc
o
m
e
s 
Period of study 
'Transferred out' outcomes across sites 
Referral 
Partial 
One-stop 
Point of 
reference for 
integration 
160 
 
 
6.4 TB TREATMENT SUCCESS RATE 
TB treatment success rate involves the number of TB cases that are cured at the end of 
treatment or completed treatment expressed as a percentage of all registered TB 
cases (p. 105). The treatment success rate before integration was 50.6%, and rose to 
69% after integration *Χ2 = 43.958, p = 0.000]. And the OR (95% CI) was 2.17 (1.72 to 
2.74) suggesting that the odds for having successful treatment after integration may 
be more than twice the odds before integration. The seeming increase in treatment 
success was however still lower than national rates of successful outcomes over the 
same period: 76.1% in 2006, 84.4% in 2007, and 85.3% in 2008 (NTP 2009b). There was 
however a demonstration of continuous improvement in treatment success over the 
period of study (Figure 26). 
Figure 26: TB treatment outcomes at all sites 
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6.4.1 ONE-STOP SHOP (OSS) 
Figure 27: TB treatment outcomes at one-stop shop 
 
 
At this site there were 375 cases evaluated at the end of TB treatment.  TB treatment 
success was 42.6% before and 52.8% after integration (Table 22). The difference in the 
TB treatment success before and after TB/HIV integration was not significant as 
demonstrated by both the Χ2 test statistic and the odds ratio (Table 22).  
Table 22: Statistical analysis of TB treatment outcomes before and after integration 
 Level of integration 
OSS PIS RS 
Treatment success rate 
before integration (%) 
42.6 69.3 46.1 
Treatment success rate 
after integration (%) 
52.8 76.0 78.5 
Χ2 (p-value) 3.855 (0.050) 1.556 (0.265) 64.539 (0.000) 
OR (95% CI) 1.50 (1.00 to 2.26) 1.40 (0.82 to 2.37) 4.28 (2.97 to 6.18) 
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It was observed that this site had the lowest treatment success rate both before and 
integration. This is not surprising as the site had the worst rates of deaths and 
transfers as observed in figures 24 and 25 above.  
6.4.2 PARTIAL INTEGRATION SITE (PIS) 
This site had the lowest number of participants registered and evaluated after TB 
treatment. Among the 284 participants for whom outcomes were declared treatment 
success rate was 69.3% before and 76% after integration. This site had the lowest 
increase in treatment success among the three sites, and the increase was not 
significant (Table 22 above).  
Figure 28: TB treatment outcomes at partially integrated site 
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least integrated site, the RS  demonstrated the greatest increase in treatment success 
after integration. and the difference was significant (Table 22 above). The difference in 
TB treatment success rates that were recorded before and after the integration 
suggests that the odds of having successful TB treatment outcome after integration 
may be greater by more than four times that before integration. 
Figure 29: TB treatment outcomes at referral site 
 
Over the period of study, the data from all sites suggested a positive trend for 
treatment success, although they were lowest at the one-stop shop (Figure 30).  While 
there was no significant change in successful outcomes at the OSS and PIS, the findings 
suggest that there was an apparent improvement at the RS. Although observing the 
trends on the graphs and statistical testing suggest that treatment success rates have 
been improving after integration, adverse outcomes still remain high preventing the 
achievement of programme targets (Figure 26). Treatment success seemed to increase 
after integration and as integration progressed as shown in figure 26 displayed above. 
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This increase in successful outcomes was associated with reductions in cases 
transferred out and default cases while deaths and failures remained relatively 
unchanged as shown in figure 26 on page 160 above. 
Figure 30: Treatment success trend across sites 
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demonstrated in figures 27 - 29. The graphs showed a decreasing trend in ‘transferred 
out’ cases at all the sites, and a decrease in defaults at the referral site and OSS.  
While the trends for all the ‘died’ outcomes had very low gradients at the OSS 
and the referral sites, deaths at the partially integrated site remained fairly stable 
(Figure 28). Therefore the reduction in cases transferred out and default cases seem to 
be more significant contributors to the improvement in TB treatment success rates. 
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6.5 TB TREATMENT OUTCOMES IN HIV-POSITIVE CASES 
Figure 31: HIV-Positive participants analysis 
 
 
 
 
 
 
 
 
 
 
Treatment outcomes in HIV-positive TB patients was assessed only after integration 
when HIV screening for TB patients was routinely done. Treatment was successful in 
72.1% of the 254 HIV-negative patients with an upward trend, while the treatment 
success rate in the 230 HIV-positive cases was 63.9% but with a downward trend 
(Figure 32). 
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Figure 32: TB treatment success rate by HIV status after integration  
 
Figure 33 below also demonstrates that treatment success at each of the three sites 
also had remained unchanged or had a downward trend over the period of study, 
reaffirming the observation in figure 31 above. 
Figure 33: Treatment success rates in HIV cases after integration 
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HIV-associated TB mortality was found to be 25.2%, which accounted for 58.6% of all 
deaths, as compared to 9.8% mortality among HIV-negative TB patients accounting for 
25.2% of all mortalities. The proportion of cases that died during TB treatment among 
HIV-positive TB patients had an upward trend contrary to what was observed among 
HIV-negative patients (Figure 34). 
Figure 34: TB deaths by HIV status 
 
It was also observed that even though successful outcomes formed 72.9% among 
patients with unknown HIV status, mortality among them was more comparable to 
that among HIV-positive patients at 19.8%. Failure and default rates were also highest 
among them at 3.7% and 2.5% respectively 
6.6 CONCLUSION 
As indicated at the beginning of the chapter, these results are presented not as 
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integration on TB treatment outcomes.  A total of 1330 TB cases were registered in all 
three study sites and out of these 95.6% were evaluated at the end of treatment. 
About 89% (1180) of all cases were newly diagnosed cases, and 92.7% of cases were 
pulmonary. Almost 11%  of cases eligible for sputum smear testing had no record of 
their sputum status, and  Of the 1161 that were to have sputum testing 10.7% did not 
have any record of their sputum status. and 598 (57.7%) out of the 1037 cases tested 
for sputum had positive sputum PTB. High death, default and transfer out rates were 
major contributors to the adverse TB treatment outcomes in all sites.  
TB treatment success rate was averagely 50.9% before and 69% after 
integration in all the cases evaluated. Pertaining to the adverse outcomes, default and 
transferred out rates reduced from 14.3% and 15.3% before integration to 1.4% and 
9% after integration respectively.  Deaths on the other hand remained high at 18.8% 
before and 17.5% after integration. At the individual sites treatment success before 
integration was 42.6%, 69.3% and 46.1% at the OSS, PIS, and RS respectively. And 
these rates increased to 52.8%, 76%, and 78.5% respectively after integration. The 
difference in the treatment success rates at each site was significant only at the RS.   
The Χ2 test statistic at 95% confidence level and the OR with its 95% confidence 
interval suggest that there was a significant difference in TB treatment success rates 
before and after integration when all the data was analysed together. However when 
analysis was stratified by the level of integration, the evidence suggested that there 
was no difference in treatment success rates at the OSS and PIS before and after 
integration. The data however suggested that there was a significant difference in 
169 
 
 
treatment success rates before and after integration at the RS. TB cases seem to be 
more likely to have a successful outcome at the referral site after integration. 
HIV-positive TB cases were also found to have lower TB treatment success rate 
of 63.9%  and higher mortalities of 25.2% as opposed to treatment success rate of 
72.1% and mortality of 9.8% among HIV-negative TB cases. HIV deaths accounted for 
58.6% of all TB deaths after integration. After integration treatment success in HIV-
positive cases deteriorated over the period of study while that in HIV-negative cases 
improved. 
In the next chapter, the three different service delivery models at the different 
study sites will be compared in another quantitative study in order to determine what 
would be the best service delivery model as outlined in the second objective of this 
study. 
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7 COMPARING TB/HIV SERVICE DELIVERY MODELS 
7.1 INTRODUCTION 
In this chapter, the objective is to explore whether increasing levels of integration are 
associated with improved outputs of TB/HIV activities and TB treatment outcomes. 
Output indicators representing HIV screening, CPT uptake, ART uptake, and the 
outcomes of TB treatment of all three sites were collected for the period from 1st June 
2007 to 31st December 2008: this covers 19 months after integration. Statistical results 
are presented here too not as conclusive findings on the effect of the degree of 
integration on TB/HIV outputs, but again as evidence of its feasibility.  
Figure 35: Participants for comparison of degrees of integration 
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7.2 PARTICIPANT CHARACTERISTICS 
There were 590 TB cases registered in all 3 sites from 1st June 2007 to 31st December 
2008 i.e. the period after integration. There were more males than females at each 
site. The mean age for all sites was about 41 years, and 60% of cases were aged 
between 20 and 49 years. Most (90.3%) of the cases were new ones (Table 23). 
Sputum AFBs testing was done for 98.6% of those eligible, and out of these 53.8% 
were sputum positive.   
Table 23: Characteristics of cases after integration 
 Level of integration (%)  
OSS PIS RS All sites 
Gender 
Female 
Male 
N = 207 
43.0 
57.0 
N=132 
48.5 
51.5 
N = 251 
33.1 
66.9 
N = 590 
40.0 
60.0 
Age 
Mean (S.D) 
Median (IQR) 
Range 
N = 207 
41.8 (18.8) 
39.0 (24) 
2 - 105 
N = 132 
41.4 (17.4) 
39.0 (22) 
3 - 86 
N = 250 
41.6 (18.4) 
40.0 (25) 
1 - 97 
N = 589 
41.6 (18.3) 
40.0 (24) 
1 - 105 
Patient type 
New 
Defaulter 
Failure 
Relapse 
N = 207 
91.3 
0.5 
3.4 
4.3 
N =132 
89.4 
2.3 
0  
7.6 
N = 251 
90.0 
1.6 
5.6 
2.4 
N = 590 
90.3 
1.4 
3.6 
4.2 
Month 0 Sputum 
Number screened 
Number positive 
N = 188 
99.5 
57.2 
N = 113 
98.2 
46.8 
N = 208 
98.1 
54.4 
N = 509 
98.6 
53.8 
Outcomes 
Cured 
Completed 
Died 
Defaulted 
Failed 
Transferred 
N = 199 
22.6 
30.2 
18.1 
3.0 
1.0 
24.1 
N = 121 
30.6 
45.5 
21.5 
0 
0.8 
0.8 
N = 247 
28.7 
49.8 
15.0 
0.8 
4.0 
0.8 
N = 567 
27.0 
42.0 
17.5 
1.4 
2.3 
9.0 
 
Out of the 590 cases after integration, 507 were screened for HIV. There were more 
females (51.7%) than males among the HIV-positive TB cases, as compared to the HIV-
negative group where women were 31.8%, and the mean age for both sexes was lower 
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at 38.8 years in the HIV-positive group of cases (Table 24). Majority of cases (90.9%) in 
both groups were also newly diagnosed TB cases . 
Table 24: Comparison of participant characteristics in HIV positive and negative cases 
 HIV-positive cases HIV-negative cases 
Number (N) 240 267 
Gender 
Female 
Male 
 
51.7% 
48.3% 
 
31.8% 
68.2% 
Age 
Mean (S.D) 
Median (IQR) 
Range 
 
38.8 (12.8) 
39 (16) 
2 - 77 
 
42.4 (19.8) 
38.5 (30) 
3 - 103 
Patient type 
New 
Defaulter 
Failure 
Relapse 
 
90.9% 
1.3% 
3.5% 
3.9% 
 
90.9% 
0.8% 
4.0% 
4.0% 
Disease site 
Extra-pulmonary TB 
Pulmonary TB 
 
6.7% 
93.3% 
 
13.9% 
86.1% 
Month 0 Sputum 
Number screened 
Number positive 
 
90% 
46.8% 
 
99.1% 
61.3% 
Outcomes 
Cured 
Completed 
Died 
Defaulted 
Failed 
Transferred 
 
22.2% 
41.7% 
25.2% 
0.9% 
1.7% 
7.4% 
 
40.6% 
31.5% 
9.8% 
1.6% 
2.4% 
13.0% 
 
Only 90% of HIV-positive cases had sputum AFBs done at the beginning of treatment 
as compared to 99.1% in the HIV-negative group. The HIV-positive TB cases were 
associated with a higher percentage of smear negative TB cases and fewer EPTB cases 
(Table 24). HIV-negative TB patients had a higher cure rate and a lower rate of 
treatment completion when compared with HIV-positive cases (Figure 36, Table 24). 
Among the adverse outcomes, only the number of deaths were higher among the HIV-
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associated TB cases. Death rate was 25.2% as compared to 9.8% in HIV-negative cases 
(Figure 36). More HIV-negative cases defaulted, failed or were transferred out. 
Figure 36: TB treatment outcomes by HIV status 
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unknown because there was no recorded evidence of testing. For all the patients with 
known HIV status at the different sites, 47.3% were positive for HIV. According to table 
25, 98.6% of cases at the OSS had been screened for HIV as compared to 91.7% and 
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Table 25: TB/HIV activities outputs across sites  
TB/HIV Activities Level of integration n (%) 
Outputs OSS Partial Referral 
Number of TB cases registered 207 132 251 
Number of TB cases screened 
for HIV 
204 (98.6) 121(91.7) 182 (72.5) 
Number of cases screened and 
are HIV-positive 
96 (47.0) 79 (65.3) 65 (35.7) 
Number of HIV-positive TB 
cases on CPT 
79 (82.3) 59 (74.7) 61(93.8) 
Number of HIV-positive TB 
cases on ART 
0 (0.0) 47 (59.5) 7 (10.8) 
 
From table 26 the OR of HIV screening done at the OSS versus the RS suggests that the 
odds of having HIV screening done at the OSS are higher than that for the RS. The 
same applies for the odds at the OSS versus PIS, as well as the PIS versus RS as 
presented in the same table (Table 26). The Χ2 test statistic (p-value) for combined OSS 
and PIS was 65.102 (0.000) suggesting a significant difference. 
Table 26: Statistical analysis  of HIV screening at study sites 
Sites Χ2 (p-value) OR (95% CI )   
OSS : Referral 
68.262 (0.000) 
 
25.78 (7.99 to 83.22 ) 
OSS : Partial 6.18 (1.69 to 22.60 ) 
Partial: Referral 4.17 (2.12 to 8.20 ) 
OSS /Partial: Referral 65.102 (0.000) 8.80 (4.82 to 16.08 ) 
 
This suggests that increasing levels of integration may be associated with higher odds 
for HIV screening among TB patients at the study sites. Graphical display of the 
proportions for trends confirm that HIV screening was highest at the OSS, and 
supporting the observation that increasing degree of integration may be associated 
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with higher proportions of patients with known HIV status (Figure 37) and therefore 
higher uptake of HIV screening. The difference between the proportions at the three 
sites though was not constant, with screening at the RS in particular showing a more 
remarkable upward trend.  
Figure 37: HIV screening among TB patients 
 
7.4 CO-TRIMOXAZOLE PREVENTIVE THERAPY (CPT) 
A total of 240 (47.3%) out of the 507 participants screened for HIV were positive, and 
were therefore eligible for CPT according to the national guidelines.   At the OSS 82.3% 
of HIV positive patients were on CPT, while the figure was 74.7% at the PIS. At the 
referral site, 61 out of the 65 (93.8%) HIV positive TB patients were on CPT (Table 25).  
The analysis using X2 and ORs imply that the OSS and PIS were rather associated with 
lower odds for providing CPT to HIV-positive TB patients as compared with the RS 
(Table 27).  
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 Table 27: Statistical comparison of CPT uptake at study sites 
Sites X2 (p-value) OR (95% CI )   
OSS : Referral 
9.288 (0.010) 
 
0.30 (0.03 to 0.95) 
OSS : Partial 1.58 (0.76 to 3.26) 
Partial: Referral 0.19 (0.06 to 0.60) 
OSS /Partial: Referral 7.517 (0.006) 0.24 (0.08 to 0.72) 
 
The study data implies that integration of TB and HIV services may be associated with 
lower odds of providing or monitoring CPT prophylaxis. HIV-positive TB patients were 
therefore more likely to be given CPT or have a record of this at the referral site. 
 Observing the trend of CPT at the study sites showed that there was more 
variation in the first 3 quarters after integration than the later 4 quarters as the 
percentages of patients on CPT at all sites had figures closer to 100 (Figure 38). The 
most dramatic increase occurred at the PIS followed by the OSS. The trend at the RS 
on the other hand had a downward slope. No one particular site was consistently 
having the highest proportion of HIV-positive TB patients on CPT. The statistical and 
trend analysis do not support the observation that CPT levels increased with increasing 
degrees of integration as was observed with HIV screening among TB patients.  
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Figure 38: Proportion of HIV-positive TB cases on CPT 
 
7.5 ANTIRETROVIRAL THERAPY (ART) 
In all, only 54 (22.5%) out of 240 HIV-positive TB patients had a record of being on ART. 
At the individual study sites the PIS had 59.5% (47 out of 79) on ART, while only 10.8% 
(7 out 65) were on ART at the RS. At the OSS there was no record of any HIV-positive 
TB patient on ART in the TB register (Table 25, Figure 39).   
Table 28: Comparison of ART at study sites 
Sites X2 (p-value) OR (95% CI)   
OSS : Referral 
95.001 (0.000) 
 
0 (0) 
OSS : Partial 0 (0) 
Partial: Referral 12.17 (4.93 to 30.04) 
 
Due to the lack of records on HIV-positive TB patients on ART at the OSS, the OR was 0 
with no confidence interval to compare the OSS with either the PIS or the RS. The odds 
of an event can be calculated only when it has occurred. Therefore it was not possible 
to directly compare ART status of HIV-positive TB patients at the OSS with the other 
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two. At the other two sites the trend analysis shows that there were more patients at 
the PIS on ART than at the RS throughout the study period after integration. However 
the trends at both sites had downward gradients for the first four quarters before 
rising again. 
Figure 39: Proportion of HIV-positive TB patients on ART 
  
 7.7 CONCLUSION 
There were 590 TB cases registered at the 3 study sites after integration, and 40% 
were females. The mean age was about 41 years for all sites and most of the cases 
were newly diagnosed ones. Sputum AFB testing was done for 98.6% of those eligible, 
and 53.8% were sputum positive. The average proportion of TB cases with known HIV 
status was 85.9%, and 43% of these were HIV positive. HIV screening among TB 
patients was highest (98.6%) at the OSS and lowest (72.5%) at the RS. HIV screening at 
the PIS was 91.7%. The odds for HIV screening among TB patients was significantly 
higher with increasing level of integration, suggesting that increasing level of 
integration may be associated with greater uptake of HIV screening services.  
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About 82.9%  and 22.5% of HIV positive TB patients were on either CPT or ART 
respectively. CPT uptake was highest (93.8%) at the RS, followed by the OSS with 
82.3%. At the PIS, CPT uptake was 74.7%.  There was no significant difference in the 
odds when the OSS and PIS were compared. CPT does not seem to be related to level 
of integration according this data. 
Only 22.5% of HIV-positive TB patients were on ART: at the PIS 59.5% were on 
ART as compared to 10.8% at the referral site. There was however no record of any 
patients at the OSS on ART, making it difficult to examine the impact of increasing 
degree of integration. A comparison of the ART access at the referral site and the 
partially integrated site suggests that there were higher odds of ART uptake at the PIS.  
The foregoing chapter has reported findings on the comparison of three service 
delivery models in the second of three results chapters. To conclude the presentation 
of findings of this study, I present the findings from the qualitative study that explored 
the influences of patient behaviour and experiences, as well as provider behaviour, on  
TB/HIV integration in the next chapter. 
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8 EXPLORING INFLUENCES ON TB/HIV INTEGRATION 
8.1 INTRODUCTION 
The aim of this chapter is to explore how user and provider experiences and 
behaviours affect outputs and the outcomes of TB/HIV services integration. Health 
service delivery as an interaction between provider and the patient implies that the 
impact of this interaction is determined by both parties. The purpose of this chapter is 
therefore to explore the influence of the provider and patient on the processes that 
account for or achieve the observed outputs and outcomes. Best practices and barriers 
related to provider behaviour, patient behaviour and the organisation of care itself can 
thereby be identified as well as more effective strategies for improved integration.  
Data collection involved using one-on-one semi-structured interviews to gather 
information about TB/HIV integration from co-infected patients, TB/HIV service 
providers at the facilities, as well as managers from the national offices of the TB and 
HIV control programmes. The providers interviewed included 7 females and 4 males 
made up of 3 national managers, 1 district TB coordinator, 2 VCT nurse/HIV 
prescribers, 1 TB nurse/HIV prescriber, and 4 TB nurses. Their level of experience of 
working with TB and/ or HIV patients ranged from 1 to 14 years. Among the 18 adult 
patients interviewed 5 were in the intensive phase of treatment and 13 in the 
continuation phase.  
Data analysis was thematic using a-priori themes that were used to design the 
study as well as emergent ones. There were 6 main sub-themes identified from the 
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data and these were: working in TB/HIV, living with TB/HIV, managing TB/HIV, 
financing care, TB/HIV perspectives, and barriers and facilitators. In accordance with 
the analytical strategy, the stated objectives for the study as well as the conceptual 
framework, the discussion and interpretation was done under broader themes which 
are provider behaviour, patient experience, patient behaviour, and organisation of 
care as described below. 
8.2 PROVIDER BEHAVIOUR  
The focus of this section is on how provider behaviour enhances coordination, how 
providers involve patients in their care, and how these practices vary across the study 
sites. Providing patient-centred care involves exploring the disease and illness 
experience, understanding the whole person, finding common ground, enhancing 
prevention and health promotion, and enhancing continuity relationship between 
provider and patient (Stewart 2001; Stewart et al. 2000). These characterise the 
process and influence outputs and outcomes of TB and HIV integration. 
8.2.1 UNDERSTANDING THE WHOLE PERSON 
All providers interviewed admitted to privacy and confidentiality being a priority in 
service delivery. Both providers and patients refer to private one-on-one counselling 
sessions as a major strategy for providing privacy and confidentiality for patients. And 
the providers include restricted access to patient folders and secure storage as an 
additional strategy as shown in the statements below:  
“Their folders are being kept at the office. We don’t allow even staff from outside this 
place to use or to touch it. So that one the privacy is there and the confidentiality too is 
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there. If you want to educate the patient on his/her disease, it’s only the patient that 
we talk to. But if he himself or she herself wants you to inform someone...even that one 
we ask the patient herself to give the information to the person he wants you to tell.” 
(TB nurse at OSS)  
 
HIV screening for example is done within the voluntary counselling and testing (VCT) 
centre in the referral site (RS) and partially integrated site (PIS), and in the one-stop 
shop (OSS) in the same building. Patients therefore do not have to join other patients 
in the general laboratory. Also patients are given the right to decide who to disclose 
their status to or should be their treatment supporter. These practices, aimed at 
improving patient involvement, compliance and patient satisfaction, were reported by 
both providers and patients from all three sites. Providers also admitted that other 
TB/HIV team members maintained privacy and confidentiality of patients:  
“...privacy and confidentiality in our unit...That one, I assure you...it’s very good. We 
don’t sell our clients out to people….”(VCT nurse/HIV prescriber at RS).  
 
However one provider at the partially integrated site said she could not vouch for 
other team members’ ability to do so:  
“I do not disclose someone’s status to another person. If someone else will do it I 
cannot tell” (TB nurse/HIV prescriber at PIS).  
 
Staff at the PIS and the OSS acknowledged that sometimes family members of patients 
bring pressure to bear on providers to breach confidentiality. Also because TB and HIV 
183 
 
 
patients use a specific area of the OPD as a waiting area on HIV clinical care days, it 
had become common knowledge that patients sitting in this area may be HIV patients. 
The same problem exists in the OSS where a specific ward is designated for TB/HIV 
cases. 
 Another challenge was the lack of patient confidence in privacy and 
confidentiality. Two patients admitted they were not sure if the nurses had kept their 
privacy. The two patients had not been assured of confidentiality and were always 
anxious whenever they met any of the nurses outside the hospital: 
“Sometimes I worry that some of the nurses, especially the students...may disclose it to 
others or point fingers at me in public. That scared me. Because of that I am unable to 
associate freely with people or go to public places.” (Female patient at OSS). 
“...there is one nurse who attends the same church I do with her children. But I don’t 
know whether she has told anyone else...If I go to the doctor, she comes around. So I 
know she and her children know. As to whether she has told someone at church, I 
cannot say.” (Female patient at referral site) 
 
During visits to the hospitals I observed that at the partially integrated site the 2 nurse 
prescribers who manned the HIV clinics used one consulting room due to lack of 
adequate rooms. This meant two patients would be seen at the same time. This lack of 
privacy severely challenges the ability of patients to discuss every problem they may 
be experiencing.   
Privacy and confidentiality is an attribute of health care delivery that 
demonstrates the provider’s recognition of the patient as a person. TB and HIV are 
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both highly stigmatised diseases and therefore the provision of privacy and 
confidentiality becomes even more crucial in demonstrating a provider’s 
understanding of the life context of the patient. This is an essential component of 
patient centred communication that enhances patients’ perception of patient-centred 
care which should be a fundamental part of the process of care to influence outputs 
and outcomes.  Stewart et al. (2000) demonstrated that patient perception of patient-
centred care improved patient health outcomes, and therefore this may have 
contributed to the overall improvement in outputs and outcomes observed after 
integration. 
8.2.2 FINDING COMMON GROUND 
This involves describing the problem, formulating a management plan with the 
patient, answering patient’s questions, and discussing management with patients. 
Provider-patient interaction is a basic and essential component of health service 
delivery. All patients interviewed confirmed that they were happy with the 
interactions they had with providers, primarily based on how they were spoken to. 
Most patients appreciated that they were not verbally abused, and that providers 
were patient with them and corrected them gently. Patient involvement in care 
involves discussing and agreeing with patients on what the problem is and the 
management plan (Stewart et al. 2000). It is not just about engagement but includes 
working with the  patient’s beliefs and values, providing for physical, psychological, 
social and cultural needs, and sharing decision-making (Pelzang 2010). The providers in 
this study however demonstrated a limited understanding of this concept as portrayed 
in their responses below to a question on how patients are involved in their care. 
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 “You know, after the counselling, you throw it to the one. If, let’s say that the one is 
from far, some of them they wouldn’t like anybody to know that they are having this 
condition. So, with that one, if that will be the case, he would say, “I will bring my 
relative.”” (TB nurse at PIS) 
“Normally … I don’t know what to say about this (long pause). I think we involve them 
in all that we do. Like when we sit down weekly, we give health talks ... and then we 
advise them on how to take their drugs and how to eat eh…well-balanced 
diet…eh…sleep and rest; we  talk a lot about it. And then they…they listen when we 
talk. So they are very much involved in all that we do for them. We don’t eh… isolate 
them. We talk to … we do everything with them.” (TB Nurse at OSS) 
“We *used to+ counsel them and tell them if there is any reaction or so, so and so, then 
they should report back. Then…what else?...we *used to+ talk to them.” (TB Nurse at 
RS). 
 
Patient involvement in care was limited to giving information to patients to let them 
understand their role in executing a pre-determined treatment plan. This practice was 
observed in all 3 study sites. Therefore finding a common ground on what the problem 
is and mutually agreeing on a management plan was flawed, thus undermining the 
delivery of patient-centred care (Pelzang 2010; WHO 2005). Actively including patients 
in their management shifts them from being passive recipients of care to being active 
decision-makers, satisfaction with care increases and adherence to medical 
recommendation improves (WHO 2005). The lack of this attribute in TB/HIV services in 
the study sites may therefore have contributed to why outputs and outcomes 
improved after integration but not enough to meet target like 85% treatment success 
rate (WHO 2010a) or better in any of the three sites. 
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8.2.3 ENHANCING PREVENTION AND HEALTH PROMOTION 
Patient education was the main strategy here. Patient information was said to be 
mainly delivered through counselling sessions which were used to convince patients to 
accept screening, to educate patients on their conditions, and to improve adherence. 
Counselling sessions were also used to help patients identify a family member or 
volunteer to be a treatment supporter, and to inform patients of an NGO or PLHIV 
support group where available. Patients are also educated on diet and other health-
related behaviour to promote wellness and healthy lifestyles which strengthens 
patient-centred care (WHO 2005). 
“They told me to cover my mouth while coughing in public. They also educated me on 
how to prevent it. They advised me against indiscriminate spitting. They said I should 
spit into a container and cover it. If the container gets full, I can pour it into the water 
closet and wash the container.”(Female patient at OSS) 
 
However at all the three sites all patients used a common waiting area during HIV 
clinic days, thus HIV patients with or without TB sat together in long queues promoting 
transmission of TB. 
8.2.4 ENHANCING CONTINUITY RELATIONSHIP BETWEEN PROVIDER AND 
PATIENT 
The existence of TB/HIV teams at the study sites which managed cases and follow-up 
visits on specific clinic days enhanced relational continuity for patients particularly at 
the PIS and the OSS where teams worked more closely together. An effective tool used 
to enhance this continuity was the giving of specific appointment dates to patients for 
review or refill at both TB and HIV centres in all sites. Informational continuity, which is 
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the use of information on past events and personal circumstances to make care 
appropriate for each individual, was however limited since TB records and HIV records 
are kept apart even in the OSS due to national programme monitoring procedures. 
However this probably did not have any significant impact on TB/HIV outputs and 
outcomes because as demonstrated by van Walraven et al. (2010) it is relational 
continuity that is associated with improved patient outcomes and satisfaction. The 
impact of informational continuity on patient outcomes was rather uncertain. 
8.2.5 ENHANCING COORDINATION 
Integration is promoted when procedures and tasks are specified for all the integrating 
units through the use of guidelines and protocols as a coordinating mechanism 
through standardisation of work (p. 69). A notable strength of TB/HIV integration in 
Ghana is the availability of a clear policy, as well as treatment guidelines for the 
management of TB/HIV co-infection. Although there were no copies readily available 
at the study sites, provider descriptions of the care process at each of the three sites 
demonstrated that they had a good knowledge of, and endeavoured to adhere to what 
was in the policy and treatment guidelines. The use of these protocols and guidelines 
also helped reduce the variation in management of cases, and provided management 
continuity through a consistent and coherent approach to disease management 
(Haggerty et al. 2003). 
Providers at the PIS and the OSS confirmed during interviews that they worked as a 
team. Teams met to plan TB/HIV activities and find solutions to problems. 
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“Here, I can say it is well integrated, because recently, both the DOTS nurses and the 
Counselling Unit nurses – we all merged with the Disease Control Staff and had a 
meeting on how we can merge and work as a team. So, there it was…decided that we 
have to screen all our cases for TB”. (VCT Nurse/HIV prescriber at PIS) 
“We don’t actually have days that we meet, but once in a while - every quarter (we) 
meet...that is all those that give CT services, the PMTCT and then the TB 
coordinators...we all meet to discuss issues about TB/HIV at the regional hospital ...So 
since we started we have met about three times at the regional hospital. It is (the 
regional HIV/AIDS coordinator) who calls that meeting” (District TB coordinator)  
 
However providers at the TB centre in the referral site experienced otherwise. They 
acknowledged there was a TB/HIV team but that it did not function as one. Even 
though they were capable of screening TB patients for HIV and were willing to assist at 
the overcrowded HIV clinics, they did not get access to test kits and were not welcome 
in the HIV clinics either: 
“When they come here...any TB patient you have to test HIV, So we [used to] send 
them 
there because we don’t have the kits here. Oh, we have been asking for it but they 
don’t  
…‘Oh, I will come, I will give you people.’ If you go there they would say, ‘Oh, I will 
come’ ... any time they come we send them there to do it”  
 
 “I have been there (HIV clinic) twice. If you go even you can’t get a chair to sit and 
treat … They would say, “Ah, this is for some …” Then you come back. They say we 
should go and help them...When you go, this one … eh, that nurse who is there would 
change the face as if you are coming to collect the money. We have to say things as 
they are. She would frown.” (TB nurse at RS).  
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This lack of teamwork may have contributed to the lower HIV screening rate at the RS 
as compared to the rates at the OSS and the PIS.  
8.2.6 VARIATION IN PROVIDER PRACTICES  
Generally the basic care across sites was standardised based on the use of the national 
treatment guidelines however none of the sites had a copy of the national treatment 
guidelines available for reference although providers were aware of its existence when 
asked. 
Another challenge had to do with the screening of HIV patients for TB. First of 
all there was no consistent definition of what TB screening referred to. In the hospitals, 
providers referred to the whole process of asking questions and then sending sputum 
to the laboratory for AFBs as screening. One manager also reaffirmed this definition:   
“The whole concept of the screening is from the question to the lab. It’s the whole 
gamut altogether, which is considered as screening… altogether. You ask your 
questions and then you do the lab. When you need the lab, then once you’ve 
done…you’ve asked your questions then you’ve done your screening” (Manager). 
 
However another manager referred to the use of the screening tool as the screening, 
which then identified suspects who needed to be tested for sputum AFBs.  
There is a testing and the screening. We’ve been correcting this misnomer for a long 
time. Any time we talk about screening people equate it to the sputum test, which is 
not. (Manager). 
Providers at the all sites stated they were aware of the TB screening tool. But one 
nurse prescriber at the referral site said the score from the screening tool identified 
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infected patients, wrongly interpreting the tool. The many uncertainties surrounding 
the screening of HIV patients for TB may be contributory to the challenges of achieving 
that target. None of the three sites had any data on TB screening among HIV patients 
in the quantitative study. 
HIV testing was available any time of day or night at the OSS because there is 
an in-patient unit as well. At the RS and PIS, although the TB and HIV units were 
located within hospitals, they just operated as clinics and did not operate in the 
evenings, during the night or on weekends. This may have contributed to the OSS 
having the highest proportion of TB patients screened for HIV. 
Generally these differences in the provider behaviours were observed not to be 
related to the degree of integration but rather more related to the systemic barriers 
and inefficiencies.  
8.2.7 POLITICAL BARRIERS 
8.2.7.1 PROTECTING FUNCTIONAL TERRITORIES 
Integration is adversely affected when members of the integrating units fear the loss 
of influence and power that comes with integration, thus resisting the change as 
described here: 
“At the regional operational level, there is a bit of – how do I say – a bit of professional 
jealousies for people who initially have worked on as HIV who are used to working in a 
certain way to be asked to immediately reconcile his activities with another. 
Sometimes, it means looking at the resources from which he is working. People feel 
threatened by it” (Manager) 
Another manager thinks people get very possessive at the district level and had this to 
say: 
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“Unfortunately, when they give people money they tend to form kingdoms. People 
want to run kingdoms…“I’m in charge; I’m doing my activities”… forgetting that at the 
end of the day we are looking at one patient. We are interested in one patient who 
must be managed. So at the District level, we are having – really at the District level – 
we are having a lot of challenges, because people want to … ‘It’s my money, so let me 
run it’. Yeah, they want to build their kingdoms, have their territories” (Manager). 
 
At the facilities some nurses talk about their experience when they tried to attend HIV 
clinics to support the staff as discussed earlier under ‘enhancing coordination’ in 
section 8.2.5 above. The lack of teamwork is due to a fear of loss of territory and may 
be the underlying cause of the unwillingness of HIV staff to acknowledge TB staff as 
partners in service delivery. When asked why the TB nurses are not a part of the HIV 
clinic in that hospital, a nurse prescriber said this: 
“No. No, they are not part of it. Because some of them have not been trained on the 
adherence counselling.” (VCT nurse/HIV prescriber at RS). 
 
8.2.7.2 FEAR OF LOSS OF RESOURCES 
Historically the NACP has always had a lot of resources at its disposal for implementing 
their activities. District and regional coordinators who have been used to managing 
these resources alone may be less inclined to collaborate or be involved in integration 
for fear of losing or sharing their resources: 
“You see, one is at the high level of programming and service provision to the 
operational level, and one has catching up to do. The one who has catching up to do 
controls more resources by way of … So, when the experienced guy wants to talk to 
him, “Are you talking to me because of my resources that I have or genuinely because 
you want us to …” (Manager) 
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This attitude undermines teamwork and hence coordination. 
8.3 PATIENT EXPERIENCES  
8.3.1 ACCESSING SERVICES 
Access to care involves services being made available by the provider and the patient’s 
ability to utilise the services. The study found that all the TB/HIV activities were 
available in all three study sites. TB services were available in all 3 sites from Monday 
to Friday during normal OPD hours. The TB services were all walk-in clinics with no 
queues. With HIV, clinics were held once a week at the OSS and the RS, and twice a 
week at the PIS. There were no strict clinic hours with the clinics closing when all 
patients had been seen: 
“But we have never refused to see anyone, not even when they are over a 100. We sit 
and see all of them” (TB nurse/HIV prescriber at PIS) 
 
Clinics can be particularly heavy at times but there were challenges in establishing a 
second clinic day at the RS:  
“They had wanted to make it (HIV clinics) a daily affair so that all other doctors can 
take care of them. But unfortunately, when they are trained some would go for other 
courses and then they would … then the whole thing will be on one person. When they 
are trained, because of other courses they want to take then they leave the system. 
That’s why we are almost every time *like that+. Other than that we would have done 
it, because many people have been coming all the time; after the training then they 
leave...So that is our problem” (VCT nurse/HIV prescriber at RS) 
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Although only two patients at the PIS complained of long waiting times, providers 
expressed sentiments about patient reactions to the long waiting times: 
“like the way they gathered here yesterday they will insult us alright…but so it is when 
working with people so what can we do?  But we continue working. Because they are 
many, there are delays. Besides, when they arrive, they don’t submit their cards in an 
orderly manner. Some come late and place their cards beneath others so when we turn 
them over and serve the cards beneath, those whose cards are on top get offended” 
(TB nurse/HIV prescriber at PIS) 
“when they come and then they think they are keeping long, they become angry. They 
can say all sorts of things” (VCT nurse/HIV prescriber at RS) 
 
And I personally observed that although patients arrived early to queue, clinics started 
late due to other commitment of the HIV prescribers, and were fraught with 
interruptions from other health workers. These experiences affect patient satisfaction 
and influence adherence (Munro et al. 2007) and eventually outcomes. 
Munro et al. (2007) identified inadequate and irregular supply of drugs as a 
factor that influenced patient adherence. However the findings of this study did not fit 
with this observation. None of the providers or patients complained of a lack of 
logistics or drugs. On the contrary there was always adequate supply of drugs and test 
kits needed to deliver the services at their levels. 
 “as for the drugs, we never run short” (Female patient at PIS)  
 “the drug for the disease itself I always get there” (Female patient at RS) 
 “at the end of every quarter, we make returns to Koforidua, and then the 
dispensary goes down to collect the drugs for us. So we don’t have problems with 
drugs” (TB nurse at OSS) 
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Both providers and patients confirmed that patients encountered a number of 
challenges in living with TB/HIV, which affected their ability to utilise services. The 
commonest of these was the financial burden. Seventy five percent of the 8 facility 
providers interviewed reported instances where patients had been unable to access 
healthcare or adhere to treatment on account of lack of money. And 44% of the 18 
patients interviewed also admitted facing financial difficulties associated with 
accessing and paying for their care, as well as their daily upkeep. Most patients lose 
their capacity to earn a living and then have the additional burden of financing care. 
Five out of the 18 patients had to stop working  when they got ill. Although TB 
treatment is free and HIV care is also heavily subsidised other additional costs can be 
prohibitive:  
“She has nothing to eat, and we have told them to eat before taking the drugs, so she 
cannot come for it. …sometimes some of them after taking the drug they do not have 
food to eat...even the food to eat before taking the drug is a problem” (TB nurse/HIV 
prescriber at PIS about a defaulter)  
“Mama, hmm. My only problem now is…I know I get the drugs, but the next thing is 
how to get money to eat and do other things. That is my only problem” (Male patient 
at OSS) 
“My family also assisted me. I was very hard working, so I had a lot of wax prints 
(cloth) and other material things. So if I needed money, I could sell some to bring me 
here. Today, I’m also counted among the living...I have been selling some of my things; 
that’s what helps me” (Female patient at PIS). 
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Family and community support was found to be key factors in making it possible for 
patients to access services from determining where to seek help to financing care. 
“My children are taking care of me. If I need something, I only have to call them and 
they would bring it. At first when the illness was severe, [my son] came to live with me. 
He was supervising me to take my drugs according to the dosage or the time table. 
When my health improved, he went back to his wife” (Female patient at PIS) 
“...shortly after I started treatment, I ran out of money. Since then, it’s my sisters who 
have been taking care of me.  So they have spent a lot of money.  Yes. They’ve been 
taking care of my feeding and everything. Excuse me to say that you have to pay even 
to use the toilet. So if I need to use the toilet I have to ask them before I can go. They 
gave me ten thousand cedis [(¢10,000), about £0.40] to come here this morning...” 
(Male patient at PIS) 
“As for the feeding I have many friends and I have a lot of people who love me. They 
come and visit me then they give me money. So all that money I have been keeping 
them and using it for feeding. And also I have a friend-brother. He is like a brother to 
me because I took him to somebody to learn driving ... So he has been doing well. 
Sometimes he allows the wife to cook and then she will bring it to me. So by 12.00 
noon she will bring me food, then in the evening time too, a church member in the 
house he too will provide food for me” (Male patient at RS who uses a wheel chair) 
 
This supports the postulate by Munro et al. (2007) in their model of factors affecting 
patient adherence, that financial burden and social contexts including family and 
community are two key influences. 
8.3.2 PATIENT INVOLVEMENT IN CARE 
Patient-centred care strengthens the role of patients in managing their own health 
problems, so that they become experts in their own care and needs (WHO 2005). In 
order to fulfil this role patients need to be informed to be able to share in decision-
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making (Pelzang, 2010). When asked, all the patients admitted they were informed of 
their diagnoses and felt comfortable talking about their problems during consultation. 
Most of them were also able to ask questions if they did not understand something, 
and felt the providers explained things to them. Some patients were comfortable 
enough to ask questions because providers had encouraged them to, because they felt 
they needed more understanding of their situation, or because of their desire to get 
help  
“And there is a saying that ‘if you don’t sell your illness you won’t get cure for it. So, if I 
meet anyone who can be of help to me in respect of my ill health, I will freely tell the 
person about my problem” (Male patient at OSS). 
 
Patient-physician communication influences patient health by first influencing the 
patient’s perceptions of being a full participant in the discussions (Stewart et al. 2000). 
And therefore the availability of opportunities, and willingness of patients to ask 
questions would enhance patient-centred care. However some patients did not or 
hesitated to ask any questions because they needed more time to familiarise with the 
new staff, they were not aware they could do so or felt there was no need to do so 
because the providers knew best. 
“When the other madam was here at first, I could do that. But it is like...since this one 
came I have not sat down with her to talk like I am doing with you now. It is now that if 
by the grace of God I go home and I begin to visit regularly the familiarity would come. 
Then if there is anything she has to tell me, then I would also be able to tell her all my 
concerns.” (Male patient at PIS). 
 
197 
 
 
Patient involvement in their care has therefore been limited in that although they 
were given information about their illness and had the opportunity to ask questions, 
there was very little or no shared decision-making in most cases. This would therefore 
be a limitation to how much it can contribute to improved patient satisfaction and 
health outcomes. 
8.3.3 SATISFACTION WITH CARE 
Out of the 18 patient participants, 55% admitted to being satisfied with care. Patient 
satisfaction with care is an important health outcome whether it is assessed 
subjectively by patient perception, or objectively. Patient satisfaction with care is a 
reflection of how care meets the expectations of patients, and according to the 
conceptual framework of integrated care for this study, is influenced by patient 
involvement, improved access as well as improved clinical outcomes (p. 87). Patients 
primarily expected to get well by coming to hospital. Some also said they wanted to be 
able to go back to work or get their strength back, among others as shown below: 
“...I was hopeful that I would recover, that’s why I came here…” (Female patient at 
OSS) 
“Others have the infection, so I don’t expect to die any time soon” (Female patient at 
RS, with two young children).  
Providers on the other hand were of the opinion that free medications, empathy, and 
acceptance were patients’ expectations. None of the patients had an expectation of 
being treated with respect and dignity, and this may be the reason why patients were 
so appreciative of this aspect of their interaction with providers as described under 
“Finding common ground” in section 8.2.2 above. 
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For most patients their expectations were being met because they had seen 
improvement in their health. However one patient from the referral site could not tell 
whether or not her expectations were being met but she trusted the providers knew 
what they were doing: 
 “Hmm. They *providers+ know what they are doing so I cannot say” (Female patient at 
RS).  
 
On how they felt they were being managed, most patients acknowledged that they 
were being managed well and believed all other patients were equally managed well. 
Five patients felt the treatment they had received was commendable. Two patients 
(one from the PIS and the other from the RS) though felt that even though they were 
being treated well they could not speak for other patients. 
 Most patients were satisfied with the care they had received for the following 
reasons: they were getting solutions to their complaints, they were happy with the 
way they were being managed, or they were confident of getting all the help they 
need.  
“... I feel better than before. Formerly I looked very slim like a skeleton, but now I can 
see that I’m fine...” (Male patient at PIS) 
“By the grace of God I have …I have received what I came for. Now I would say that 
almost all my expectations have been met. Because now…I couldn’t walk at first...I 
could not go anywhere, but now I can walk a little. So I feel that …err…God is doing his 
work” (Male patient at OSS)  
“Oh! Now I am better. By the grace of God I am better.  Yes. I am better” (Female 
patient at RS). 
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One female patient acknowledged she was not yet satisfied with the care. This 
woman’s dissatisfaction may be due to the fact that even though she was in the 6th 
month of TB treatment and over a year on ART she still had significant symptoms of 
pain in her legs and not able to walk without support. Her expectations for coming to 
hospital initially was to get medication so she gets well, and at the time of this 
interview  the expectation was to get pain relief and not to die soon. This suggests that 
patient satisfaction may not just be related to the meeting of expectations, but that 
patient expectations also change throughout treatment. It may therefore be important 
to use counselling to identify patient expectations and align the management plan 
with these patient expectations.  
8.4 PATIENT BEHAVIOUR 
Factors that affected patient behaviour and influenced health outcomes include socio-
cultural barriers like stigma and beliefs about the illness.  
8.4 1 STIGMA 
Seventy five percent of providers said they strictly adhered to privacy and 
confidentiality because it was a means to prevent patient status from being known 
leading to stigmatisation. Only three patients made reference to stigma: they were all 
females with one each from each site. Two of these were cases of perceived stigma 
while the third from the OSS had experienced both perceived and enacted stigma. 
Stigma has become a major cultural barrier associated with both TB and HIV control 
programmes. It influences the behaviours of health workers, family, communities, as 
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well as patients themselves. Home visits, contact tracing and community education for 
instance are organised in ways that protect patients. 
“if the client doesn’t give you the go-ahead to do that *contact education+… we have 
various catchment areas. So that if you know there is a problem here you can go there 
on a different day. And so that nobody would know. You can gather about two, three 
houses including the house in which the patient is, so that you do your education”. 
(District TB Coordinator at RS) 
 
However some staff go on home visits in their uniforms and think patients should be 
able to accept their conditions and not be ashamed: 
“Sometimes, you go they would feel shy or something like that. Then we tell them that 
they shouldn’t be shy from those people because TB is everywhere. A doctor can get it; 
nurse, child... everybody can get TB. So we [used to] talk to them. We have to talk to 
them to be free...Even Nelson Mandela got it” (TB nurse at RS) 
 
Due to the fear of rejection patients expect after such ‘exposures’ some have been 
known to give false addresses or relocated in the middle of treatment. This makes 
monitoring and follow-ups difficult, increasing the risk of default and loss to follow-up. 
Other health providers who are not members of the TB/HIV team have been 
known to stigmatise both TB/HIV team members and patients. The TB/HIV team 
members are treated like they are infectious. And this may explain why it is difficult to 
recruit and retain new team members. Also there have been instances where TB/HIV 
patients present to hospitals and are asked to wait till a TB/HIV team member is 
available to attend to them. One provider had this to say:  
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“it looks as if those of us attending to the cases, the cases are ours (laughter). When 
they (other health workers) should see an HIV or TB patient outside, “Hey, one of your 
patients is here.” Something like that. And it shouldn’t be that way” (VCT nurse/HIV 
prescriber at PIS) 
 
Patients may be presenting with any of the other illness for which patients present to 
the outpatients department (OPD), but the TB or HIV ‘label’ means no one outside the 
team is willing to touch them. This may lead to delays in providing service, and 
preventable exposure where patients have sputum positive TB. These behaviours may 
contribute to adverse treatment outcomes. 
The response of family and friends to the news of one’s diagnosis is a major 
factor in deciding who to disclose to or solicit help from. Two patients describe their 
individual experiences: 
“At our place, if they get to know that you have this sickness they will treat you like you 
are useless. Even if you sell, they won’t buy. They think they could be infected even 
through a handshake. Then this one will tell that person and then another and another. 
So, if they get to know they can behave in a manner that can make you die 
prematurely” (Female patient at PIS) 
“Sometimes I worry that some of the nurses, especially the students, because they 
know what is wrong with me they may disclose it to others or point fingers at me in 
public. That scared me. Because of that I am unable to associate freely with people or 
go to public places...Yes. I feel shy… even when I’m going to church I feel shy.” (Female 
patient at OSS) 
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Stigma has been the reason why a number of patients travel long distances to access 
TB or HIV care, making it impossible to directly observe the continuation phase of 
treatment. Clinic attendance is more costly for such patients, and they can easily 
default because home visits and follow-ups are near impossible. It was observed that 
at the most integrated site where there is a dedicated ward for TB/HIV; the patients 
had more challenges in dealing with stigma because the community was well aware 
that that particular ward was for people with TB or HIV.  
 “Those living in this (...) town...They know it, that this ward belongs to those with HIV 
and those with TB.  But, you know, when they come and they are looking for a 
relative...Those who still have that thing at the back of their mind they would tell you, 
“I’m looking for where those who are coughing are.” …So when they come, what we 
normally do is that we sit them down and explain to them to minimise that 
stigmatisation” (TB nurse at OSS) 
 
Anyone admitted there or seen attending the clinics there is more likely to be 
identified with TB/HIV more easily than would occur in the two other sites. At the 
referral and partially integrated sites the problem of stigma was not as much of a 
problem because the premises used for clinics are different and these are also 
consulting rooms used for general clinics on other days. The problem of stigmatisation 
could arise when people become aware of the specific days for TB and HIV clinics. 
However this did not come up in this study. 
8.4.2 BELIEFS ABOUT ILLNESS 
The beliefs patients have about the source of illness influenced when and where help 
was sought. Most patients said they did not know where they got the disease from, 
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some felt it was related to the type of work they did, and one knew she contracted the 
HIV from her former fiancé. Most of the patients first sought help from hospitals. 
There were two patients who thought the source of the illness was spiritual and 
therefore first sought help from church. According to one of them: 
“When it started, I was taken to a church. There, the priest said it was a spell. Yes, that 
someone had cast a spell on me and the priest will be able to remove the spell from 
me. So after the spell had been removed, I was told I could now visit the hospital.” 
(Male patient at PIS) 
 
The second one said the pastor told him it was a spiritual problem. Even though he 
now knew it was HIV he still believed it was a spiritual problem.   These attitudes may 
lead to delays in getting to hospital for the appropriate care because they usually get 
to hospital only if they have a pastor’s permission or they are not seeing any 
improvement in their condition. One lady spent 4½ months at a prayer camp where 
her mother sent her until her husband asked that she be sent to a hospital. As 
demonstrated by this patient, where and when to seek help is determined by 
significant others for a number of them. Only about half of patients interviewed said 
the decision about when and where to get help was theirs. These behaviours were 
observed at all sites with no difference with the different levels of integration. 
8.5 ORGANISATION OF CARE 
As discussed in the theoretical review chapter (p. 62), integrated care focuses on 
changing care processes by organising new collaborations and allocating tasks 
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differently. This section therefore discusses how the organisation of TB/HIV services 
may influence the outputs and outcomes of integration by influencing provider and 
patient behaviours, as well as patient experiences in accordance with the objectives of 
this study. The major issues discussed here are the care process, the facilitators of 
integration through enhanced coordination, and barriers to integration. 
8.5.1 CARE PROCESS  
The different degrees of integration at the three study sites translate into different 
care pathways for patients. Patients referred to the one-stop shop therefore go 
through fewer steps from diagnosis to initiation of treatment as compared to those at 
the referral site as described by both patients and providers (Figures 40 - 42). Thus the 
different configurations of the services based on the degree of integration influences 
continuity of care by enhancing coordination. Haggerty et al. (2003) suggest that 
continuity of care is not an attribute of the health system but it describes how patients 
experience care. 
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Figure 40: Care pathway at referral site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key: 
                                   Variable time dependent on when patient reports to hospital or when staff is available for the function 
 
 
 
Patients from OPD, walk-ins, or referred by NGOs or other facilities 
TB counselling & home verification or 
referred for community-based care 
Registration and start TB treatment 
TB Centre for TB screening 
HIV clinic 
CPT, CD4 count, TB screening, 
opportunistic infection treatment 
 
HIV + 
VCT centre for counselling and testing 
Has TB 
Has TB 
Adherence counselling & 
ART 
Patient assessment: CD4 < 350 
 
Referral to HIV clinic 
Same day 
7 days 
2 days 
Same day 
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Figure 41: Care pathway at partially integrated site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients from OPD, walk-ins, or referred by NGOs or other facilities 
TB counselling & home verification or 
referred for community-based care 
Registration and start TB treatment 
TB Centre for TB screening 
HIV clinic: CPT, CD4 count, TB screening, 
opportunistic infection treatment 
 
HIV + 
VCT centre for counselling and testing 
Has TB 
Has TB 
Adherence counselling & 
start ART 
Patient assessment:  CD4 < 350 
Same day 
Same day 
7 days 
2 days 
Referral to HIV clinic 
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Figure 42: Care pathway at one-stop shop 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients from OPD, walk-ins, or referred by NGOs or other facilities 
TB counselling & home verification or 
referred for community-based care 
Registration and start TB treatment 
Referral to HIV clinic 
HIV + 
Fevers unit: counselling & screening for TB and 
HIV 
Has TB 
Patient assessment: CD4 < 350 
 
 
HIV clinic: CPT, CD4 count, TB screening, 
opportunistic infection treatment 
 
2 days Same day 
7 days 
Same day 
Adherence counselling & 
ART 
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Continuity of care facilitates coordination (Haggerty et al. 2003) which then 
improves access as depicted in the conceptual framework of this study (p. 84). 
Outputs and outcomes after integration would therefore be expected to be more 
significantly improved at the one-stop shop because the co-location of services 
improves coherence, connectedness, and improves access. However this trend was 
not demonstrated in all outputs in the quantitative study. Only HIV screening 
among TB patients improved with increasing integration as expected: 99% at the 
OSS (one-stop shop), 92% at the PIS (partially integrated site) and 72% at the 
referral site (RS) (pp 174). The proportion of HIV-positive TB patients on co-
trimoxazole prophylaxis (CPT) was highest (94%) at the RS, as compared to the OSS 
(82%) and PIS (75%). This may be explained by the fact that the staff at the OSS and 
PIS laid more emphasis on HIV screening to know the status before treating for TB 
than on the prophylaxis. This was evident when they described the care process for 
patients with very little reference to CPT apart from the nurse at the RS: 
“If the fellow is positive, we refer them ... to be registered on Mondays and 
Thursdays during our clinical hours...we give another lab form to be sent ...for CD4 
and Hb. ... depending on the…eh…CD4, then we do adherence counselling for the 
ART” (VCT nurse/HIV prescriber at PIS) 
“If they are tested positive, the next step is to...do CD4 before ... clinical care...If 
they are due for drug, then we prepare them for adherence counselling...then we 
start giving them medicine.” (TB nurse/HIV prescriber at PIS) 
“All those TB cases that come in are tested for HIV, because you have to know the 
HIV status and then treat. Let them know the implications of the HIV and AIDS so 
that they would be aware” (TB nurse at OSS) 
“Someone can walk in to have the counselling and testing, and then that person 
can be positive...they will be referred to any of the doctors ... Then they will be 
asked to do the CD4 count and other tests. And it is upon that that they can be put 
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on either the opportunistic infection treatment or on ART” (VCT nurse/HIV 
prescriber at RS) 
 
This lack of appropriate emphasis may be due to the fact that the very high level of 
awareness of HIV even among the general Ghanaian public (Population Council 
2010), may not be matched with adequate knowledge about the usefulness of CPT 
and ART or monitoring them for that matter. And this mismatch may partly be 
responsible for the incomplete records for CPT and ART; particularly at the OSS 
where  there was no record of any patient on ART. 
8.5.2 STRENGTHENING COORDINATION 
8.5.2.1 DIRECT SUPERVISION 
In the interviews with managers all three stated that the leadership role of the 
Regional Deputy Directors of Health, who are also responsible for Public Health, 
had been instrumental in ensuring coordination at the district level: 
“you need a strong Deputy Director -Public Health, who can sit the two together as 
lieutenants and compel them to work and report to him” (30: Manager) 
“The SMO PH or Deputy Director – PH, that’s how they are now called, would …give 
leadership and ensure that there is a team – TB/HIV team – and they should 
collaborate and do monitoring together.” (31: Manager) 
“At the Regional level, we have the TB teams, the HIV teams…we have a team that 
is in charge of TB headed by the Regional Coordinator and supported by the SMO 
PH. So we try to rope in the SMO PHs into these things so that they are interested 
in what is happening. All these SMO PHs have been trained in TB/HIV collaboration 
– the concept, the principles, and everything. So it’s prepping them to be together” 
(32: Manager) 
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The managers also identified the fact that in districts where there was one person 
as the coordinator for both TB and HIV integration worked better. This direct 
supervision ensured that the multidisciplinary collaboration occurred and each 
party performed the activities allocated to them. 
8.5.2.2 STANDARDISATION OF OUTPUT 
This is achieved by identifying a common set of outputs and outcomes. Integration 
of TB and HIV services in Ghana is not intended to create a new programme, but to 
identify and effectively manage the interfaces between the two services so that 
access to one becomes an entry point to the other. The TB/HIV policy therefore 
identifies a number of outputs whose indicators are used to monitor the 
integration (Ghana Health Service 2007). These indicators are the number of TB 
patients identified through the HIV clinic and treated, and the number of HIV 
patients identified through the TB centre and given prophylaxis or ART.  At all the 
three sites all the indicators were reported on except the number of TB cases 
identified through the HIV clinics which none of the sites had any data on. 
8.5.2.3 STANDARDISATION OF SKILLS AND KNOWLEDGE 
This occurs by training different people in different skills so that each one knows 
what is expected of them as well as what is expected from others. It was observed 
in this study that although most providers have been trained in the policy and basic 
services like counselling and testing, other staff had specific duties in addition. 
Some nurses have been trained as adherence counsellors and prescribers, and 
there were also data management staff specifically responsible for record keeping 
and reporting. As described below, there are also plans to train doctors in the 
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management of TB co-morbidities and complications to strengthen capacity at the 
district level.  
“We call them Referral Clinicians for both TB and HIV. The Referral Clinician is 
expected to be at the regional hospitals so that when districts have problems they 
can discuss...So the next step in our TB/HIV collaborative activities is to train 
doctors who have experience in managing what we refer to as ‘Managing the TB 
Co-morbidities’. That is, they should go beyond managing TB/HIV, but managing 
TB, HIV, diabetes, hypertension” (30: Manager) 
 
Standardising knowledge and skills would therefore help reduce process variations 
and reduce discontinuities (Murray 2009). Since this mechanism was employed in 
all three sites it would contribute to improved indicators after integration but not 
across the different study sites. 
8.5.2.4 MUTUAL ADJUSTMENT 
The existence of TB/HIV teams in hospitals, districts and regions is a further 
strength of integration, as this encourages both formal and informal 
communication at all levels. Managers have been particularly interested in team 
building as a means of promoting integration at all levels through flexible 
communication between the integrating units: they adapt as work progresses 
(Glouberman and Mintzberg 2001a).  
“When we are training, let’s say, a new site for ART we do not separate anybody. 
We put doctors, nurses, pharmacists, medical assistants; we put them together to 
build a team.” (31: Manager) 
 
Providers at the referral site also talked about examples of mutual adjustment 
when they described situations where nurse prescribers identified and managed 
- 212 - 
 
routine HIV cases so the doctors  handled those who were ill or had complications. 
This helped to reduce the waiting time. There were instances where the different 
teams at the site coordinated to supply both TB and HIV drugs on the same day, 
especially for patients who travelled long distances; this example though was more 
of an exception at the referral site. 
“But when the people were plenty we decided to... prescribe for those who are not 
having any other ailment... those who are not sick will come here for their refill ... 
We have the pharmacists and other counsellors from the wards who help with the 
counselling” (21: Nurse prescriber at RS)”  
 
At the partially integrated site patients could go for TB drugs on HIV clinic days.  
8.5.2.5 LEADERSHIP/ POLITICAL WILL 
Another facilitator of integration was the political will that translated to 
responsiveness of the leadership at the national level to address the needs and 
challenges brought to their attention. Leadership was quick in reviewing guidelines 
and protocols in order to achieve set objectives of TB/HIV integration. When it 
became obvious that the reporting of screening of TB among HIV patients was not 
being done, TB screening tool was designed to facilitate the screening, and the HIV 
patient booklet also altered to make reporting of TB screening easier.  
“... if you did a thorough analysis of the booklet…it’s gone through a lot of phases. 
And it’s been revised about twice. What we have now makes room for you to say 
that the patient has been screened – whether the patient has been screened or 
not” (Manager) 
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And then also the leadership has made it a priority to quickly decentralise ART 
services from the regional and district levels to catch up with the level of access of 
TB services. 
8.5.3 STRUCTURAL BARRIERS 
Differentiation gives rise to structural and cultural barriers (Axelsson and Axelsson 
2006; Barki and Pinsonneault 2005). The structural barriers to integration that were 
identified arise from the differences in the access to the individual programmes, 
differences in the calibre of staff delivering services, differences in their 
information systems, development of local focus within each programme, and 
different financial systems. 
8.5.3.1 DIFFERENCES IN ACCESS 
It was observed that the National TB control programme (NTP) has effectively 
decentralised service delivery through the DOTS strategy. From 1994 when Ghana 
adopted the WHO strategy, by 2005 there was 100% coverage in Ghana (WHO 
2007a). The National AIDS/STI control programme (NACP) on the other hand is not 
as decentralised. Comprehensive HIV/AIDS services are currently available only in 
Teaching Hospitals, Regional hospitals and some District and Mission Hospitals 
(NACP 2009).  As at the end of 2007 for instance, there were 422 VCT sites and ART 
centres as opposed to 1600 TB treatment sites (NTP 2009a). One manager had this 
to say: 
“ART? … We are on course as far as the target for doing that is concerned. We 
would wish to go down to sub district level, but first, we want to put …at least one 
ART site in every district. We have covered more than half of the districts across the 
country. Now, our challenge is that a lot of the districts don’t have adequate 
capacity to do the ART, because some of the newer districts… don’t have hospitals 
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at all. So you cannot put ART… The challenge is that we tend to have … a lot more 
of DOTS treatment centres than ART centres.” (Manager) 
There is therefore a limit to the level of integration that can be achieved in the 
districts and sub districts where only TB services are available. What TB centres can 
offer will be pre-test counselling with or without the testing itself. Therefore to 
address this barrier: 
“The ART treatment should be rapidly decentralised” (Manager). 
 
8.5.3.2 DIFFERENCES IN INFORMATION SYSTEMS 
The two programmes have two different and separate recording, reporting and 
feedback systems. Different indicators are reported on in a parallel fashion from 
the facilities through the districts and regions to the National programme offices.  
The TB/HIV indicators that are reported on are exchanged at the facility level and 
then on through their usual channels to the national level. The indicators are 
reported on at review meetings at all levels but not much else is exchanged 
between the two programmes by way of information at the facility and district 
levels. 
It was observed that these TB/HIV indicators were regularly reported on 
from the TB programme but not from the HIV programme. Some participants 
interviewed are of this opinion: 
“Of all the indicators, there is only one indicator that we are not meeting. That is 
screening people living with HIV – the number of TB cases identified in people 
screened. That is the only indicator so far that we haven’t met” (Manager) 
“We realised that … TB people were screening more people for HIV than the HIV 
people screening persons who are HIV positive for TB, because they don’t really 
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take them through the screening process, and also, test those who become 
suspects.” (Manager) 
“As I was saying getting the data from HIV to TB is becoming a bit of a problem” 
(District TB coordinator) 
 
The only reference to TB/HIV in the NACP 2008 annual report was how much 
money was spent on TB/HIV, but not on any specific activity or indicator (NACP 
2009). There was no reference to TB/HIV in the 2009 report (NACP 2010a). The NTP 
on the other hand had already started reporting on TB/HIV activities in the 2007 
annual report (NACP 2010a; NACP 2009). This was corroborated by the quantitative 
study in which no data for TB screening among HIV patients was available in any of 
the sites. 
8.5.3.3 DEVELOPMENT OF LOCAL FOCUS 
Due to the specialisation, each programme and the workers within it develop 
procedures, activities and routines that were followed to achieve the goals of each 
unit. However integration demands that some of these procedures, activities and 
routines be altered, but some staff are unable to move away from these 
established ways of doing things. Some TB physicians will therefore fail to look for 
any other illness apart from TB. Once TB is diagnosed it becomes the main focus of 
management, neglecting the fact that there may be other co morbidities that will 
influence the outcome of their management. 
“We have seen that if you don’t take time, they look for the diseases that they think 
they are specialists in and manage to the neglect of others. So, now we are going 
to talk about TB co-morbidities.”  (Manager) 
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This local focus also manifests when monitoring teams visiting service delivery 
points look out for only TB or HIV activities instead of doing both to facilitate 
integration. 
“Sometimes everybody is busily doing their activities; and we forget that we have 
to merge some of our activities and plan them together. So I plan to say, like TB, I 
plan to say maybe, visit my TB sites. But I forget to add on that in the same TB 
clinic, I could be looking at the HIV clinic and finding out the challenges they have, 
and reporting to the HIV programme when I get back. Some of us do; some of us 
don’t do.” (Manager).  
 
Development of local focus therefore threatens the achievement of TB/HIV targets 
as collaborating partners may neglect TB/HIV activities. 
8.5.3.4 DIFFERENT FINANCIAL SYSTEMS 
Although both programmes are funded through the Global fund, the funding is 
vertical and comes for specific activities designed by the programmes. Staff may 
therefore get preoccupied with achieving these goals and satisfying funding 
agencies to the detriment of integration  
“The challenge is that with a lot of the funding that comes, it’s vertical – funding is 
somewhat vertical – because we are using Global Fund a lot. And so, sometimes 
everybody is busily doing their activities; and we forget that we have to merge 
some of our activities and plan them together.” (Manager) 
8.6 CONCLUSION 
In this chapter, the impact of provider behaviour, patient behaviour, and patient 
experiences on TB/HIV indicators have been explored using a qualitative approach. 
Provider-patient interactions were characterised by provision of privacy and 
confidentiality, and provision of information on the illness, its management, and 
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prevention but very limited shared decision-making. Other provider behaviours 
included using information to enhance healthy lifestyles and continuity of 
relationship between provider and patient. These mechanisms were used to 
enhance patient-centeredness of care. Other mechanisms including 
standardisation of work, and mutual adjustment were employed to enhance 
coordination. Political barriers were the main factors that led to provider 
behaviours that adversely affected health outcomes. 
 Patient experiences that enhanced perception of patient-centeredness of 
care, and therefore health outcomes were involvement of patients in their care, 
and satisfaction with care. Stigma and beliefs about illness were other influences 
on TB/HIV outcomes. There were other organisational characteristics of TB/HIV 
care that affected providers and patients: differences in the care processes across 
sites, and strengthened coordination through direct supervision, standardisation, 
mutual adjustment, political will, and structural barriers of integration.  
 The next chapter will be a discussion that seeks to bring together the three 
results chapters, relate them to how they have achieved the objectives set up at 
the beginning of the study, as well as national and international implications.     
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9 DISCUSSION  
9.1 INTRODUCTION 
This penultimate chapter is intended to bring the whole study together and 
demonstrate the extent to which the identified objectives and research questions 
have been addressed, and the implications of the research on current knowledge, 
policy and practice. The first section of the chapter therefore provides a summary 
of all key findings in both the qualitative and quantitative studies. This is then 
followed by another section which describes the implications of this study on 
TB/HIV integration in Ghana and in the international context. The subsequent 
sections include one in which the methods of the study are evaluated, followed by 
what areas are recommended for the future, and finally the conclusion of the 
study. 
9.2 KEY FINDINGS 
The purpose of the study is to provide evidence for the improvement of the 
integration of TB and HIV services in Ghana so as to facilitate effective 
implementation and nation-wide scale-up. It was therefore a study to explore the 
delivery of the intervention and pilot methods of evaluation, to pre-empt factors 
that could undermine effective evaluation of Ghana’s TB/HIV programme, and to 
give recommendations on how to improve implementation nationwide. The 
objectives were to examine the impact of integration on TB and HIV service 
delivery, to compare different service delivery models of TB/HIV activities, and to 
explore the influences of behaviours and experiences of providers and patients on 
the outputs and outcomes of TB/HIV services.  
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9.2.1 TB/HIV INTEGRATION AND TB TREATMENT OUTCOMES 
In response to the first research question as to whether or not TB/HIV integration 
has improved TB treatment outcomes, the study demonstrated that TB treatment 
success may improve after integration, and was supported by statistical 
significance as well as graphical trends. Based on the methods therefore TB/HIV 
integration has the potential to improve treatment success rates, corroborating 
other research findings that integration improves successful outcomes (Huerga et 
al. 2010; Miti et al. 2003). 
However ascertaining the extent of the contribution of TB/HIV integration 
to this improvement in treatment success is challenging and may be 
misrepresented as the improvement may be due to other strategies being 
implemented concurrently by the TB control programmes to improve its 
effectiveness. As demonstrated earlier in chapter 6, improvement in TB treatment 
success was also associated with significant decreases in ‘default’ and ‘transferred 
out’ cases which may have improved as a result of other TB-specific strategies that 
were in place like community-based TB treatment and the use of treatment 
supporters in all three study sites.  
According to Miti et al. (2003) community-based care and treatment 
support improve compliance and adherence, and thereby reduce default. Outcome 
indicators are primarily about recovery, restoration of function and survival, and 
they seek to measure changes in health status that can be attributed to care (Mainz 
2003; Donabedian 1978) and therefore any intervention that improves care 
contributes to outcomes. They are therefore generally  non-specific and not very 
sensitive (Mainz 2003). TB treatment success rates may therefore be appropriate 
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for monitoring TB control strategies as a whole but may not be adequately specific 
for monitoring and evaluating the impact of TB/HIV services integration as an 
intervention, especially in health care settings where interventions are already 
implemented and all confounders cannot be controlled for. 
Also TB treatment success rates of new smear positive cases i.e. cure rates, 
which are used for the TB treatment quarterly cohort analysis may not be 
appropriate as the incidence of HIV-associated TB increases. This is because 
treatment success rates based on only smear positive TB cases exclude EPTB cases 
and smear negative PTB. However HIV has been shown to lead to more EPTB and 
false smear negative cases because of reduced expectoration especially with 
advancing disease in which case sputum cultures are recommended to identify the 
truly smear negative cases (Getahun et al. 2007). This was confirmed in this study 
where only 47% of HIV-positive TB cases had sputum positive TB as compared to 
61% of HIV-negative TB cases. Only 45% of all new cases in this study were sputum 
positive and this represented 38% of all TB cases registered.   Therefore in settings 
like Ghana where sputum cultures are not routinely requested for HIV-associated 
smear-negative TB cases, using smear-positive TB treatment success rates to 
monitor TB/HIV activities may be unrepresentative and increasingly inappropriate.  
An emphasis on an indicator which includes smear positive and smear negative 
PTB, as well as EPTB would be more appropriate in monitoring both TB and TB/HIV 
activities.  
Research has also established that HIV-associated TB is associated with an 
increased risk of TB deaths (Reid et al. 2006) and TB treatment failure especially 
among those not on ART (Khan et al. 2010).  Even though TB deaths include death 
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from any cause while on TB treatment, Elliot et al. (1995) demonstrated that most 
deaths in HIV-associated TB is due to active TB and its complications or 
complications of the HIV infection itself. The study confirmed this as the mortalities 
in HIV-positive TB patients accounted for 59% of all TB deaths. In view of the 
findings of this study that TB/HIV co-infection may have a more direct impact on TB 
deaths than on successful treatment outcomes, it would be suggested that TB 
deaths could be explored as an indicator to monitor the impact of TB/HIV 
integration in similar contexts. This fits with propositions of Maher et al. (2005) 
that TB deaths are crucial for monitoring programme performance but are limited 
by incomplete coverage of all incident TB cases, inaccurate routine programme 
reporting of deaths, and the unknown contribution of deaths from TB and HIV 
alone. Even though their study focussed on countries with high HIV prevalence in 
addition to heavy TB burden, this study suggests that TB mortalities can also be 
useful for monitoring TB/HIV integration in low income countries with high TB 
burden but lower HIV prevalence. 
9.2.2 COMPARING TB/HIV SERVICE DELIVERY MODELS 
HIV screening increased with increasing degree of integration, but CPT and ART did 
not. The RS was associated with higher levels of CPT while ART was highest at the 
PIS. The study therefore did not produce sufficient evidence to support the school 
of thought that increasing degrees of integration led to better service delivery 
outputs and outcomes. This is contrary to the findings of Kachiza et al. (2010) who 
reported that the OSS provided the best model of delivery for TB/HIV services. 
Increasing levels of integration did not result in increasing treatment 
success rates. TB treatment success rates were lowest in the OSS after integration 
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in all cases and in HIV-positive TB cases as well. The RS was associated with the 
highest odds for successful treatment in all cases, but in HIV-positive cases the 
highest odds were in the PIS though difference between the RIS and PIS for HIV-
associated cases was not significant. There seemed to be no relationship between 
integration and treatment success in HIV-positive TB patients. 
There were a lot of missed opportunities not utilised by providers to deliver 
TB/HIV services: 14% of TB patients were not screened, and only 83% and 23% of 
those who were HIV-positive were put on CPT and ART respectively all below the 
national and regional targets for these indicators (NTP 2009). This confirms the 
study by Tribble et al. (2009) and Pevzner et al. (2011) which found that there were 
still many missed opportunities to HIV screening. Both studies suggested that the 
missed opportunities were due to limited availability of services as opposed to low 
utilisation.  
Fraser et al. (2007) suggested that these gaps are due to providers not 
offering the service or they do not record what they do, as observed in this study: 
at the OSS for instance there was no data on ART use. These discrepancies in data 
result in poor and inaccurate data, lead to underestimation of the burden of 
disease and make it impossible to determine the impact of the intervention 
(Pevzner et al. 2011). More resources therefore have to be invested in the search 
and research for strategies to improve data accuracy and completedness in the 
context of increasing patient numbers and fewer providers. Fraser et al. (2007), 
suggest that electronic information systems can be used to support overwhelmed 
staff in resource-limited settings to effectively track and follow-up patients, provide 
easy access to extensive data for providers, and address the challenges of referrals, 
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feedback and duplication in addition to informational continuity. The usefulness of 
the electronic information system in addressing the above problems and the 
challenges of accuracy and completeness depends on using well-trained staff who 
also understand the usefulness of the data being collected. 
 The capacity of TB/HIV team members to effectively handle the data 
management of TB and HIV services is one of the many the barriers identified in 
this study: these were structural and political barriers of integration, and health 
system barriers to implementation. This underscores the findings of Okot-Chono et 
al (2009) that health system barriers to implementation are a major source of 
barriers to TB/HIV integration. The evidence from this study suggests that the 
existing barriers to integration, particularly the health system barriers to 
implementation, impair its effectiveness and hence the ability to assess the 
intervention accurately.  
The impact of these barriers may prevent the accurate assessment of the 
effect of different degrees of integration on outputs and outcomes. Although the 
OSS has been advocated as the best model for service delivery (p. 37), a categorical 
statement on which model of service delivery is best would be inappropriate in this 
study. The success of integration is determined by multiple interactions arising 
from the contexts and settings (Greenhalgh et al. 2004), and as long as factors from 
these settings and contexts remain a major barrier to integration, these barriers 
would have a significant impact on integration as an intervention than the service 
delivery model. The study therefore did not have adequate information to draw 
any conclusions on which would be the best service delivery model. 
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9.2.3 EXPLORING PATIENT AND PROVIDER INFLUENCES ON TB/HIV 
INTEGRATION 
A key objective of this study was the identification of patient and provider 
influences targeted at the processes of TB/HIV integration to determine outputs 
and outcomes. The focus of this study was on patient-provider interactions that 
demonstrated patient-centeredness and enhanced coordination or otherwise.  
The study observed that patient-provider interactions and their behaviours 
reflected a limited role of the patient. The interaction reflected the traditional, 
compliance-oriented approach in which patients are seen as the recipients of 
medical decisions and prescriptions (Aujoulat, D‘hoore and Deccache 2007). 
Patients therefore surrender varying amounts of control to health care 
professionals in order to gain the expertise, technology, and compassion available 
from health care professionals (Anderson and Funnell 2005). The health care 
providers take responsibility for solving their patients’ problems and this feeling of 
responsibility leaves many health care professionals feeling frustrated when their 
patients do not follow recommendations (Anderson and Funnell 2005).  
At the study sites patient-provider interactions were characterised by 
providing privacy and confidentiality, giving information on the diagnosis to 
patients, health promotion and prevention, what was expected of them during 
management, and answering patient questions where they had the courage to ask. 
Patient involvement was limited to determining what time of day they wanted to 
take their daily medication and who they wanted to be their treatment supporter. 
Patient-provider interactions therefore lacked many of the characteristics 
demonstrating that the disease and illness experience has been adequately 
explored, understanding of the whole person, and finding common ground. 
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Patient behaviours in this study also reinforced this compliance-oriented paradigm 
as this defined their behaviour and expectations: to be told what to do and do 
what you are told because providers ‘know best’. Patients seemed ignorant of their 
rights to be treated with dignity and respect and therefore patients viewed such 
behaviour from providers as an additional service. Patient-centred care leads to 
greater enablement, improves adherence and patient satisfaction, and leads to 
better outcomes (Pelzang 2010; Holmström and Röing 2010). 
The study findings seem to imply that integrated TB/HIV services delivery 
portrays more characteristics of the process model of patient-centred care than the 
systems approach as described under the theoretical review chapter (p. 64). Both 
providers and patients need to be adequately equipped to take up their respective 
roles in patient-centred care. And the question remains as to whether there are 
measures in place to equip both provider and patient. Preparing the health worker 
includes providing skills including interviewing and communicating effectively, 
assisting changes in health-related behaviour, supporting self-management and 
using a proactive approach to coordinate care across time (WHO 2005). Patient 
empowerment can be used to strengthen the role of the patient in patient-centred 
care, which is limited to the clinical health care setting, as well as for life outside 
this setting. Patient skills needed to fulfil this role include coping skills, goal setting 
for changing behaviour, self-monitoring, changing their environment to support 
behavioural changes, self reward, accessing social support (WHO 2005), and the 
ability to reflect on the benefits of changing behaviour (Holmström and Röing 
2010).   
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It was also observed that the TB/HIV policy in Ghana also demonstrated the 
perception that the provider was responsible for the patient’s health, confirming 
the school of thought that the compliance-based approach to care as a paradigm is 
not only embedded in the minds of individual health care professionals, but is also 
the basis for most of the policies and procedures of health care organizations 
(Anderson and Funnell 2005). The focus of the policy was therefore to find a way of 
‘giving’ TB/HIV patients what they needed, and presupposing that providers as 
‘experts’ knew what the patients needed. TB control programmes have 
traditionally employed a compliance-based approach to complete treatment while 
HIV control adopts a more patient-centred approach to encourage long term 
adherence. One rationale for integration was to take advantage of the natural 
synergies and complementariness of the two programmes (Ghana Health Service 
2007). However with more commitment being exhibited by the more decentralised 
TB component of integration and the existing health system challenges, the 
patient-centred approach which was to be emphasised seems to be subsumed 
instead as observed in the study.   
All the three patients who talked about stigma reported instances of felt or 
perceived stigma which refers to the fear of being discriminated against as opposed 
to enacted stigma in which there is an experience of a prejudicial act. One of them 
had also experienced enacted stigma.  Daftary, Padayatchi and Padilla (2007) 
observed a similar trend and also noted that perceived stigma was a barrier to 
accessing services and prevented TB patients from utilising TB/HIV services.   Bond 
and Nyblade (2006) identified three main causes of TB/HIV stigma, namely the 
perception that TB is a sign of HIV, the judgemental attitudes of communities that  
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immoral people get HIV, and finally the exaggerated fear of contagion.  The study 
also confirmed some of the findings of Dodor and Kelly (2010) about the 
manifestation of TB stigma in Ghana. The study corroborated their results that 
health care workers who were not part of the TB/HIV teams feared being infected 
by TB patients and therefore avoided interacting with them. When TB patients 
presented with other illness they would have to wait to be seen by TB/HIV team 
members. Although this study did not elicit that health care workers perceived 
being asked to work with TB/HIV patients as a punishment, there was the high 
attrition rate among trained staff that could be another manifestation of the 
unwillingness to work with TB/HIV patients. There was however no evidence to 
support their view that TB units were located in isolated places and they lacked 
tools and equipments.  
The study also identified the financial burden of illness, social support 
structure and beliefs about the illness as other determinants of patients’ 
willingness and ability to access services, and adherence to treatment. Seventy five 
percent of facility providers and 44% of patients interviewed admitted the 
challenges faced in relation to financing of their care and daily maintenance. The 
high financial burden identified was an affirmation of the findings of Gyapong et al. 
(2009) in their study to determine the cost of TB treatment in Ghana. They found 
that there was an average reduction of 40% and 82% in monthly household and 
patient incomes respectively. On the average pre-diagnosis and diagnosis costs 
were 38% of monthly household incomes, while treatment costs were equivalent 
to 108% of monthly household incomes. These determinants although based 
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outside the health care setting, have a profound impact on patient outcomes based 
on their ability to cope with them.  
The study did not provide any data to suggest that patient or provider 
behaviours varied significantly with the different levels of integration, but as 
observed with the quantitative study results patient and provider behaviours were 
mostly influenced by barriers that were mostly unrelated to the degree of 
integration apart from stigma. The qualitative study therefore confirms the 
quantitative findings that barriers to implementation may currently be more 
important in determining the impact of integration than the degree of integration.  
A more patient-centred approach is therefore required to address and minimise 
the effects of health system challenges, and to optimise the impact of facilitators to 
ensure more effective integration.  
9.3 IMPLICATIONS OF STUDY 
9.3.1 POLICY AND PRACTICE: LOCAL AND NATIONAL CONTEXT 
The integration of TB and HIV services in Ghana is an on-going intervention 
introduced as part of a nationwide drive to improve the control of both TB and HIV. 
This study identifies in chapters 6 and 7 that output and outcome indicators are 
below national targets. And in accordance with programme objectives and the 
objectives of this study this section identifies both good and bad practices, and 
then makes recommendations for improvement. A number of best practices and 
strategies employed which have resulted in improved access to TB/HIV services and 
contributed to improved treatment outcomes were identified. However existing 
barriers have undermined effectiveness such that anticipated targets are yet to be 
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achieved. In order to maintain and build up on achievements to facilitate 
nationwide scale-up, the best practices identified should be re-enforced and 
replicated, while the barriers and detrimental practices identified should be 
addressed through prudent management of resources. Outlined below are best 
practices and recommendations arising from this study to achieve this. 
9.3.2 BEST PRACTICES 
A number of strategies were identified as enhancing coordination and facilitating 
continuity of care as discussed in the theoretical review in chapter 3. Outlined 
below is a summary of these practices and their areas of impact.  
Table 28:  A catalogue of best practices and facilitators of integration 
Area of intervention Best Practices 
TB/HIV Policy - A clearly defined policy being implemented, and which has 
led to the development of treatment guidelines and related 
protocols and tools 
- On-going refinement and contextualising of national policy 
based on feedback from early learning sites 
- Demonstrable leadership, commitment and political will 
- On-going decentralisation of services to address the 
difference in access to TB and HIV services 
Human Resource for 
TB/HIV 
- Systematic and continuous training of TB/HIV workers 
- The use of different types of staff, particularly the use of 
both highly skilled and less skilled staff in TB centres 
especially within the context of acute health worker 
shortages 
- The use of community volunteers and family treatment 
supporters to promote adherence 
- Promotion of teamwork 
- Staff motivation through enabler’s package and training 
Monitoring & 
Evaluation 
- Standardised output and outcome indicators for monitoring 
and evaluation are clearly specified 
- The use of existing recording and reporting systems and 
structures, as well as updating these where they do not 
meet the requirements for integration 
- Regular joint review meetings at district,  regional and 
national levels 
- Defined hierarchical leadership at facility, district and 
regional levels to provide direct supervision.  
Service delivery - Provision of patient privacy and confidentiality, patient 
education and counselling 
- Treating patients with dignity and respect 
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- Drug treatment: use of FDC with Rifampicin-based regimens, 
in conjunction with appropriate ART 
- Availability of resources: no stock outs 
- Use of appointments to follow-up patients and enhance 
management continuity 
- Teamwork at the facility level with division of labour 
Socioeconomic  
support 
- Enabler’s package that provides food and money for 
patients  
- Collaboration with NGOs to identify cases and support 
patients 
- Mechanisms for financing care like health insurance and 
credit facility for ARVs  
 
9.3.3 RECOMMENDATIONS 
In addition to the best practices identified, there were also some practices that 
have not been beneficial or been detrimental to efforts to integrate TB and HIV 
services. The following recommendations are therefore based on suggestions to 
address these not so beneficial practices. The recommendations are related to the 
TB/HIV policy, human resources for TB/HIV, monitoring and evaluation of TB/HIV 
activities, and TB/HIV service delivery. The purpose of these recommendations are 
to make care more patient-centred, enhance coordination further, and to promote 
greater continuity of care.  
9.3.3.1 MAKING CARE MORE PATIENT-CENTRED 
 The study observed that there was very limited decision sharing between 
providers and patients concerning patient management. And often patients 
had inadequate knowledge about their treatment. Patients were also 
ignorant of their roles in management. Care therefore needs to be made 
more patient-centred, 
 A clear definition of what patient-centred TB/HIV care means in Ghana 
should be provided. Teaching models and educational curricula based on 
this definition should be introduced to provide adequate educational 
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emphasis. The focus of the policy should not be deciding what patients 
need and providing them for patients to comply with. Policy should 
recognise patients as partners in their care and let this reflect in protocols 
and guidelines, 
 Patient counselling sessions can be used as opportunities to provide 
patients with skills including coping skills, goal setting to support 
behavioural changes, self-monitoring skills, and how to access social 
support, 
 It was demonstrated in the study that patients received a lot of counselling 
through which they were educated on their conditions and the treatment 
plan. Making care more patient-centred will require the inclusion of 
different dimensions to the patient-provider interaction. The interaction 
should explore the patient’s life context and how the illness has impacted 
them, and more involvement of patients in decision making that considers 
all that is important to them. These interactions should also be used to 
manage patient expectations to enhance patient satisfaction by identifying 
patient needs and addressing them. This would promote adherence and 
reduce adverse outcomes.  
9.3.3.2 ENHANCING COORDINATION 
 
 Barriers to coordination included the lack of cooperation from other staff 
due to their fear of loss of influence and resources, the separate funding 
streams of both programmes, and the development of local focus as a 
result of the different requirements from external funding agencies. The 
different information systems was also a barrier, 
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 The study recommends that due to the pervasive nature of health system 
barriers identified, a move towards OSS for all TB/HIV services should rather 
be seen as a long term objective. The health system barriers undermine the 
effect of the degree of integration to an extent that investing limited 
resources to create OSS nationwide will not yield the anticipated benefits. 
The priority should be to identify effective ways of strengthening the health 
system. In the mean time the referral and partially integrated models can 
be effectively used within contexts suggested in the subsequent sections,   
 Enhancing coordination in care is primarily focused on exploring strategies 
that improve coordination and improve continuity within existing services. 
Strategies like strengthened linkages, feedback and patient appointments 
should be used to improve referral services and patient follow-up. These 
strategies would then enhance coordination for referral and partially 
integrated models to effectively deliver TB/HIV interventions, 
 The referral and partially integrated models may also be preferable in a TB 
and HIV programming context where there is an effective community-based 
care with treatment supporters, as well as an effective collaboration and 
referral system between the two programmes, 
 The referral and partially integrated models are recommended especially 
for patients in communities where both diseases are highly stigmatised 
(enacted or perceived) to the extent where it interferes with utilisation of 
services, while stigma is addressed. 
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9.3.3.3 MONITORING AND EVALUATION 
 Less than satisfactory practices that need to be remedied include 
incomplete and inaccurate data, and lack of feedback from referred cases 
and from the regular reports submitted through the districts and regions to 
the national offices. Improving data quality should be prioritised, 
 Appropriate indicators are critical components in effective evaluation, and 
they have to be sensitive enough to give adequate information on what is 
being measured. One recommendation to improve the relevance and 
usefulness of indicators in monitoring TB/HIV activities is to emphasise the 
use of treatment success rates which include cured and completed cases 
among sputum positive and negative TB, as well as EPTB cases. This should 
be in addition to cure rates (includes only new smear positive cases). It is 
also being recommended that TB mortality be included as a contributor to 
monitoring and evaluation. 
9.3.4 POLICY AND PRACTICE: INTERNATIONAL 
This study establishes its relevance by contributing to the body of knowledge in 
both integrated care, and TB and HIV control, and also provides evidence for 
practice that is transferable to other settings and contexts as defined in the key 
findings above. The following recommendations can be transferrable in similar 
contexts: 
  TB mortality rates may be a more relevant indicator for monitoring and 
evaluating TB/HIV integration in a context where TB/HIV integration is part 
of a complex of strategies for TB control, low access to ART, and low rates 
of MDR- or XDR-TB, 
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  In health systems where barriers to implementation contribute most 
significantly to TB/HIV outputs and outcomes, organisation of care should 
focus on overcoming these barriers as opposed to providing different 
degrees of integration as the impact of the varying degrees of integration 
may not be felt,  
 Patient empowerment may be relevant in addressing the challenges 
patients face in living with TB and HIV, especially those outside the health 
care settings. Patient empowerment should be a component of strategies 
to address stigma; these should not just be stigma-reducing interventions 
but should include skills for patients to deal with perceived or experienced 
stigma. 
9.4 RESEARCH IMPLICATIONS 
9.4.1 STUDY DESIGNS 
The study  further contributes to knowledge by providing information relevant for 
designing studies to explore delivery of TB/HIV interventions, to pilot methods of 
evaluation, or the design and execution of a definitive evaluation study. The study 
identifies and emphasises the following: 
 The development of a conceptual framework of integrated care for studying 
TB/HIV indicators and factors influencing them,  
 The relevance of characterising and standardising an intervention prior to 
its evaluation, 
 The study also demonstrates how routine, anonymised data can be used for 
monitoring and evaluation in TB/HIV integration, 
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 Based on the findings of this study recruitment rate for each of the 
indicators used can be determined in designing subsequent evaluative 
studies in Ghana and in similar context of TB and HIV disease burdens, 
 The study informs sample and cluster sizes determination for statistically 
representative samples and clusters to address confounders in future more 
rigorous studies, 
 This study also informs how mixed method approaches can be used to 
explore and understand other integrated health services.  
9.4.2 FUTURE WORK  
 Study designs: research using more robust and rigorous study designs and 
mixed methods approaches should be conducted for more effective TB/HIV 
evaluation,  
 Revision of guidelines on the time of initiation of ART: current guidelines 
suggest that the CD4 count be used as an indicator to initiate ART. However 
current research through mathematical modelling suggests that yearly HIV 
testing  of every adult and immediate initiation of ART on diagnosis of HIV 
has the potential to reduce transmission of both HIV and TB (Granich et al. 
2009).  Research should therefore be directed at exploring the implications 
of these findings in real life settings, 
 In order to improve the completeness, accuracy and data quality the 
following are recommended to explore and pursue strategies to improve 
accuracy of recording and reporting of TB/HIV activities, using trained data 
management staff to take over all recording and reporting. and improve 
accuracy and completeness of data. There should also be encouragement of 
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local use of data to enhance awareness of the usefulness of data being 
collected, 
 Another area of research would be the readiness of patients in low-income 
countries to take up the responsibility of being empowered, and tools for 
empowering patients within the limitations of resources, time, technology 
and educational levels, 
 The feasibility and safety research on the use of IPT in low-income settings 
should be made a priority to accelerate the review of policies to make this 
intervention available to patients,  
 More research on post-mortems and clinical/microbiological studies of 
sufficient size to determine TB case fatality rates and the specific causes of 
TB deaths more accurately is needed.  
9.5 EVALUATION OF STUDY METHODS 
This was a study intended to inform the implementation and nationwide scale-up 
of integrated TB/HIV services in Ghana. It informs the evaluative study designs to 
assess the effect of integrated TB/HIV services, compares different degrees of 
integration for service delivery, and explores the patient- and provider-related 
factors influencing outputs and outcomes. Statistical representation and 
generalisability of findings was not an objective and therefore even though the 
study design was not robust enough to provide causal linkages between integration 
and TB/HIV outputs and outcomes, it provided timely and relevant information to 
inform TB/HIV integration and its implementation. A natural experiment with 
before-and-after studies and qualitative interviews provided the flexibility and the 
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tools to study the practice of integration. The findings of the study therefore may 
not be generalisable because of the impact of the context, but they are 
transferable to similar contexts for facilitating integration and its implementation.  
A particular challenge of this type of intervention research is the balancing of 
methodological rigour and feasibility. Realistic threats to rigour include the cost of 
research, local political factors as well as the socioeconomic environment.  
Outlined in the following subsections are strategies that could be employed to 
enhance the validity and reliability of this research. 
9.5.1 STUDY DESIGN 
 A sequential study made up of an initial quantitative study followed by a 
qualitative one would have provided more opportunities to use the 
qualitative study to explore the underlying factors accounting for the 
quantitative findings, 
  Restricted randomisation using matching or stratification on a larger 
number of factors affecting the outcomes of interest would limit the 
confounders, increase precision and improve the statistical power (Atienza 
and King 2002), 
 Direct observation of patient-provider interactions, as well as patient 
experiences at the hospitals would have provided more insight into the 
influences on integration and also to improve quality and reliability of data. 
9.5.2 SAMPLING 
 A larger number of sites as well as larger number of participants per site 
would reduce cluster effect as well as the within-group variances in the 
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output and outcome measures of interest (Atienza and King 2002; 
Grimshaw et al. 2000). 
9.5.3 DATA COLLECTION 
 The patient interviews could have been used to explore patient experiences 
of the continuity of care to enhance the understanding of the processes of 
integrated care, and therefore how to improve them.  
9.5.4 METHODS OF ANALYSIS  
 Analysis of co-variances and other multi-level analyses can be used to 
account for the heterogeneity in individual participants, and between the 
sites (Atienza and King 2002; Cook and Campbell 1979,). These analytical 
methods and models can also be used to account for the effect of history 
and statistical regression, 
 Joint analyses can also be done by pooling data from multiple studies with 
similar measures. In which case the different studies should have common 
or comparable measures, and then the specific sources of variation 
associated with each study has to be considered as well (Atienza and King 
2002). 
Based on the design and methods the findings of these studies have been 
appropriately described as recommendations but not categorically proven 
statements. 
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10 CONCLUSIONS  
This was a study to pilot methods of evaluation of TB/HIV integration and to 
explore the factors influencing the delivery of the intervention. It was made up of a 
quantitative study to explore the effect of TB/HIV integration on TB treatment 
outcomes and the impact of increasing degrees of integration on outputs and 
outcomes. The second component was a qualitative one to explore barriers and 
facilitators of integration.  
The study observed that integration has the potential to improve TB and 
HIV treatment outcomes but its effect is currently undermined by health system 
barriers. These barriers seem to overshadow the impact of the degree of 
integration on the outputs and outcomes of integration. TB treatment success 
improved after integration and at all sites too but this increase was not related to 
the degree of integration. Although HIV screening among TB patients improved 
with increasing integration, CPT and ART did not. Therefore the study was unable 
to provide evidence to support the view that increasing degrees of integration 
resulted in increasingly better TB/HIV outputs and outcomes. Consequently an 
optimal delivery model could not be identified.  
Although many facilitators were identified, the study also identified some 
barriers to integration: these include inadequate patient involvement in their care, 
unwillingness of providers to collaborate with others, patient beliefs about illness, 
and patient socio-economic status.  
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Following these findings recommendations have been made to improve integration 
by making care more patient-centred, improving continuity and enhancing 
coordination in four main areas namely, TB/HIV policy, human resource for TB/HIV, 
monitoring and evaluation, and service delivery both locally and internationally. 
Areas for further research to expand knowledge and improve TB/HIV practice have 
also been recommended to include the use of multi-method approaches of 
evaluation, feasibility and safety of IPT in individual nations in SSA to improve 
uptake, and paradigmatic changes to make care more patient-centred.   
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APPENDICES 
Appendix I: Literature Search Strategy 
Database:  Web of Knowledge 
Limits:   All years 
English language 
Lemmatization on 
Search terms: Tuberculosis and HIV and Integration and Africa - 42 
Tuberculosis and AIDS and Integration and Africa - 32 
Tuberculosis and HIV and Collaboration and Africa - 46 
Tuberculosis and AIDS and Collaboration and Africa - 36 
Tuberculosis and HIV and Management and Africa - 333 
Tuberculosis and AIDS and Management and Africa - 184 
Tuberculosis and HIV and Partnership and Africa - 50 
Tuberculosis and AIDS and Partnership and Africa - 34 
 
Database:  Science Direct 
Limits:   English language 
Journals 
2004 to date 
Search terms: Tuberculosis and HIV and Integration in Africa - 583 
Tuberculosis and AIDS and Integration in Africa - 593 
Tuberculosis and HIV and Collaboration in Africa - 909 
Tuberculosis and AIDS and Collaboration in Africa - 836 
Tuberculosis and HIV and Management in Africa - 2363 
Tuberculosis and AIDS and Management in Africa - 1969 
Tuberculosis and HIV and Partnership in Africa - 879 
Tuberculosis and AIDS and Partnership in Africa - 854 
 
Resource:  Medline OVIDSP 
Databases:  Embase 
Global Health 
Health Management Information Consortium 
Ovid Medline (R) (1996 to September 2011) 
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Ovid Medline (R) In-process and other non-indexed citations – 
October 16 2011 
Leeds University Library’s Journals @ Ovid (full text) 
Search terms: 1. Tuberculosis in Africa - 105 
2. TB in Africa - 41 
3. HIV in Africa – 408 
4. AIDS in Africa - 848 
5. TB and HIV integration in Africa - 0 
6. TB and HIV collaboration in Africa – 0 
7. TB and HIV management – 16 
8. 1 or 2 – 142 
9.  3 or 4 – 1228 
10.  8 and 9 – 4 
 
Additional Search terms 
11. Tuberculosis and HIV integration – 13 
12. Tuberculosis and HIV collaboration – 23 
13. Tuberculosis and HIV partnership – 3  
14. TB-HIV in Africa – 0 
15. TB-HIV – 988 
 
Limits:   English Language 
Human 
2004 to current  
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APPENDIX II: Provider (Manager) Interview guide 
Date:       
Position: 
Time (start):      (end):  
1. How far would you say have the objectives of the national TB/HIV 
programme been achieved? 
2. How have the NTP and NACP cooperated at the various levels to implement 
the TB/HIV policy? 
3. Global Fund has been the major financier of the policy? How sustainable is 
the source of funding? 
4. In the national policy 3 levels or types of integration are described. How 
does this redefine the process of care at the point of delivery? 
a. How have the known processes and procedures for managing TB (or HIV) 
changed?  
b. How do you intend to approach the resolution of these challenges? 
5. The staffs at the point of delivery complain of heavy workloads. What is 
being done? 
6. Is there going to be a facility HIV register? Why not or when? 
7. The screening of HIV patients for TB, what is it supposed to refer to: the use 
of the questionnaire or doing sputum AFBs? 
8. Most of the patients complain of the inability to go back to their jobs due to 
the loss of strength. Are there any plans in the future for occupational 
rehabilitation? 
9. The ARVs are subsidised to increase access. How sustainable is this subsidy? 
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a. Are there any intentions to make it entirely free? 
b. What are the factors that determine when ART should start in a TB 
patient who qualifies for it? 
c. For newly diagnosed TB patients on TB treatment, if they are found to 
be HIV positive and qualify for ART, when should treatment start? 
10. How accessible is the National TB/HIV guidelines? 
11. How has the retraining of staff been achieved? 
12. In your opinion, how have you done as a programme? 
a. What have been the main challenges to the effective implementation? 
b. What have been the major achievements of the TB/HIV policy? 
13. What would you say is the way forward for TB/HIV integration in Ghana? 
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APPENDIX III: Provider Interview Guide 
Date:     ID: 
Location    Start:   End: 
 
1. Tell me about the TB/HIV team in this hospital? 
a. Who are the members? 
b. How does the team work? 
c. How do team members relate to each other? 
 
2. How did you become a member of the TB/HIV team? 
a. How would you describe your work as a member of the TB/HIV team? 
 
3. How are the TB and HIV clinics organized? 
a. What days and times do they operate? 
b. Where do the patients come from? 
 
4. How do you get equipments, medicines and other logistics the team needs? 
a. Are he following always available: HIV test kits, laboratory reagents, specimen 
containers, relevant stationery? 
b. Have you run out of any of these in the past year? 
c. How long did it take to resolve? 
 
5. Do TB/HIV patients pay for their care? 
a. What do they pay for? 
b. Is there any support or subsidy available? 
c. If yes, where is it from and how is it used? 
d. Any NGOs involved in TB/HIV care or support? 
 
6. How are new patients managed? 
a. What happens when a new patient comes to the DOTS centre? 
b. What about a new patient at the HIV clinic? 
c. What happens to a new TB/HIV case? 
d. What about old (already known) cases? 
 
7. How do you decide what treatment a new TB/HIV patient gets? 
a. Is there any protocol or guidelines you use to manage TB/HIV cases? 
b. If yes, where is it from? Who develops it? 
c. Do you own a copy? 
d. Is there a copy in the room where patients are seen? 
e. How do you use them? When? How often? 
f. Are you aware of any national TB/HIV guidelines/protocol? 
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8. How are TB/HIV patients involved in the decisions about their care? 
a. Do you ask them what they want? 
b. Are they educated on all treatment and procedures they undergo? 
 
9. What do you think TB/HIV patients want when they come to hospital? 
a. How do you work to meet these expectations? 
b. How do you know whether or not you have met these expectations? 
 
10. How would you describe the attitudes of TB/HIV patients towards you? 
a. How do their attitudes affect the way you do your work? 
b. Are you able to treat all patients the same? 
c. If yes, how are you able to do that? 
d. If no, why do you think it is so? 
 
11. Apart from the type of disease, what else do you consider as important in 
managing TB/HIV patients? 
a. Tell me about patient privacy. 
b. What about patient confidentiality? 
c. How do you provide these for your patients during consultation, counseling 
and other treatment? 
 
12. In general, how do you feel about your work and the care you provide for TB and 
HIV patients? 
a. What makes your work difficult? 
b. What makes it easier? 
c. What more do you think can be done? 
 
13. What else would you like to say or add to what we have said so far? 
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APPENDIX IV: Patient Interview Guide 
Date:     ID: 
Location    Start:   End: 
 
1. Please tell me about yourself 
a. What do you do? 
b. What was your life like before you fell ill? 
 
2. Tell me about this illness? 
a. How did this illness come about? 
b.  How has it affected your family? 
c. How has your life changed since you fell ill? 
 
3. Why did you come to this hospital for your treatment 
a. When do you come to clinic?  
b. How often do you come? 
c. How do you get here from your house? 
d. Who comes with you? 
 
4. What happened the first time you came here with this illness? 
a. How did they find out that you had 2 diseases? 
b. What was done for you the first time? 
c. What treatment were you given? 
 
5. What happens when you come to hospital now?  
a. What treatment do you get now when you come for review? 
b. What do you pay for when you come here? 
c. How long do you stay here during visits? 
d. How do you get your medicines, and your tests done? 
 
6. What did you want to be done for you when you first came here with these 
diseases? 
a. How would you describe the treatment you receive here? 
b. Is it what you expected? 
c. Do you get all the treatment you need here? 
d. If yes, in what way? 
e. If no, what more do you need? 
 
7. Do you think the best of care is given here? 
a. Why or why not? 
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8. What are the staff’s attitudes towards you?? 
a. How do the hospital staffs treat you when you come here? 
b. Are all patients treated the same?  
c. If no, why the difference? 
 
9. How are you involved in deciding what treatment you get? 
a. Are you asked for your opinion or consent for any care given? 
 
10. Do you feel comfortable in this environment? 
a. Are you able to tell the staff all your problems  
b. Are you able to ask any questions about anything you do not understand? 
c. What is it in this place that makes you comfortable enough to tell or ask them 
all you want to? 
 
11. What can you say about the treatment given so far? 
a. How has the treatment affected the illness so far? 
b. What do you like about the care received? 
c. What do you not like? 
d. What are the problems you face when you come here? 
e. What more do you think can be done to improve the care for you? 
 
12. Is there anything you would like to say or add to what we have already said? 
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APPENDIX V: Patient Consent Form 
Researcher Address:   
Gloria A. Ansa 
University Hospital, Legon 
P.O.Box LG 79 
Legon, Accra     Contact: 021 513 890, 0267 893 219 
 
Part I: Information Sheet 
Tuberculosis (TB) and HIV affect a lot of people in Ghana, and they harm not only the sick, 
but their families and communities as well. It is therefore very important that these 
patients are identified and treated early to restore health and to prevent spread to other 
people. Health workers are therefore working together (i.e. integration) in some districts 
to improve the care of TB/HIV patients, and there are plans to spread to all parts of the 
country. The purpose of this study is to improve integration and hence the care of TB/HIV 
patients. Information will be collected from district hospital TB and HIV clinic records 
between January and July 2010 to find out if the care for patients follows national 
guidelines, and if outcome of patient care has improved. The study will also find out the 
problems of integration and what can be done to solve these by interviewing a few 
patients and health workers. The results of this study will be used to improve care in this 
and other hospitals where TB/HIV care is given through the National AIDS/STI and TB 
Control Programs. The information from the study will be reported as part of my studies, 
and parts published to educate other people on TB and HIV integration. This hospital will 
also receive a report about all the findings. 
 
Taking part in this study means spending about an hour to answer some questions about 
the kind of TB/HIV care provided in this hospital. If you allow it, the interview will be 
recorded. It is not compulsory to take part in this study because whether you take part or 
not will not affect the kind of care you receive. If you decide to take part, nobody apart 
from me will know what you or any other participant says. No names will be put on 
reports, and the record of this interview will be kept safe in a locked drawer for up to 2 
years after the study and then destroyed. You are therefore encouraged to be honest 
about your opinions. You can also withdraw from the study at any point, and that will not 
be held against you either. 
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Part II: Certificate of Consent 
 I have read the above information (or had it translated to me) 
 I have had the opportunity to ask questions about it 
 All my questions have been answered to my satisfaction 
 I understand that I have a right not to take part or to withdraw from the discussion 
at any time. 
 I consent voluntarily to be a part of this study  
Name of Participant ________________________________                
Signature of Participant _____________________________ 
Date (DD/MM/YYYY) _______________________________ 
 
 I have witnessed the accurate reading (translation) of the consent form to the 
potential participant 
 The individual has had the opportunity to ask questions.  
 I confirm that the individual has given consent freely. 
Name of Researcher ____________________________________ 
Signature of Researcher ________________________________ 
Date (DD/MM/YYYY) ___________________________________ 
 
A copy of this Informed Consent Form has been given to the participant:  
 
Local Contact: 
Peace Barnor 
University Hospital, Legon 
P.O.Box LG 79 
Legon, Accra    Contact: 0302 513 890, 0244 560 016 
 
 
 
THUMBPRINT 
Yes No 
